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Abstract 
Transcriptional States and microRNA Regulation of Adult Neural Stem Cells 
 
Annina Maria Fiorella di Primavera DeLeo 
 
Adult neural stem cells are specialized astrocytes that generate neurons in restricted 
regions of the mammalian brain. The largest neurogenic region is the ventricular-subventricular 
zone, which lines the lateral ventricles and generates olfactory bulb neurons. Stem cell astrocytes 
give rise to new neurons in both homeostatic and regenerative conditions, suggesting that they 
can potentially be harnessed for regenerating the brain after injury, stroke, or neurodegenerative 
disease. Previous work has shown that stem cell astrocytes exist in both quiescent and activated 
states, but due to a lack of markers, it was not feasible to purify them. Using a novel fluorescence 
activated cell sorting (FACS) strategy that allows quiescent neural stem cells (qNSCs) and 
activated neural stem cells (aNSCs) to be purified for the first time, we performed transcriptome 
profiling to illuminate the molecular pathways active in each population. This analysis revealed 
that qNSCs are enriched in signaling pathways, especially G-protein coupled receptors, as well 
as for adhesion molecules, which facilitate interactions with the niche. qNSCs and aNSCs utilize 
different metabolic pathways. qNSCs are enriched for lipid and glycolytic metabolism, while 
aNSCs are enriched for DNA, RNA, and protein metabolism. Many receptors and ligands are 
reciprocally distributed between qNSCs and aNSCs, suggesting that they may regulate each 
other. Finally, comparison of the transcriptomes of qNSCs and aNSCs with their counterparts in 
other organs revealed that pathways underlying stem cell quiescence are shared across diverse 
tissues.  
A key step in recruiting adult neural stem cells for brain repair is to define the molecular 
pathways regulating their switch from a quiescent to an activated state. MicroRNAs are small 
non-coding RNAs that simultaneously target hundreds of mRNAs for degradation and 
translational repression. MicroRNAs have been implicated in stem cell self-renewal and 
differentiation. However, their role in adult neural stem cell activation is unknown. We 
performed miRNA profiling of FACS-purified quiescent and activated adult neural stem cells to 
define their miRNA signatures.  
Bioinformatic analysis identified the miR-17~92 cluster as highly upregulated in 
activated (actively dividing) stem cells in comparison to their quiescent counterparts. Conditional 
deletion of the miR-17~92 cluster in FACS purified neural stem cells in vitro reduced adult 
neural stem cell activation, proliferation, and self-renewal. In addition, miR-17~92 deletion led 
to a selective decrease in neuronal differentiation. Using an in vivo conditional deletion model, 
we showed that loss of miR-17~92 led to an increase in the proportion of GFAP+ cells and 
decrease in MCM2+ cells, as well as decreased neurogenesis. Finally, I identify Sphingosine 1 
phosphate receptor 1 (S1pr1) as a computationally predicted target of the miR-17~92 cluster. 
S1pr1 is highly enriched in quiescent neural stem cells. Treatment of quiescent neural stem cells 
with S1P, the ligand for S1PR1, reduced their activation and proliferation. In vivo deletion of 
miR-17~92 lead to an increase in S1PR1+ cells, even among MCM2+ cells. Together, these data 
reveal that the miR-17~92 cluster is a key regulator of adult neural stem cell activation from the 
quiescent state and subsequent proliferation. 
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Chapter 1 Introduction 
Stem Cells 
Stem cells are defined by two cardinal properties; the ability to self-renew, that is to give 
rise to another cell that is identical to itself, and the ability to differentiate into diverse cell types. 
Stem cells broadly fall into two categories; embryonic stem cells, which are pluripotent and give 
rise to all organs and tissues, and adult stem cells, which are multi or even unipotent, and 
responsible for the maintenance of organs and tissues over the lifetime of an organism. These 
adult stem cells are thought to be active during organ homeostasis, but can also act as a reservoir 
for replenishing cells during a crisis in the organ, such as injury.  
The location of adult stem cells within a given tissue is thought to play an important role 
in the regulation of their behavior. These specialized stem cell locations are known as “niches” 
and often contain other types of specialized support cells and secreted factors, which may signal 
the cells to remain quiescent, to divide, or to leave the niche (reviewed in Li & Clevers, 2010).  
A Brief History of Adult Neurogenesis 
In 1897, Schaper proposed that a reserve of “indifferent cells” would exist postnatally 
and, “play an important role in in regenerative processes within the central nervous system” 
(Schaper, 1897). Indeed, dividing cells within what would later be identified as the ventricular-
subventricular zone (V-SVZ), adjacent to the lateral ventricles, were first discovered by Ezra 
Allen in adult albino rats in 1912 (Allen, 1912). These studies were confirmed by other 
researchers, some of whom proposed that immature cells might divide and become neurons 
(reviewed and further confirmed in Globus & Kuhlenbeck, 1944). Despite these studies, it was 
long believed that the adult brain was a static entity incapable of new neuron formation because 
no signs of mitosis were convincingly shown in neurons. This led the eminent neuroscientist 
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Santiago Ramon y Cajal to declare that, “nervous restoration is a purely expansional act, in 
which the cell body never participates” and that, “Everything may die, nothing may be 
regenerated” (Cajal & May, 1991; Kershman, 1938). Although we now know that neurons 
themselves do not divide, the formation of new neurons via adult neurogenesis would not be 
shown definitively until Joseph Altman’s seminal studies with audioradiographic [H]3-thymidine 
in 1962, 1963, and 1965. These studies showed that neurons in the adult had incorporated 
radiolabeled thymidine, indicating that they had arisen from progenitors dividing at the time of 
thymidine treatment (Altman, 1962a; Altman, 1962b; Altman, 1963; Altman & Chorover, 1963; 
Altman & Das, 1965). Since then, dividing cells capable of neurogenesis have been found in the 
adult brain of many species, including cats, dogs, songbirds, monkeys, and humans (reviewed in 
Altman, 1969 and Sanai et al., 2011). In 1965 and 1966, it was determined that these immature 
thymidine incorporating cells were capable of forming new neurons that integrated into the 
hippocampus (Altman & Das, 1965), as well as the olfactory bulb (OB), cerebellum, and 
cochlear nucleus (Altman & Das, 1966). The exact identity of the progenitor cells for these 
regions in mammals was unknown until 1999, when the V-SVZ cells capable of giving rise to 
immature neuronal precursors were found to be glial fibrillary acidic protein (GFAP+) positive 
stem cell astrocytes (Doetsch et al., 1999a), and were confirmed to give rise to OB neurons 
(Doetsch, et al., 1999b). Soon after these discoveries, GFAP+ cells were shown to be the stem 
cells for the subgranular zone (SGZ) of the hippocampus (Seri et al., 2001). 
Adult Neural Stem Cells and Their Progeny 
We now know that in mammals, adult neural stem cells (NSCs) exhibit features of 
astrocytes and exist in two major reservoirs; the V-SVZ and the subgranular zone (SGZ) in the 
hippocampal formation. In both areas, the stem cells have radial morphology and are in fact 
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derived from embryonic radial glial progenitors (reviewed in Kriegstein & Alvarez-Buylla, 
2009). This resemblance has earned them the moniker “stem-cell astrocytes” and indeed they 
express GFAP and the Glutamate Aspartate Transporter (GLAST, also called Slc1a3 or EAAT1) 
much as radial glia and astrocytes do (Doetsch et al., 1997, radial glial and astrocyte marker 
expression reviewed in Kriegstein & Alvarez-Buylla, 2009). In both regions, adult neural stem 
cells contact blood vessels and go on to form mature neurons that migrate away from their niche. 
While the progeny of stem cells from the V-SVZ travel several millimeters to their maturation 
site in the OB, in the SGZ, the progeny migrate only a few cell layers to the adjacent granule cell 
layer of the dentate gyrus (Lois & Alvarez-Buylla, 1994, reviewed in Montalbán-Loro, 2015).  
The stem cells within the V-SVZ reside within the first few cell layers adjacent to the 
lateral ventricles. The layer immediately adjacent to the ventricle consists mostly of ependymal 
cells, which are large, cuboidal, and multi-ciliated. Ependymal cells use their cilia to maintain 
the flow of cerebrospinal fluid (CSF) throughout the ventricular system (Yamadori & Nara, 
1979). V-SVZ stem cells contact the CSF at the center of ependymal cell pinwheels (Mirzadeh et 
al., 2008).  
GFAP-positive stem cells are largely quiescent. Once activated, they upregulate 
epidermal growth factor receptor (EGFR) (Doetsch et al., 2002; Pastrana et al, 2009), and divide 
to form transit amplifying cells. Stem cells can divide symmetrically or asymmetrically 
depending on context. Although V-SVZ neural stem cells undergo asymmetric division in vitro, 
their precise mode of division in vivo is still unknown (Costa et al., 2011; Doetsch et al., 1999b; 
Figure 1.1).  
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Transit amplifying cells (TACs) make up the bulk of proliferating cells in the V-SVZ 
(Doetsch et al., 1997; Ponti et al., 2013). Their divisions are mostly symmetrical, thereby 
expanding the pool of progenitors (Costa et al., 2011; Doetsch et al., 1997). Unlike their 
quiescent and activated stem cell forbearers, TACs have lost expression of GFAP, but retain that 
of EGFR. Additionally, they express the transcription factors Ascl1 and Dlx2 (Parras et al., 2004; 
Kim et al., 2011; Doetsch et al., 2002; Figure 1.1). 
Neuroblasts arise after TACs have undergone several rounds of divisions. Interestingly, 
Costa et al. found that transit amplifying cells increase their cell cycle length as they become 
neuroblasts, as compared to the divisions that give rise to more transit amplifying cells. 
Neuroblasts can be further characterized by their migratory behavior and expression of 
Doublecortin (DCX) (Gleeson et al., 1999; Nacher et al., 2001; Garcia et al., 2004), CD24 
(Calaora et al., 1996) and TuJ1 (also called Beta-III tubulin, Doetsch et al., 1997), as well as 
continued expression of Dlx2 (Doetsch et al., 2002). In vivo, neuroblasts form chains in the V-
SVZ and migrate towards the OB along a specific pathway called the rostral migratory stream 










Figure 1.1 The adult V-SVZ stem cell lineage and markers.  
(Top) Sagittal view of the adult murine brain. The V-SVZ lies adjacent to the lateral ventricles (LV, blue). (Middle 
and Bottom) Markers of V-SVZ cells and their progeny. Within the V-SVZ stem cells are GFAP+ and GLAST+ 
astrocytes. Activated adult neural stem cells express GFAP, GLAST, and EGFR (light blue bar). aNSCs also express 
Ascl1 (green). Transit amplifying cells express EGFR, Ascl1, and Dlx2 (yellow). Transit amplifying cells give rise 
to neuroblasts, which are CD24 (orange bar), DCX (tangerine bar), and TuJ1 (red bar) positive. Neuroblasts leave 
the V-SVZ and traverse the rostral migratory stream (RMS) into the olfactory bulb (OB). Mature OB neurons 
express TuJ1 and NeuN. Some aNSCs and TACs are capable of forming MBP+ (lilac bar) oligodendrocytes.  
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In the OB, newly generated neurons, which are TuJ1 positive (Parras et al., 2004), exit 
the RMS and turn radially to migrate to different layers. For these cells, navigating from the 
inner to the outer cortex of the OB can take at least 6 days (Altman, 1969; Lois & Alvarez-
Buylla, 1994). Within the OB, newly generated neurons generally become granule cells, which 
reside in the granule cell layer. A small number of the newly generated neurons become 
periglomerular cells, which reside in the glomerular layer. Mature, NeuN positive (Neuronal 
Nuclei, or Rbfox3, Mullen et al., 1992) olfactory bulb interneurons are largely GABAergic and 
inhibitory, outnumbering the primary mitral and tufted neurons of the OB by 50 or 100 to 1 
(reviewed in Sakamoto et al., 2014a). Periglomerular cells can be further differentiated by their 
expression of tyrosine hydroxylase (TH), Calbindin (CalB), or Calretinin (CalR) (Reviewed in 
Merkle et al., 2014; Sakamoto et al., 2014a). Some granule cells express Calretinin as well. Due 
to a lack of markers that can distinguish between the different OB interneuron subtypes, granule 
cells are usually sub-categorized by what layer their cell body resides in (i.e. the superficial, 
intermediate or deep layer) (reviewed in Merkle et al., 2014). Recently, additional adult-derived 
OB neuronal subtypes in the external plexiform layer, mitral layer, and internal plexiform layer 
have been identified (Merkle et al., 2014). More and more studies are unveiling the connection 
between stem cell location within the V-SVZ, expression of certain transcription factors, and 
mature olfactory bulb interneuron subtype and location (reviewed in Lim & Alvarez-Buylla, 
2014).  
Strikingly, only 50% of the neurons that reach the olfactory bulb will be integrated into 
existing circuits, and less than 10% of neurons formed in rats during young adulthood survive for 
more than 21 months (Imayoshi et al., 2008; Kaplan et al., 1985). In conjunction with the 
expression of apoptotic markers in the OB and the static volume of this structure, this low 
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survival rate is thought to indicate turnover of OB neurons (Petreanu & Alvarez-Buylla, 2002; 
Sakamoto et al., 2014a). The normal function of these newly formed interneurons is to modulate 
the activity of mitral and tufted cells, thereby optimizing olfactory information processing by 
reducing overlapping odor signals to the brain (Gheusi et al., 2000; reviewed in  Sakamoto et al., 
2014a). The continual replacement of OB neurons is also important for modification of odor-
related memory as well as the value assigned to it, as ablation of adult neurogenesis impairs the 
ability to discriminate between new odors in rodents (Sakamoto et al., 2014a). 
Adult V-SVZ stem cells do not only give rise to neurons. In fact, some adult neural stem 
cells and a small subset of TACs express the transcription factor Olig2 and go on to form 
immature oligodendrocytes that are O4-antigen positive (Reynolds & Hardy, 1997; Marshall et 
al., 2005; Menn et al., 2006), followed by myelin basic protein (MBP) expressing mature 
oligodendrocytes (Nait-Oumesmar et al., 1999; Figure 1.1) 
V-SVZ GFAP+ stem cells are also present in adult humans, where they are largely 
quiescent (Sanai et al., 2004; Sanai et al., 2011; Van Den Berge et al., 2010). Unlike in rodents, 
olfactory bulb neurogenesis in humans ends in infancy, and there is very little turnover of 
neurons over the lifetime of an individual (Sanai et al., 2011; W. Wang et al., 2011; Bergmann et 
al., 2012). Recent evidence using carbon dating suggests that new neurons may be added to the 
striatum, and that the formation of striatal interneurons is reduced in Huntington’s disease (Sanai 
et al., 2011; Ernst et al., 2014; reviewed in Sakamoto et al., 2014b).  
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Quiescence and Activation are Important for Stem Cell Function 
It is becoming increasingly apparent that quiescent (non-dividing) and activated (actively 
dividing) stem cells coexist in many adult stem cell niches (Li & Clevers, 2010). Stem cell 
quiescence and activation play an essential role in many organs, underlying tissue maintenance, 
regeneration, function, plasticity, aging, and disease. For example, in homeostatic conditions, a 
small amount of the cells that make up a tissue or organ may be dying and replaced at a steady 
rate. Under these conditions, most stem cells will be in a quiescent state, while a few are 
activated in order to replace the cells that have died. In the case of injury, the balance may switch 
such that the majority of stem cells are in an activated state to compensate for the large number 
of cells lost in an injury.  
It is currently unknown if the same pool of stem cells is responsible for both tissue 
homeostasis and regeneration, or if there are separate pools of stem cells for each process. 
Importantly, maintaining the balance between quiescence and activation is essential to sustaining 
homeostasis. Without such balancing mechanisms, an excess of cells might remain in a quiescent 
or activated state, preventing homeostasis and appropriate injury response. Furthermore, an 
excess of divisions increases the chance of mutation occurring. Increased chance of mutagenesis, 
in combination with excess proliferating cells, could lead to cancer.  
Quiescent stem cells dynamically integrate extrinsic and intrinsic signals to either 
actively maintain their dormant state or become proliferative and give rise to differentiated 
progeny (Cheung & Rando, 2013). The signals maintaining and potentially regulating transitions 
between quiescent and active stem cell states are only beginning to be understood. Recent 
findings suggest that quiescent and activated states are differentially regulated at multiple levels 
including adhesion, transcriptional regulators, diffusible signals, and cell-cell contact. In the 
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adult V-SVZ, interaction with extracellular matrix proteins such as β1 integrin, Ncam1, or 
Vcam1 prevents adult neural stem cells from dividing and migrating (Kazanis et al., 2010; Porlan 
et al., 2014; Kokovay et al., 2012). Cell-cell signaling involving Notch1 promotes activation 
(Basak et al., 2012). Diffusible signals such as neurotransmitters or epidermal growth factor 
(EGF) also promote proliferation (Young et al., 2011; Alfonso et al., 2012; Doetsch et al., 2002). 
More recently, diffusible signals have also been show to play a role in quiescence, as in the case 
of endothelial-derived NT-3 (Delgado et al., 2014).  
Quiescent and activated neural stem cells are also likely to have distinct transcriptional 
programs through differentia expression of transcription factors. For example, p21 has been 
shown to prevent NSC division by upregulating the transcription factor Sox2 (Marqués-Torrejón 
et al., 2013) and suppressing Bmp2 (Porlan et al., 2013). Interestingly, other components of the 
Notch signaling pathway have also been implicated in maintaining quiescence; notch effector 
Hes5 expression is linked to quiescent cells, while Dll1, a Notch ligand, is expressed in activated 
NSCs, and signals neighboring cells to be quiescent through Notch receptors expressed there 
(Giachino et al., 2014; Kawaguchi et al., 2013).  
Understanding how stem cell astrocytes become activated is important to eventually 
harnessing the regenerative power of stem cells for treating brain injury and neurodegenerative 
diseases. Conversely, stem cells are thought to be the source of some brain tumors (reviewed in 
Reya et al., 2001; Sanai et al., 2005; Nicolis, 2007) and understanding what maintains their 
quiescence will be important to combating cancer. Thus, a key step in recruiting adult neural 
stem cells for brain repair or treating cancers is to define the molecular pathways regulating their 
switch from a quiescent to an activated state.  
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Approaches for Studying Stem Cells 
In order to explore the biology of adult stem cells, it is key to be able to identify them in 
vivo, to be able to trace the progeny they give rise to, and to be able to isolate them prospectively 
from their niche to study their properties. Below, I briefly outline approaches I have used in my 
thesis.  
Sphere Forming Assays 
Neurospheres have been widely used as a retrospective assay to identify neural stem 
cells, as they allow one to test if a cell can self-renew and is multipotent. In the neurosphere 
assay, cells are plated at clonal density in non-adherent conditions in the presence of growth 
factors. If the cells are actively dividing, they give rise to spheres. The efficiency of sphere 
formation can be used to assess activation, while size of spheres can give a rough idea of 
proliferative ability. Passaging of spheres to form secondary spheres can be used to assess self-
renewal capacity. Subsequent plating of these cells on adherent substrates without mitogens can 
give an idea of the cells’ ability to differentiate into mature cell types. However, several recent 
studies have shown that in addition to stem cells, other proliferative populations can give rise to 
neurospheres (reviewed in Pastrana et al., 2011).  Therefore, the neurosphere assay cannot be 
used as a measure of in vivo stem cell identity. 
Fluorescence-Activated Cell Sorting 
Fluorescence-activated cell sorting (FACS) is a specialized type of flow cytometry that 
allows sub-populations of live cells to be purified based on their expression of markers that have 
been tagged with fluorescent molecules (Herzenberg et al., 2002). This method was originally 
used to sort lymphocytes (Julius et al., 1972), and has since been widely applied to understanding 
the subpopulations of cells within other tissues and tumors, as well as to assess cell cycle or 
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survival status. This method has been especially useful for prospectively isolating stem cells, in 
both quiescent and activated states, from other tissues.  
More recently, FACS approaches have been applied to the brain to isolate stem cells from 
their in vivo niches using cell surface markers or transgenic reporter mice (Morrison et al., 1999; 
Uchida et al., 2000; Capela & Temple, 2002; Lim et al., 2006; Doetsch et al., 2002; Barraud et 
al., 2005; Kawaguchi et al., 2001; Ciccolini et al., 2005). However, most of these methods fail to 
uniquely isolate stem cells, as the markers used are too widely expressed.  
A major limitation in the adult neural stem cell field has been the lack of markers that 
allow mature astrocytes to be distinguished from stem cell astrocytes. GFAP::GFP mice, in 
which green fluorescent protein (GFP) is expressed under the GFAP promoter, are a powerful 
tool that allow the isolation of GFAP-expressing cells. By combining different surface markers 
and FACS with GFAP::GFP mice, it is now possible to prospectively isolate V-SVZ stem cells. 
A combination of EGF ligand and CD24 allows the simultaneously isolation of activated NSCs 
and their progeny (Pastrana et al., 2009). Another marker that has been used is CD133 
(Prominin). In the adult, CD133 is highly expressed by ependymal cells (Coskun et al., 2008), as 
well as by a subset of V-SVZ astrocytes (Mirzadeh et al., 2008; Beckervordersandforth et al., 
2010). Transcriptome analysis of FACS purified CD133+GFAP::GFP+ cells,  as compared to 
ependymal cells and other brain astrocytes, was proposed to define a neural stem cell signature 
(Beckervordersandforth et al., 2010). However, this strategy did not differentiate between 
quiescent and activated neural stem cell populations.  
Lineage Tracing 
Lineage tracing is generally defined as marking a single cell or population such that, “the 
mark is transmitted to the [labeled] cell’s progeny, resulting in a set of labeled clones” 
 
 12 
(Kretzschmar & Watt, 2012). To identify stem cell populations in vivo, lineage tracing 
approaches often use conditional expression of the Cre recombinase protein under a promoter of 
interest that causes deletion of a floxed stop cassette and subsequent expression of a reporter 
gene, such as GFP, Tomato, or Lac-Z, thereby permanently marking the cell and its progeny. 
This approach allows the fate of the marked cells to be followed and to determine whether they 
self-renew or differentiate, the two cardinal properties of stem cells. This approach can also be 
used to delete genes of interest to define their functional roles.  
microRNAs: Biogenesis and Mode of Action 
MicroRNAs (miRNAs or miRs) are a subset of non-coding RNAs (ncRNAs) that are 
emerging as key post-transcriptional regulators. miRs are conserved in animals, plants, single-
celled eukaryotes, and have even been observed in viruses (reviewed in Stroynowska-
Czerwinska et al., 2014). miRs are endogenously transcribed in the nucleus and are located in 
both intronic and intergenic regions. Transcripts may contain one or many miRs, the latter of 
which is called a “microRNA cluster”. Each miR generally has a hairpin or stem-loop secondary 
structure within a larger transcript, which collectively is known as a “Pri-miR”. These hairpins 
are cleaved from the rest of the transcript by Drosha and DGCR8 (DiGeorge syndrome critical 
region 8) and, once freed, are called “Pre-miRs”. The Pre-miRs are transported into the 
cytoplasm by Exportin 5 where they are loaded into the protein Dicer in complex with TRBP 
(TAR RNA binding protein 2), where the loop is cleaved from the stem, resulting in a ~22 bp 
duplex. This duplex is then loaded onto Argonaut 2 (Ago2), to form the RNA-initiated silencing 
complex (RISC). In RISC, the RNA duplex is unwound and a single mature miR strand kept for 
guiding RISC to target mRNAs, while the passenger strand is degraded. An overview of the 




Figure 1.2 Overview of the primary pathway of miRNA biogenesis  
miRs are often transcribed from within the intronic regions of genes or from intergenic regions as hairpin structures 
called Pri-miRNA. Drosha and DGCR8 cleave the hairpin from the rest of the transcript to make a Pre-miRNA. The 
Pre-miRNA is loaded into Exportin 5 and transported to the cytoplasm. Here, the proteins Dicer and TRBP cleave 
the loop of the hairpin to leave an RNA duplex, which is loaded into AGO2. AGO2 then joins the  RIS-Complex, 
where the duplex is unwound, and only the mature miR is retained for later targeting of RISC to mRNAs. Adapted 
from Li and Rana 2014 and He and Hannon 2004. 
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miRNAs use nucleotide positions 2 through 6 or 8, also known as the “seed sequence”, to 
guide RISC to mRNA targets. In mammals, miRs largely act through imperfect base pairing 
between the seed sequence and the 3’ untranslated region (UTR) of an mRNA. This base-paring 
causes deadenylation of the polyA tail via recruitment of exonuclease, followed by decapping of 
the mRNA by mRNA-decapping enzyme 1 or 2 (DCP1/2) (Figure 1.3, reviewed in Brümmer & 
Hausser, 2014; Li & Rana, 2014). Imperfect binding of the seed sequence to the coding region of 
mRNAs causes translational inhibition without affecting measurable mRNA abundance, 
although the exact mechanism of this process is not well understood (Figure 1.3, reviewed in 
Brümmer & Hausser, 2014; Wilczynska & Bushell, 2014). In other organisms, perfect seed 
sequence to mRNA binding has been observed, and results in mRNA degradation via the 
catalytic action of Ago2. However, this form of miR-mediated regulation is thought to occur 
only rarely in animals (reviewed in Jonas & Izaurralde, 2015).  
 
Figure 1.3 Post-transcriptional regulation by miRNAs 
(Left) Imperfect binding of miRs within the 3’ UTR of an mRNA target (navy line) results in deadenylation of the 
poly-A tail, followed by decapping (red circle) by DCP1/2 and 5’ à 3’ digestion. (Right) miRNA binding within 
the coding region (green)  of a target mRNA results in translation inhibition, which does not result in mRNA 
degradation. Figure modified from Li and Rana, 2014 and He and Hannon, 2004. 
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As the microRNA seed sequence is short in length and, especially in mammals, often acts 
with imperfect base-pairing, miRs have the potential to regulate hundreds of mRNAs 
simultaneously (reviewed in Jonas & Izaurralde, 2015; Brümmer & Hausser, 2014; He & 
Hannon, 2004). Additionally, because miRs act to suppress translation from mRNAs, the 
functional output of their regulatory action is highly dependent on the mRNAs expressed in a 
given cell (reviewed in Ha, 2011).  
microRNA Function in Stem Cells 
microRNAs are gaining wide acceptance as essential regulators of normal stem cell and 
progenitor function in many tissues, although most of the work so far has focused on the 
microRNA regulation of the proliferation-differentiation axis (Gangaraju & Lin, 2009). For 
example, miR-363 maintains adipose stem cells (called adipose tissue-derived stromal cells) in a 
multipotent state, and must be downregulated in order for these cells to differentiate (Chen et al., 
2014). Likewise, in osteoblasts, miR-125b maintains a proliferative progenitor state and is 
downregulated upon differentiation (Mizuno et al., 2008), as is miR-155 in the hematopoietic 
system (Georgantas et al., 2007). miR-203 acts in the opposite manner in the skin, where its 
expression prohibits proliferation and promotes differentiation (Yi et al., 2008). miRs have 
recently been linked with stem cell quiescence; in muscle stem cells, global loss of miR function 
causes them to become activated. Furthermore, miR-489 expression was found to be sufficient to 
mediate the quiescent state of muscle stem cells (Cheung et al., 2013). 
microRNA Function in Neural Stem Cells, Their Progeny, and Brain Tumors 
microRNAs are essential for normal brain development; Ago2-deficient mice fail to have 
full neural tube closure, and exhibit forebrain mis-patterning (Liu et al., 2004). Selective loss of 
Dicer under various brain specific promoters causes mice to have smaller cortices and abnormal 
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neuronal maturation, and caused hippocampal stem cells to fail to proliferate and differentiate 
(Hébert et al., 2010; reviewed in Sun & Shi, 2015; Bian & Sun, 2011). Additionally, deletion of 
Dicer from postnatal astrocytes caused a rapid neurological decline, and death 4-5 weeks after 
deletion (Tao et al., 2011). Several miRs have been implicated in proliferation and differentiation 
of neural stem cells and progenitors. In terms of specific microRNAs, miR-184 keeps cells in an 
NSC/progenitor state where cells are actively cycling but do not differentiate (Liu et al., 2010). 
miR-137 is expressed in the V-SVZ, where it functions to reduce cell cycling and increase neural 
differentiation (Silber et al., 2008). let-7b, one of the first microRNAs discovered in C. elegans, 
also promotes cell cycle exit and differentiation in perinatal neural stem cells (Zhao et al., 2010). 
miR-9 acts in a similar manner to let-7b in these cells, perhaps because they both target the 
transcription factor Nr2e1 (Tlx) (Zhao et al., 2009; Zhao et al., 2010). miR-124 is the most 
abundant microRNA in the brain and is highly expressed in neurons (reviewed in Shi et al., 
2010, Cheng et al., 2009). miR-124 is also expressed by V-SVZ-generated neuroblasts and 
promotes the timing of lineage progression via repression of the transcription factor Sox9 (Cheng 
et al., 2009).  However, functions of miRs at the earliest stages of the V-SVZ lineage have not 
been described.  
miRs are also misexpressed in disease states, most notably and widely in cancers. 
Glioblastoma multiforme (GBM) has strong upregulation of miR-221, while miR-128 and miR-
7, both of which target EGFR, are often downregulated in these tumors (reviewed in Garg et al., 
2013; Mira et al., 2010). miR-363 expression is high in GBMs, and promotes tumor migration 
and survival (reviewed in Garg et al., 2013). miR-25 expression is also high in pediatric high-
grade gliomas and seems to have a similar function to miR-363 (reviewed in Garg et al., 2013). 
Interestingly, in the context of GBMs, miR-124 and miR-137 can act as tumor suppressors as 
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they are able to induce cell cycle arrest and differentiation, which explains their low expression 
in many of these malignancies (reviewed in Garg et al., 2013; Mira et al., 2010). miR-124 likely 
also exhibits low expression in medulloblastomas for the same reason (reviewed in Garg et al., 
2013). Recent studies have further implicated misexpression of miRs in neurological and 
neurodegenerative disorders, including Schizophrenia, Alzheimer’s disease, and Huntington’s 
Disease (reviewed in Bian et al., 2013). 
The miR-17~92 Cluster and The Brain 
The miR-17~92 cluster was first identified as an oncomiR, as it stimulates proliferation 
and cell survival in tumors (He et al., 2005) including secondary glioblastoma, pediatric high 
grade glioma, neuroblastomas, and medulloblastomas (Ernst et al., 2010; Malzkorn et al., 2010; 
reviewed in Garg et al., 2013). However, this cluster also plays an essential role in development. 
Homozygous deletion of the miR-17~92 cluster in the embryo results in death at P0 because the 
neonates have extensively underdeveloped hearts and lungs (Ventura et al., 2008). Notably, 
deletion of only one copy of the 17~92 cluster resulted in pups that were viable and fertile, but 




Interestingly, the miR-17~92 cluster has two paralogs, the miR-106a~363 cluster and the 
miR-106b~25 cluster (Figure 1.4). These clusters are thought to have arisen through a 
duplication event as the individual miRs within the clusters share sequence homology with those 
in the miR-17~92 cluster, and the overall ordering of the miRs within each cluster are strikingly 
similar. However, the additional clusters are not essential for normal development; homozygous 
deletion of either the miR-106a~363 or miR-106b~25 clusters resulted in normal pups (Ventura 
et al., 2008). Intriguingly, deletion of both miR-17~92 and miR-106b~25 increased the severity 
of defects as opposed to when miR-17~92 alone was deleted. This suggests that miR-106b~25 
may have redundant functions to miR-17~92 (Ventura et al., 2008). Recent work has shown the 
miR-106b~25 cluster to be important for proliferation, self-renewal, and neurogenesis of 
cultured neural progenitors from the forebrain of adult mice (Brett et al., 2011).  
Figure 1.4 The miR-17~92 cluster, its paralogs and seed sequence family members 
(A) The polycistronic miR-17~92 cluster shares overall ordering of miRs with its homologs, the miR-
106a~363 and miR-106b~25 clusters. (B) The individual miRs from these clusters can be grouped into 
family based on sequence homology, although the rest of their mature forms show homology as well.  
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Since the 2008 Ventura study, miR-17~92 has been shown to have diverse roles in many 
tissues where it promotes proliferation, cell survival, and angiogenesis, and inhibits 
differentiation, both during development and in cancers (Reviewed in Olive et al., 2010; 
Mogilyansky & Rigoutsos, 2013). The function of the miR-17~92 cluster in the central nervous 
system has begun to be uncovered as well. A minor product of the miR-17~92 cluster is needed 
for normal spinal cord motor neuron patterning (Chen et al., 2011), while the whole cluster 
promotes survival of limb-innervating motor neurons (Tung et al., 2015). miR-17 and 20a have 
been shown to downregulate pro-neuronal differentiation genes in the SH-SY5Y cell line 
(Beveridge et al., 2009). The miR-17~92 cluster is also important for maintaining NSC 
proliferation in the embryonic cortex (Bian et al., 2013; Mao et al., 2014). Furthermore, this 
cluster is important to maintaining embryonic neurogenesis and must be downregulated for 
gliogenesis to occur in engineered multipotent neural stem cells (Naka-Kaneda et al., 2014). 
Expression of miR-17~92 is elevated in neural progenitors following a model of stroke (Liu et 
al., 2013). In humans, the second ever miRNA-based disease was recently identified: a subset of 
patients with Feingold syndrome, in which patients present with microcephaly, short stature, 
digital abnormalities, and varying degrees of learning disabilities, have been found to harbor a 
hemizygous deletion of the miR-17~92 cluster (de Pontual et al., 2011), further highlighting the 
need to better understand the role of this cluster in normal development and disease.  
Sphingosine 1 Phosphate Receptor 1 Function  
Sphingosine 1 phosphate receptor 1 (S1pr1) is the first of five known receptors for the 
ligand sphingosine 1 phosphate (S1P), and is a computationally predicted target of the miR-
17~92 cluster. Of the five S1P receptors, S1pr1 is the only one for which homozygous deletion is 
embryonic lethal. In homozygously deleted mice, the lack of S1PR1 results in death between 
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e12.5-14.5, as, despite having formed a normal vascular network, there is a defect in the vascular 
barrier. Especially on major vessels, there is a lack of coverage by pericytes and vascular smooth 
muscle cells (reviewed in Blaho & Hla, 2014). In fact, a major role of S1PR1 is helping cells to 
migrate towards concentrated areas of S1P. This ability is necessary for hematopoietic stem cells 
to egress from the lymph nodes and bone marrow (reviewed in Chun & Hartung, 2010; Blaho & 
Hla, 2014).  S1PR1-mediated migration is also needed for neural precursors to reach S1P-rich 
sites of injury in the spinal cord (Kimura et al., 2006). S1PR1 is very important for normal 
angiogenesis postnatally; inhibition of S1PR1 signaling from P8 retinas leads to increased 
endothelial sprouting and ectopic vessel branches, whereas signaling though S1PR1 prohibits 
angiogenic sprouting and promotes cell-cell adhesion (Gaengel et al., 2012). 
In the human brain, S1PR1 staining is present at the V-SVZ. S1PR1-positive cells exhibit 
similar staining patterns to those positive for GFAP and Aquaporin4 (AQP4) (Nishimura et al., 
2010; Akiyama et al., 2008). Together, these data suggest that S1PR1 may also play an important 
role in the stem cells of the human brain.  
In this thesis, I describe the transcriptional states of FACS purified qNSCs and aNSCs, as 
well as a key role for miRNA regulation of aNSCs. First, I shed light on the regulatory, 
metabolic, and signaling pathways active in each stem cell type in Chapter 2. Then, I compare 
the quiescent and activated stem cell transcriptomes to their counterparts in other tissues. In 
Chapter 3, I show that the miR-17~92 cluster is greatly enriched in aNSCs over qNSCs in the V-
SVZ. I next present data on the functional role of this cluster. Finally, I show that S1PR1 is a 
miR-17~92 target in adult neural stem cells in Chapter 4.  
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These studies provide the first transcriptome-based insight into quiescent adult neural 
stem cells, and highlight a role for miR-based regulation of activated neural stem cells, a 
potential target of which mediates adult neural stem cell quiescence.  
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Chapter 2 Transcriptional states of Quiescent and Activated stem cell states 
The data in this chapter are largely published in Codega et al., 2014 which is included in the 
Appendix. Erika Pastrana, Paolo Codega, and Violeta Silva-Vargas developed the FACS purification 
strategy. Paolo Codega and Annina DeLeo performed FACS purification of cells for qPCR and 
microarrays. Annina DeLeo performed RNA extraction and cDNA synthesis for qPCR and microarrays. 
Annina DeLeo performed all bioinformatic analysis. Alex Paul performed the small molecule screen. 
Annina DeLeo and Alex Paul performed qPCR. 
Introduction 
Quiescent and actively dividing (activated) stem cells coexist in adult stem cell niches (Li 
& Clevers, 2010). Stem cell quiescence and activation play an essential role in many organs, 
underlying tissue maintenance, regeneration, function, plasticity, aging, and disease.  
Currently, little is understood about the molecular differences driving the biology of 
quiescent and activated stem cells. The main difficulty lies in identifying and prospectively 
purifying stem cells, especially the quiescent subpopulations, from their in vivo niches. In this 
chapter, I briefly outline a fluorescence-activated cell sorting (FACS) strategy developed by the 
Doetsch laboratory that allows qNSCs and aNSCs to be purified for the first time from the adult 
brain, and describe the functional properties of each population (Codega et al., 2014). I took 
advantage of this FACS approach to perform transcriptional profiling of freshly isolated qNSCs 
and aNSCs so as to illuminate their molecular regulation, marker expression, and important 
pathways, as well as to determine whether they shared features with quiescent and activated stem 




FACS Purification and Functional Properties of qNSCs and aNSCs 
Previous work in the Doetsch lab developed a simple strategy to simultaneously isolate 
activated stem cells (GFAP::GFP+EGFR+), transit-amplifying cells (TACs, EGFR+), and 
neuroblasts (CD24+) from the V-SVZ by combining EGF-A647 and CD24 immunostaining with 
GFAP::GFP mice (Pastrana et al., 2009). CD133 is highly expressed by the ependymal cells 
(Coskun et al., 2008), while a subset of GFAP+ astrocytes contacting the ventricle also express 
CD133 (Mirzadeh et al., 2008; Beckervordersandforth et al., 2010).  By including CD133 in the 
above sorting strategy, we are able to distinguish and isolate two CD133+ stem cell astrocyte 
populations, which, based on the functional data described below, correspond to qNSCs 
(GFAP::GFP+CD133+) and aNSCs (GFAP::GFP+CD133+EGFR+) (Figure 2.1). The remaining 




Functional studies on the FACS-purified populations showed that the qNSC population 
was slowly dividing, resistant to anti-mitotic drug treatment, and lacked expression of MCM2 
and Ki67, intrinsic markers of cell division (figure 2.2). In contrast, the aNSC population was 
rapidly dividing, killed by anti-mitotic treatment, and highly enriched in MCM2 and Ki67 
expression (Figure 2.2B, green line, Codega et al., 2014). Importantly, qNSCs only very rarely 
gave rise to colonies in vitro, and gave rise to neurons in vivo with delayed kinetics as compared 
Figure 2.1 FACS purification strategy using CD133 
(A) Table of markers used to identify and FACS-purify V-SVZ cells and their progeny. (B and C) 
Representative FACS plots showing gating strategy. In (B), the gate used to select GFAP::GFP+CD24- 
cells, which are then gated on EGF-A647 and CD133-PE-Cy7. In (C), three populations are clearly defined: 
GFAP::GFP+ (gray), GFAP::GFP+CD133+ (qNSCs, blue), and GFAP::GFP+ CD133+EGFR+ (aNSCs, 




to aNSCs, which were highly enriched in colony formation, and rapidly formed neurons in vivo 
(Figure 2.2B, cyan and purple lines). Notably, qNSCs also lacked Nestin expression, but 
upregulated both Nestin and EGFR upon activation (Figure 2.2A, green and cyan bars 
respectively). The ability to purify qNSCs and aNSCs directly from their in vivo niche opens up 
many avenues to further explore their functional and molecular properties. In the next section, I 
describe my findings on the transcriptional profiles of qNSCs and aNSCs from the adult V-SVZ. 
 
Figure 2.2 Markers and functional properties of qNSCs and aNSCs 
(A) Distribution of selected markers in adult V-SVZ stem cells. (B) Functional 
properties of qNSCs and aNSCs.  
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Bioinformatic Analysis of Purified qNSCs and aNSCs Reveals Distinct Molecular 
Signatures 
To define the transcriptomes of qNSCs and aNSCs, I FACS purified both populations as 
described above. Total RNA was isolated, cDNA amplified, labeled, and hybridized to 
Affymetrix MOE430.2 chips. The data was then normalized and analyzed using the Genespring 
GX 11 software suite. 
Differential expression analysis revealed that a few thousand genes were uniquely and 
significantly enriched in each population (Figure 2.3A, 2312 probes enriched in qNSCs, 1503 in 
aNSCs, corrected p-value less than 0.05 by Benjamini-Hochberg multiple testing correction, 
complete list in Table S1). To understand the functional properties of these differentially 
expressed genes, I analyzed their associated Gene Ontologies (GO). Gene Ontology is an ever-
growing database used to categorize genes and their proteins by their known biological process, 
molecular function, or presence in a particular sub-cellular compartment or component 
(Ashburner et al., 2000). I focused my analysis on the biological process categories of the 
differentially expressed genes to understand the molecular underpinnings for the behavior 
differences observed between quiescent and activated NS. Gene Ontologies with a p-value less 
than 0.05 were considered.  
In accordance with their actively cycling status, most of the categories found for aNSC-
enriched genes were related to cycle and division. aNSCs show a concordant increase in the 
number of genes involved in cellular metabolic processes over qNSCs (Figure 2.3B and C, light 
orange wedges). In contrast, qNSCs were enriched for the GO categories of cell communication 
and response to stimulus, suggesting that either they are poised for activation and are awaiting 
crucial “activation” signals, or that quiescence is actively maintained via signaling from the 
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niche (Figure 2.3B; full categories can be found in Table S2). qNSCs also show enrichment in 
genes involved in cell adhesion, further underscoring the dynamic regulation of the quiescent 
state via interaction with the microenvironment.  
 
Figure 2.3 Gene Expression Analysis of qNSCs and aNSCs Reveals Distinct Molecular Signatures 
(A) Volcano plot of differentially expressed probesets in qNSCs and aNSCs. Probes have at least 2-fold change in 
expression and a corrected p value < 0.05. (B and C) Pie charts showing representative GO categories for 





The GO analysis gives only a glimpse into the differences between qNSCs and aNSCs, as 
it only considers a small fraction of genes expressed by each population. To explore the 
transcriptomes in greater depth, I turned to Gene Set Enrichment Analysis (GSEA) 
(Subramanian et al., 2005). GSEA analyzes the entire transcriptome, and instead of looking for 
single genes with large fold changes (greater than 2-fold), this method identifies sets of genes 
that exhibit an accumulation of enough small fold changes (less than 2-fold) in the same 
direction to be considered significant. These gene sets are defined from the literature and 
correspond to biological pathways, changes in response to drugs, or genes regulated by the same 
transcription factors. GSEA may therefore find biologically relevant changes to the 
transcriptome that might be overlooked by other methods.  
GSEA revealed that qNSCs and aNSCs have distinct molecular features and confirmed 
the functional differences observed in vivo (Figure 2.4A–C, Figure 2.2). GSEA again highlighted 
the actively dividing state of aNSCs; their transcriptome was enriched in genes involved in the 
cell cycle, transcription and translation, and DNA repair (Figure 2.4A cyan bars; Table S2; full 
GSEA categories in Table S3). The most represented GSEA groups for qNSCs were related to 
transport, signaling, receptors, cell surface, and extracellular matrix (Figure 2.4A royal blue bars; 
Table S3), again relating to and underscoring the quiescent cells’ interaction with the niche and 




Figure 2.4 Gene Set Enrichment Analysis gives insight into overall transcriptional changes 
between qNSCs and aNSCs 
(A) GSEA thematic categories for qNSCs (royal blue bars) versus aNSCs (cyan bars). Sets have a false 
discovery rate (q value) of <0.05 and are hand curated into thematic categories. (B and C) Specific metabolic 
pathways enriched (B) in qNSCs or (C) in aNSCs. See Supplemental Table 3 for full list of sets.  
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Notably, with GSEA analysis we could better appreciate the differences in the types of 
metabolism enriched in qNSC and aNSC. The majority of the metabolism sets enriched in 
qNSCs were related to lipids (Figure 2.4B), which are emerging as important signals in NSC 
(Knobloch et al., 2013). In contrast, and in alignment with an actively dividing state, the 
metabolism sets enriched in the aNSCs were DNA/RNA-related metabolism. These sets also 
included proteasome activity related to the degradation of cell-cycle regulators (Figure 2.4C).  
Interestingly, qNSCs are uniquely enriched for sets relating to the extracellular matrix 
and cell adhesion. One such gene is Vcam1, which encodes an adhesion molecule that prevents 
cells from proliferating and maintains V-SVZ architecture. Indeed, Vcam1 is expressed in qNSCs 
at a high level (Figure 2.6A; Kokovay et al., 2012). Other adhesion genes such as Itga6, Ncam1, 
and Numb, which have been reported to be expressed in neural stem cells are also enriched in the 
qNSC population (Table S4; Kazanis et al., 2010; Kokovay et al., 2010; Kuo et al., 2006; Lim et 
al., 2006), suggesting that maintaining close contact with the niche may be necessary for 
quiescence.  
Analysis of Microarray Data Reveals Bi-Directional Regulation Between qNSCs and aNSCs 
From the transcriptional profiles of qNSCs and aNSCs, a very interesting pattern of 
bidirectional regulation emerged, with one population expressing ligands of one pathway, and 
the other expressing the receptor. Below, I have outlined a few examples of this in our data, with 
special focus on factors previously reported to have relevance in the V-SVZ adult neural stem 
cell niche.  
Notch signaling plays an important role in adult V-SVZ biology. Several Notch ligands 
are enriched in aNSCs, as compared to qNSCs. For example, by microarray and quantitative 
PCR (qPCR), aNSCs show enrichment of Delta-like ligand 1 (Dll1) (Figure 2.5, Table 2.1, 
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Figure 2.6B), as has been previously reported (Kawaguchi et al., 2013). Jagged 1 (Jag1) is also 
enriched in aNSCs and TACs (Figure 2.5, Table 2.1), which is in agreement with its ability to 
maintain a proliferative state and promote self-renewing divisions (Nyfeler et al., 2005; Andreu-
Agulló et al., 2009). While Jag1 is known to be expressed in opposition to cells expressing 
Notch1 (Nyfeler et al., 2005), as discussed below, Notch1 is also enriched in aNSCs. In contrast, 
Delta-like 1 homolog (Dlk1) expression is significantly enriched in the qNSCs and was 
previously shown to be important for V-SVZ stem cell self-renewal (Figure 2.5, Table 2.1, 
Ferrón et al., 2012).  
My analysis showed that Notch1 is expressed in aNSCs, in accordance with the finding 
that Notch1 deletion selectively reduces aNSC number (Figure 2.5, Table 2.1; Basak et al., 
2012). Conversely, Notch 2 and 3 are enriched in the qNSCs (Figure 2.5, Table 2.1). These 
receptors have previously been found on GFAP+ V-SVZ cells, although Notch2 is also present 
on neuroblasts (Basak et al., 2012). Rbpj, the immediate downstream transcription factor for the 
intercellular domain of Notch, is enriched in aNSCs (Figure 2.5, Table 2.1). RBPJ expression is 
sufficient to convert neural progenitors into neural stem cells in embryonic brain development 
(Mizutani et al., 2007) and to maintain stemness and self-renewing division in the adult SGZ 




There are several Notch-effector transcription factors, three of which show a differential 
expression pattern in our dataset: Hes1, Hes5, and Hes6. In accordance with its ability to 
suppress proliferation (Shimojo et al., 2008), Hes1 is enriched in qNSCs (Figure 2.5, Table 2.1). 
Hes1 is also known to suppress Ascl1 expression (Bae et al., 2000), and indeed Ascl1 expression 
is restricted to the aNSCs (Figure 2.6C). Excitingly, Hes6, a known antagonist of Hes1, is also 
enriched in the aNSCs (Figure 2.5, Table 2.1), indicating a potential regulatory loop between the 
two stem cell populations (Bae et al., 2000; Gratton et al., 2003). Hes5 is also enriched in the 
qNSC population (Figure 2.5, Table 2.1), and has been shown to mark a slowly dividing 
population in the V-SVZ (Giachino et al., 2014). Hes5, together with Hes1, is known to 
downregulate Dll1 expression (reviewed in Salomoni & Calegari, 2010).  




The inhibitors of Notch, Numb and Numb-like (Numbl), are expressed in the qNSCs and 
aNSCs, respectively (Figure 2.5, Table 2.1). The selective postnatal loss of Numb and Numbl 
from both V-SVZ stem cells and ependymal cells causes a failure of adult neural stem cells to 
stay in the more quiescent niche, directly in contact with the ventricular lumen, as their ability to 
connect with ependymal cells is lost and the quiescent niche is compromised (Kuo et al., 2006, 
niche reviewed in Fuentealba et al., 2012 and Kokovay et al., 2012).  
Interestingly, Wnt4 expression has been reported to be activated by Notch1-Jag1 co-
expression (Wang et al., 2013). Wnt4 is also upregulated after Notch2 expression, which leads to 
G1-stage arrest and reduced proliferation (Fujimura et al., 2010). In our system, Wnt4 is 
expressed by the qNSCs (Figure 2.5, Table 2.1). Sox5 is similarly present in our qNSCs (Table 
2.1), and is another activator of Wnt4 expression. As with Notch2, expression of Sox5 results in 
reduced proliferation (Martinez-Morales et al., 2010). BLBP, a marker of stem cell astrocytes, 
has been shown to be a direct target of Notch in the CNS and is expressed in the qNSCs 
(reviewed in Louvi & Artavanis-Tsakonas, 2006). Egfr (Andreu-Agulló et al., 2009, discussed 
below) and Sox2 (Table S4, Ehm et al., 2010, discussed below) are also direct targets and are 








Probe Set ID 




Examinations of function in 
adult brain 
1418633_at Notch gene homolog 1  Notch1 1.299 Basak et al., 2012; Ables et 
al., 2010; Imayoshi et al., 
2010; Andreu-Agullo et al., 
2009 1418634_at 1.005 
1451889_at Notch gene homolog 2 Notch2 -1.711 Basak et al., 2012 
	   1455556_at -2.78 
1421964_at Notch gene homolog 3 Notch3 -9.633 Basak et al., 2012 
1421965_s_at -4.649 
1419204_at delta-like 1 (Drosophila) Dll1 15.73 Kawaguchi et al., 2010 
1449939_s_at delta-like 1 homolog  Dlk1 -17.071 Ferron et al., 2011 
1442724_at -4.167 
1418102_at hairy and enhancer of split 1  Hes1 -1.166 Andreu-Agullo et al., 2009 
1423146_at hairy and enhancer of split 5  Hes5 -2.698 Lugert et al., 2010; Giachino 
et al., 2013 
1456010_x_at -2.957 
1436050_x_at hairy and enhancer of split 6  Hes6 14.964 Lugert et al., 2010; Giachino 
et al., 2013 
1452021_a_at 22.392 
1421105_at jagged 1 Jag1 2.411 Nyfeler et al., 2005 
1421106_at 2.74 
1434070_at 2.725 
1416891_at numb gene homolog  Numb -3.17 Kuo et al., 2006 
1425368_a_at 1.04 
1416491_at numb-like Numbl 1.095 Kuo et al., 2006 
1418114_at recombination signal binding protein for 
immunoglobulin kappa J region 





1450782_at wingless-related MMTV integration site 4 
Wnt4 -1.643 Beckervordersandforth, 2010 
 
Table 2.1 Notch Pathway components and their enrichment in V-SVZ stem cells 
Less reliable probesets are italicized (for reference, _a_ denotes detection of a gene family, _s_ hybridizes 
to multiple transcript variants, while _x_ hybridizes to multiple genes. Direction of fold change is denoted 
by highlight color where deeper reds indicate fold change enrichment in aNSCs and deeper green 
indicates fold change enrichment for qNSCs.  
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Kokovay et al. identified the CXCR4-CXCL12 (SDF-1) axis as important for proper 
homing of CXCR4+ adult neural progenitor cells to the blood vessels, a largely proliferative 
niche  (Tavazoie et al., 2008; Shen et al., 2008). Additionally, Kokovay et al., find that CXCl12 
is expressed by ependymal cells. In our data set, I find that aNSCs express Cxcr4, while Cxcl12 
is expressed by qNSCs (Table S4). It would be interesting to explore the function of this 
signaling axis within the more quiescent niche near the ventricular lumen.  
The quiescent stem cells of the V-SVZ express high levels of Lrig1 (Figure 2.6C), which 
is a known marker of stem cell quiescence in the skin and the intestine (Jensen & Watt, 2006; 
Jensen et al., 2009; Powell et al., 2012). Previous work has shown that Lrig1 targets EGFR 
protein for degradation from the membrane, thereby downregulating EGFR signaling (Gur et al., 
2004). There is little to no Egfr expression in our qNSCs (Figure 2.6D), although both Egfr and 
Lrig1 are expressed in aNSCs, where Lrig1 could have a tuning effect on the amount of EGFR 




Transcription Factors Associated with NSCs Are Differentially Expressed in qNSCs and 
aNSCs 
As cells progress down the V-SVZ stem cell lineage to differentiate into neurons, they 
upregulate different pro-neural and neurogenic transcription factors, a list of which may be found 
in Table S4. One such example is Dlx2, which is known to be expressed at the protein level by 
V-SVZ transit amplifying cells and neuroblasts (Doetsch et al., 2002) but not in aNSCs or 
qNSCs. Interestingly, the expression of Dlx2 mRNA was found by qPCR to be present in aNSCs 
at a 2-fold increase over the total V-SVZ (Figure 2.6E). This pattern of mRNA and protein 
expression suggests that aNSCs may be primed for Dlx2 protein expression or that there could be 
post-transcriptional regulation of this transcript. Another transcription factor, Ascl1, is expressed 
at the protein level by approximately 50% of aNSCs (Codega et al., 2014). Ascl1 is strongly 
expressed at the mRNA level by aNSCs, but not by qNSCs (Figure 2.6F). Sox2 is considered a 
neural stem cell transcription factor and is often used as a marker for the identification of stem 
Figure 2.6 qPCR validation of genes enriched in the V-SVZ stem cells 
(A-H) mRNA expression levels in the qNSCs and aNSCs as normalized to total SVZ. (A) Vcam1 (B) Dll1 (C) 
Lrig1 (D) Egfr (E) Dlx2 (F) Ascl1 (G) Sox2 and (H) Nestin.  
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cell astrocytes both in the adult and embryonic brain (Lendahl et al., 1990; Graham et al., 2003; 
Kazanis et al., 2010; Imayoshi et al., 2011; Marqués-Torrejón et al., 2013). Interestingly, while 
Sox2 mRNA is enriched in both qNSCs and aNSCs (Figure 2.6G), and more than 90% of qNSCs 
and aNSCs expressed Sox2, protein expression was stronger among the aNSC population 
(Codega et al., 2014). The fact that Sox2 is more highly enriched in aNSCs lends weight to the 
idea that high Sox2 levels may be related to a more proliferative state (Marqués-Torrejón et al., 
2013). Remarkably, all three of these transcription factors have mRNA expression that does not 
match their protein expression, suggesting that in some cases post-transcriptional regulation may 
be important to restricting protein expression.  
Importantly, Nestin, an intermediate filament protein widely considered a hallmark of 
NSCs both during development and in the adult (Lendahl et al., 1990; Imayoshi et al., 2011), was 
not expressed in qNSCs. Both microarray and qPCR analysis showed that qNSCs express very 
low to no levels of Nestin mRNA in contrast to aNSCs, in which Nestin mRNA is highly 
expressed (Figure 2.6H). Further functional experiments showed that Nestin is upregulated as 
qNSCs become activated (Codega et al., 2014). As such, Nestin cannot be used to detect qNSCs. 
Comparison of our Neural Stem Cell Populations to Others Previously Identified 
We directly compared our transcriptional profiles with those Beckervordersandforth et al.  
generated from FACS-purified CD133+ GFAP::GFP+ cells. By comparing their 
GFAP::GFP+CD133+ cells to CD133+ or GFAP+ only V-SVZ cells as well as diencephalic 
astrocytes (which are GFAP+ but post-mitotic and non-neurogenic), Beckervordersandforth et al. 
proposed sets of genes that are adult neural stem cell specific (Figure 2.7A and B). When we 
examined the expression of these genes in our qNSCs and aNSCs, we found that we could 
resolve two distinct subsets of NSCs with different molecular and functional properties from the 
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single population collected by Beckervordersandforth et al. (Figure 2.7A and B; Table S7). 
Importantly, we found that neurogenic transcription factors such as Dlx1, Dlx2, Sox4, Sox11, and 
Ascl1, which were proposed to be lineage priming and hallmarks of the GFAP::GFP+CD133+  
NSCs (Beckervordersandforth et al., 2010), were in fact primarily expressed by or restricted to 
aNSCs (Table S4, Figure 2.6E and F).  
 
Features of Quiescence or Activation are Shared Across Adult Tissue Compartments 
Populations of quiescent and activated stem cells have been identified in other tissue 
compartments. To investigate whether qNSCs and aNSCs from the adult brain shared 
transcriptional features with their counterparts in other organs, I used Genespring to compare our 
data sets with published lists from hematopoietic, muscle, skin, and intestinal stem cells (Ivanova 
et al., 2002; Venezia et al., 2004; Forsberg et al., 2010; Pallafacchina et al., 2010; Powell et al., 
2012; Blanpain et al., 2004; Fukada et al., 2007; Cheung & Rando, 2013). The genes in each list 
Figure 2.7 Gene Expression Profiling Compared to Beckervordersandforth et al., 2010 
(A-B) Comparison of our microarray data with those of Beckervordersandforth et al. 2010. The expression of genes 
present in “genes enriched in adult NSCs in comparison to diencephalic astrocytes” (A) (corresponding to Table S5 
from Beckervordersandforth et al., 2010) and “adult NSC-enriched genes” (B) (corresponding to Table S6 from 
Beckervordersandforth et al., 2010) lists was analyzed and genes subcategorized by enrichment in qNSCs and 
aNSCs, expression in both or not present (as defined by expression in raw data < 50 for no expression). Gene lists 
are in Supplementary Table S7 
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were categorized by fold change analysis as being qNSC enriched, aNSC enriched, expressed in 
both, or not expressed if their expression in the raw data was less than 50. Indeed, those genes 
published in the short-term/proliferative stem cell lists from other tissues were up-regulated in 
our activated population, and the majority of these genes are involved in the cell cycle and cell 
division (Figure 2.8B; Table S5). Interestingly, the majority of genes in long-term/quiescent 
populations were also upregulated in our quiescent V-SVZ stem cells (Figure 2.8A; Table S5). 
Gene Ontology analysis of the list of genes expressed by at least two quiescent stem cell types 
shows that they commonly upregulate lipid metabolism, cell signaling pathways, and adhesion 
molecule binding (i.e. ECM) (Table S5). Together, these data suggest that common 





Signaling Pathways, Including G-Protein Coupled Receptors, Modulate Activation and 
Proliferation 
To gain insight into signaling pathways that modulate quiescence or activation, we mined 
our transcriptome data using GSEA (Figure 2.9A and B). Notably, not only is EGFR enriched in 
aNSCs at both the mRNA and protein levels, but components of the EGFR signaling pathway are 
also enriched in these cells. Therefore, EGFR may not only be a marker of, but be functionally 
involved in the activated stem cell identity (Figure 2.9B, Doetsch et al., 2002).  
Figure 2.8 Quiescence or Activation Gene Expression overlap with stem cells of other 
tissues 
(A-B) Percentage of overlap with signatures of quiescent and dividing stem cells from other organs: 
(E) long-term (LT)/quiescent signatures and (F) short-term (ST)/proliferative signatures as 
determined by fold-change analysis of published lists compared to qNSC and aNSC populations. 
Qui, quiescent; HSC, hematopoietic stem cells; qMuSC, quiescent muscle stem cells; qBulgeSC, 
quiescent bulge stem cells; qISC, quiescent intestinal stem cells. G-H) in both or not present (as 




Interestingly, quiescent stem cells also show a significant enrichment for signaling 
pathways, the largest of which is G protein-coupled receptor (GPCR) signaling (30% of all 
GSEA qNSC signaling sets; Figure 2.9A, Table S3). To assess the role of GPCR-signaling on 
the regulation of qNSCs, we selected 25 GPCRs that were more than 10-fold enriched in qNSCs 








Figure 2.9 GSEA reveals differences in signaling between q and aNSCs 




Gene Title Symbol Targeting compound Fold Change  
(qNSC vs. aNSC) 
sphingosine-1-phosphate receptor 5 S1pr5 Sphingosine-1-phosphate 53.72806 
lysophosphatidic acid receptor 1 Lpar1 1-Oleoyl lysophosphatidic acid sodium salt 46.594353 
sphingosine-1-phosphate receptor 3 S1pr3 Sphingosine-1-phosphate 39.406864 
adenosine A2b receptor Adora2b Adenosine 31.048176 
neuropeptide Y receptor Y1 Npy1r Neuropeptide Y 29.172924 
histamine receptor H1 Hrh1 Histamine dihydrochloride 27.785969 
endothelin receptor type A Ednra Endothelin 1 26.673853 
adenosine A2b receptor Adora2b Adenosine 25.13803 
G protein-coupled receptor 17 Gpr17 Leukotriene D4 24.492632 
adrenergic receptor, alpha 2a Adra2a (-)-Epinephrine / (-)-Norepinephrine 20.029146 
endothelin receptor type A Ednra Endothelin 1 19.084913 
calcitonin receptor-like Calcrl Amylin 18.947807 
lysophosphatidic acid receptor 1 Lpar1 1-Oleoyl lysophosphatidic acid sodium salt 18.843597 
adrenergic receptor, alpha 1a Adra1a (-)-Epinephrine / (-)-Norepinephrine 18.837431 
glutamate receptor, metabotropic 3 Grm3 L-CCG-I 17.349558 
adenosine A2b receptor Adora2b Adenosine 16.695187 
neurotensin receptor 1 Ntsr1 Neurotensin 16.52517 
adenosine A2b receptor Adora2b Adenosine 16.485117 
leucine-rich repeat-containing G 
protein-coupled receptor 4 
Lgr4 R-spondin1 13.53013 
latrophilin 3 Lphn3 α-Latrotoxin 13.519957 
G protein-coupled receptor 146 Gpr146 Proinsulin C-Peptide 13.392646 
lysophosphatidic acid receptor 1 Lpar1 1-Oleoyl lysophosphatidic acid sodium salt 12.428424 
endothelin receptor type A Ednra Endothelin 1 12.049671 
adrenergic receptor, alpha 2a Adra2a (-)-Epinephrine / (-)-Norepinephrine 11.954656 
hypocretin (orexin) receptor 2 Hcrtr2 Orexin A 11.6158285 
sphingosine-1-phosphate receptor 1 S1pr1 Sphingosine-1-phosphate 11.028068 
tachykinin receptor 2 Tacr2 Neurokinin A 10.985823 
G protein-coupled receptor 37 Gpr37 Prosaptide 10.867761 
5-hydroxytryptamine (serotonin) 
receptor 6 
Htr6 Serotonin Hydrochloride 10.586905 
adenosine A1 receptor Adora1 Adenosine 10.397678 
growth hormone releasing hormone 
receptor 
Ghrhr GRF 10.390047 
secretin receptor Sctr Secretin 10.334803 
leucine-rich repeat-containing G 
protein-coupled receptor 4 
Lgr4 R-spondin1 10.199413 
prostaglandin F receptor Ptgfr Prostaglandin D2 10.063209 
prostaglandin D receptor Ptgdr Prostaglandin D2 10.0564 
Table 2.2 GPCRs assayed and their enrichment in aNSCs 
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This screen revealed that both Sphingosine 1 Phosphate (S1P) and prostaglandin D2 
reduced the activation of qNSCs by about one half, with S1P selectively acting on qNSCs but not 
aNSCs (Codega et al., 2014, Figure 2.10A). S1P also decreased the proliferation of activated 
qNSCs by approximately 50% (Figure 2.10B). Together, these functional data suggest that the 
adult NSC quiescent state is actively maintained, and that the GPCR ligand S1P is an important 
ligand for stem cell quiescence.  
 
Conclusions 
Here, we prospectively identified and isolated quiescent adult NSCs by defining a 
combination of markers (CD133, GFAP, and EGFR) that allows the simultaneous purification of 
quiescent and activated populations of stem cell astrocytes from the V-SVZ niche.  
The bioinformatic analyses I have performed, including Differential expression, Gene 
Ontology, and Gene Set Enrichment, highlight that qNSCs and aNSCs have very different 
transcriptomes. Processes related to cell cycling and the concomitant DNA/protein metabolism 
Figure 2.10 GPCR modulation screen 
(A) Plot of the fold change of qNSC activated Nestin+ clones. Compounds that were statistically significant are in 
red (n=3, mean ± SEM, *p<0.05, unpaired Student’s t-test). Different shades of grey demarcate compounds in the 
same diluent, and open circles are controls. (B) Quantification of percentage of MCM2+ cells within activated 
Nestin+ clones in qNSC.  
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required to support active cycling dominate the aNSC transcriptome. Conversely, qNSCs show 
enrichment for lipid metabolism and adhesion.  
GSEA revealed that both qNSCs and aNSCs are enriched for signaling pathways, 
indicating that signals from the outside may be important to the maintenance of quiescence. 
GPCR signaling is especially enriched in qNSCs. While GPCRs modulate many different facets 
of adult neurogenesis (Doze & Perez, 2013), our findings highlight that they are also key 
regulators of qNSCs. Strikingly, the S1P ligand, as well as Prostaglandin D2, which we identify 
in our GPCR screen, inhibits the activation of qNSCs, suggesting that stem cell quiescence is an 
actively maintained state.  
Investigation of genes previously associated with NSCs shows that many are 
differentially expressed by qNSCs and aNSCs. In fact, exploration of ligand and receptor binding 
patterns show that qNSCs and aNSCs are engaged in bi-directional regulation. Exploration of 
important pro-neural and neurogenic V-SVZ transcription factors shows a similar pattern of 
differential expression between the two newly defined stem cell populations, including Dlx2, and 
Ascl1. Furthermore, we find that Nestin, which is frequently used as a pan-NSC marker, is 
restricted to aNSCs. Finally, adhesion molecules show enriched expression in qNSCs, further 
highlighting that interaction with and maintenance of niche architecture may be essential for 
quiescence.  
This work reveals important molecular features of activated and quiescent NSCs, which 
importantly highlight overarching biology common to each state and provides a platform to 
dissect the essential pathways of each. Future functional experiments that manipulate 
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differentially expressed genes and pathways will be important to fully understand the gene 




FACS Purification Strategy 
The SVZs from 2-3 month old heterozygous GFAP::GFP mice (The Jackson 
Laboratory), which express GFP under the control of the human GFAP (glial fibrillary acidic 
protein) promoter (Zhuo, 1997), and wild-type CD-1 mice (Charles River Laboratories) were 
dissected, digested with papain (Worthington, 1,200 units per 5 mice, 10 min at 37ºC) in PIPES 
solution (120 mM NaCl, 5 mM KCl, 50 mM PIPES (SIGMA), 0.6% glucose, 1x Pen/Strep 
(Gibco) in water, pH adjusted to 7.6) and mechanically dissociated to single cells after adding 
ovomucoid (Worthington, 0.7 mg per 5 mice) and DNAse (Worthington, 1,000 units per 5 
mice). Cells were centrifuged for 10 min at 4ºC without brakes in 22% Percoll (SIGMA) to 
remove myelin and incubated for 15 min with PE-conjugated rat anti-mCD24 (1:1000; BD 
Pharmingen), A647-complexed EGF (1:300; Molecular Probes) and biotinylated rat anti-
mCD133 (1:300, clone 13A4, eBioscience), washed by centrifugation and incubated for 15 
min with PE-Cy7-conjugated streptavidin (1:1000; eBioscience). All stainings and washes were 
carried out on ice in 1% BSA, 0.1% Glucose HBSS solution. To avoid clumping, cells were 
passed through a 40-μm filter. To assess cell viability, 4’,6-diamidino-2-phenylindole (DAPI; 
1:1000; SIGMA) was added to the cells before sorting. All cell populations were isolated in a 
single sort using a Becton Dickinson FACS Aria II using 13 psi pressure and 100-µm nozzle 
aperture. Cells were collected in neurosphere medium (details below) without growth factors. 
Gates were set manually by using control samples (see appendix). Data was analyzed with 
FlowJo 9.3 data analysis software and displayed using biexponential scaling. 
qPCR Analysis 
RNA was purified from FACS sorted populations by the miRNeasy kit, which allows 
the extraction of both large RNA and enriches for smaller RNAs such as miRs (Qiagen). cDNA 
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was generated using WT- Ovation Pico System (NuGEN). The total SVZ sample consisted of 
all live cells (all cells shown in Figure 2.1). For qRT-PCR, all reactions were carried out in 
duplicate on 4 biological replicates using Brilliant III Ultra Fast SYBR Green QPCR Master Mix 
(Agilent) in a Stratagene Mx3000P machine with an annealing temperature of 60ºC. Data was 
normalized to GAPDH expression and analyzed by the 2-ΔΔCt method which normalizes 
expression to both a control sample (here, total SVZ) and a reference gene (GAPDH) (Livak & 
Schmittgen, 2001). All primers used for qPCR are in Table 2.3. 
 
Gene name Forward primer Reverse Primer 
Ascl1 (Mash1) ATGCAGCTACTGTCCAAACG AACAGTAAGGGGTGGGTGTG 
Dll1 CTACTACGGAGAAGGTTG GTATCCATGTTGGTCATC 
Dlx2 GTTGTGAAAGCTGCGACGTA ACCCCCAAATACCTTGCATT 
EGFR AGGCCGTGAACCACGTCTGC CACGCACTCCCTGCCTCTGC 
GFAP CTCCGCCAAGCCAAGCACGA GCGCAGGGACTCCAGATCGC 
GFP TGGCGATGGCCCTGTCCTTTT AAGGGCAGATTGTGTGGACAGGT 
Gapdh AACTTTGGCATTGTGGAAGG ACACATTGGGGGTAGGAACA 
Lrig1 TGCCAGAGCAAGCACGCTGA GCCTCTCAGAAGCAGCAAATTCACA 
Nestin GGGCCCAGAGCTTTCCCACG GGGCATGCACCAGACCCTGTG 
Prom1 GCCTCTACCCTGGAAGCAAA GATGCTGGTGGATGGCTCTT 
Sox2 CCCCCTTTTATTTTCCGTAGTT TCTCAAACTGTGCATAATGGAGT 
Vcam-1 AAGAGAACCCAGGTGGAGGT TCTGCTAATTCCAGCCTCGT 
 




RNA was purified from FACS-sorted populations with the miRNeasy kit (QIAGEN) from 
three biological replicates. cDNA was synthesized with the NuGen Pico amplification kit 
and hybridized to Affymetrix MOE430.2 chips by the Collaborative Science Genome 
Technology Center of New York University Langone Medical Center. 
Bioinformatic Analysis of Microarray Data 
Normalization, quality control, differential expression, and gene ontology analysis were carried 
out using Genespring GX 11.  
Pre-Analysis Processing 
Once all chips were hybridized, raw image data was loaded into Genespring GX 11. The files 
were then collectively normalized using the MAS5 method, which takes into account miss-
matched probes, and has been shown to outperform other methods (Lim et al., 2007). No 
baseline normalization was taken. Quality control was performed using Principle Component 
Analysis (PCA). Biological replicates were examined for spatial and regression correlation by 
this method. All were found to have an r2 value greater than 0.87 and clustered tightly.  
Differential Expression Analysis and Gene Ontology (GO) 
Differentially expressed probesets were filtered by average expression level greater than 50 in at 
least 1 population in the raw data, at least 2-fold differential expression, and corrected p-value 
less than 0.05 by Benjamini-Hochberg multiple testing correction. GO categories were obtained 
with p-value less than 0.05.  
Gene Set Enrichment Analysis (GSEA) 
GSEA sets with FDR (q value) < 0.05 were hand-curated into thematic categories to highlight 
transcriptional differences between populations. This analysis was carried out with GSEA 
software from the Broad Institute, using MSigDB v3.0. 
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Identification of Conserved Transcriptome Features 
Gene lists of published quiescence or activation stem cell signatures from other adult tissue 
compartments were downloaded and then imported into Genespring GX 11. The expression of 
genes in these lists was then determined for our system using our microarray data. 
GPCR screen 
FACS-purified qNSCs were plated at 100 cells per well on adherent substrates in the presence of 
EGF and different GPCR ligands or vehicles for 4 days. At 4 days, their activation as measured 
by number of Nestin+ clones was quantified.  
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Chapter 3 miR-17~92 Regulation of Adult Neural Stem Cells 
Introduction 
In the previous chapter, I showed that the transcriptional states of qNSCs and aNSCs are 
strikingly different and reflect their differing behaviors. Interestingly, this analysis showed that 
for some factors, RNA expression precedes protein expression suggesting post-transcriptional 
regulation (Codega et al., 2014). I hypothesized that microRNAs (miRs) might be a key 
regulatory step in modulating the transition from quiescence to activation in the V-SVZ. 
Currently, little is known about how stem cells transition from the quiescent to active state, 
especially in the adult neural stem cell niche.  
miRNAs (miRs) are small non-coding RNAs capable of rapidly modulating cell states 
through their ability to target hundreds of mRNAs simultaneously at the post-transcriptional 
level. Recent work has demonstrated the importance of microRNAs in stem cell differentiation 
and self-renewal, as well as stem cell quiescence (Brett et al., 2011; Zhao et al., 2009; Cheung et 
al., 2013). However, the role of miRNAs in regulating the transition from quiescence to 
activation in neural stem cells has not been explored. 
In this chapter, I analyze microRNA expression in FACS-purified qNSCs and aNSCs. I 
identify the miR-17~92 cluster as significantly enriched in aNSCs over qNSCs. I then investigate 
the functional effect of miR-17~92 in the V-SVZ by conditionally deleting the miR-17~92 
cluster in vitro and in vivo, thereby testing my hypothesis that this miRNA cluster is necessary 





microRNA Profiling of Quiescent and Activated Adult Neural Stem Cells 
Using the FACS purification strategy outlined in Chapter 2, Codega et al., 2014, and 
Pastrana et al., 2009, I collected quiescent and activated adult neural stem cells, as well as other 
astrocytes, transit amplifying cells, and neuroblasts from the V-SVZ (Figure 2.1). RNA 
containing both mRNA and miRNA fractions was extracted from the purified populations. 
cDNA libraries made from the resulting RNA were applied to Taqman low-density arrays 
(TLDAs) in order to survey 384 miRs in parallel (Figure 3.1 top). TLDA expression data was 
normalized in the Statminer software package. These results were then loaded into the 




Using analysis of variance (ANOVA) within the Genespring software, I identified a 
cohort of miRs with enriched expression in aNSCs (Figure 3.2A) and a second cohort enriched in 
the qNSCs (Supplemental Figure 1). Interestingly, among the cohort enriched in the aNSCs were 
four out of the six members of the miR-17~92 cluster, as well as members from the paralogs of 
miR-17~92; the 106a~363 and 106b~25 clusters (Figure 3.2A-C). To confirm the TLDA 
Figure 3.1 ANOVA of miRNA expression and Schematic of the miR-17~92 cluster and 
paralogs 
(A) Schema of experimental paradigm. FACS was used to purify qNSCs and aNSCs. RNA retaining 
both mRNAs and microRNAs was then isolated. For microRNA profiling, half of the RNA sample 
underwent a single round of amplification for the TLDA. For mRNA profiling, cDNA was synthesized 
from the other half of the RNA sample and then hybridized to Affymetrix microarray chips. Splitting 
the sample in this way allows for the simultaneous analysis of microRNA and mRNA expression.  
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profiles, I performed qPCR for members of the miR-17~92 cluster in V-SVZ cells. In agreement 
with the arrays, expression of members of the miR-17~92 cluster are enriched in aNSCs and 
TACs over qNSCs (Figure 3.2D).  
 The presence of members of the miR-17~92 cluster is exciting, as this cluster is known 
to play an essential role in promoting proliferation and survival during embryonic development 
(Ventura et al., 2008). Furthermore, the miR-17~92 cluster is often over- or mis- expressed in 
malignancies, where these same qualities, so essential for development, enhance tumor 
progression and growth (Reviewed in Olive et al., 2010; Mogilyansky & Rigoutsos, 2013). 
Therefore, I chose to focus my work on understanding the role of the miR-17~92 cluster in the 




Figure 3.2 The miR-17~92 cluster shows enrichment in aNSCs by qPCR 
(A) Analysis of Variance identifies a cohort of miRs enriched in aNSCs. Among these are members of the 
miR-17~92 cluster (indicated with black triangles) and its paralogs mir-106a~363 (black diamonds) and 
miR-106b-25 (black circles). The three clusters share a similar order of miRs (B) and sequence homology 
among the individual miRs (C). Seed sequence conservation is used to group miRs into families, and those 
miRs encoded in the miR-17~92 cluster and paralogs fall into four families represented but the gray boxes 




Development of Tools to Investigate the Role of miR-17~92 in the Adult V-SVZ 
To directly probe the role of miR-17~92 in adult neural stem cells, I wanted to combine 
the powerful ability to purify cells directly from their niche by FACS, with the ability to 
conditionally manipulate expression levels of miR-17~92 using transgenic mouse lines.   
Transgenic Mouse Line 
Several conditional mouse lines have been generated that allow the genetic manipulation 
of miR-17~92 cluster (Ventura et al., 2008; Chen et al., 2013; Feuermann et al., 2012; Marrone 
et al., 2014; Mu et al., 2009). To be able to investigate the role of the miR-17~92 cluster in adult 
FACS-purified V-SVZ stem cells, I generated CAGG-CreERT2+/-; miR-17~92fl/fl ; ROSA (ACTB-
tdTomato,-EGFP+/+) mice by breeding  CAGG-CreERT2+/-; miR-17~92fl/fl  (Ventura et al., 2008) with 
ROSA (ACTB-tdTomato,-EGFP+/+) mice (Muzumdar et al., 2007). Upon the addition of hydroxytamoxifen 
(4OHT), a ubiquitously expressed CreERT2 induces deletion of the miR-17~92 cluster, as well 
as causing the reporter locus to switch from expression of the tdTomato reporter to eGFP 
(enhanced GFP, Figure 3.3) allowing cells that have undergone recombination to be readily 
identified. 
 
Figure 3.3 Recombination system for miR-17~92 in vitro functional analysis 
Schema adapted from Ventura et al., 2008 and Muzumdar et al., 2007 showing genetic loci before Cre-




In order to purify qNSCs and aNSCs from the CAGG-CreERT2+/-; miR-17~92fl/fl ; ROSA 
(ACTB-tdTomato,-EGFP+/+) mice, I first adapted the sorting strategy described in Chapter 2 and (Codega et 
al., 2014) (hereafter referred to as the “Astro-sort”), which relies on the presence of the 
GFAP::GFP locus. The new strategy used hereafter will be referred to as the “Wild-type sort”.  
For the wild-type sort strategy, CD24-FITC, EGF ligand-Alexa647, and CD133-PE-Cy7 
antibodies were used. Forward and side scatter were used to exclude cellular debris (Figure 
3.4A), and then doublets were excluded (Figure 3.4B). To exclude any dead cells, only DAPI-
negative single cells were collected (Figure 3.4C). Next, tdTomato+ cells were selected (Figure 
3.4D) to ensure that only cells expressing the reporter locus were collected, thereby allowing 
tracking of recombination in downstream applications. From tdTomato+ cells, two gates were 
defined for aNSCs and qNSCs, both of which exclude FITC positive cells (Figure 3.4E). The 
FITC-exclusion serves two purposes: first, as eGFP expression occurs after recombination, 
removing FITC+ cells ensures that none of the cells collected have already recombined, a 
possibility due to the fact that even when present only as a single copy, CAGG-CreERT2 can 
sometimes activate aberrantly (Figure 3.4G and H). Secondly, CD24+ cells were also FITC 
labeled, and so neuroblasts and ependymal cells were excluded (Calaora et al., 1996). To isolate 
an aNSC-like population (hereafter referred to aNSC+ due to the possible inclusion of some 
TACs) that were used for all experiments, FITC-EGF-Alexa647+ cells (Figure 3.4E) were gated 
on EGF-Alexa647 and CD133-PE-Cy7 expression to define the FITC-EGF-Alexa647+CD133-
PE-Cy7+ population (Figure 3.4I). To isolate a qNSC-like population, FITC-EGF-Alexa647- cells 
were selected (Figure 3.4E) and then gated based on expression of CD133-PE-Cy7 to define a 
population of FITC-EGF-Alexa647-CD133+ cells (Figure 3.4F). In all experiments, the CreERT2- 
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population was used for control due to the leaky nature of CreERT2 activation, an example of 





Figure 3.4 Wild-type Sort gating strategy 
(A-I) FACS plot flow chart of the 5 color strategy used for sorting and analyzing V-SVZ astrocyte subpopulations 
using DAPI, CD24-FITC, EGF-A647 and CD133-PE-Cy7 in CAGG-CreERT2+/- or -/-; miR-17~92fl/fl; ROSA 
(ACTB-tdTomato,-EGFP+/+) mice. (A) Exclusion of cell debris (A), (B) gating to exclude doublets and (C) gating 
for live DAPI negative single cells. (D) Gating on Tomato expression (E) Gating on FITC expression to exclude 
already recombined cells and neuroblasts. From this population, two sub-populations could be derived (F) FITC-
EGF-CD133+ and (I) FITC-EGF+CD133+. (G) CreERT2- control (H) CreERT2+ control. Percentages and Astro-sort 
population being captured are labeled in pink. 
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Comparison of the neurosphere formation rates for the aNSC+ population collected from 
the wild-type and the aNSCs from Astro-sort (reviewed in Pastrana et al., 2011) showed no 
significant differences (Figure 3.5). This sorting strategy therefore provides an aNSC+ 
population from mice that do not express GFAP::GFP, and can be used for experiments in which 
the miR-17~92 locus can be inducibly deleted. 
  
Validation of miR-17~92 Deletion 
Although miR-17~92 is efficiently deleted after addition of tamoxifen in CAGG-
CreERT2+/-; miR-17~92fl/fl mice (Ventura et al., 2008; Chen et al., 2011), I wanted to confirm that 
aNSC+ cells were able to delete miR-17~92 with the added ROSA (ACTB-tdTomato,-EGFP+/+) reporter.  
FACS-purified aNSC+ cells were expanded in EGF for 5 days before recombination was 
induced with the addition of 4OHT, in order to have enough material to test deletion efficiency 
(Figure 3.6A). After tamoxifen treatment, cells were cultured for an additional 5 days.  
Figure 3.5 Comparison of Neurosphere formation by activated neural 
stem cells cells from Astro- or wild type sorts 
(Left) Sphere formation for aNSCs purified by the Astro-sort method; rate is 4.57% 
± 1.38. (Right) Sphere formation for aNSCs+ isolated by the Wild-type sort method; 




At 5 days after tamoxifen treatment, cells were FACS-purified to separate non-
recombined cells (tomato+ only) from recombined cells (either GFP+ only [both reporter loci 
recombined] or  GFP+Tomato+ [only one reporter locus recombined, appear yellow]) (Figure 
3.6A). Recombination of the miR-17~92 locus was then assessed at the genomic level as well as 
for loss of mature miRs after deletion. Preliminary assays for genetic recombination revealed that 
the miR-17~92 locus was more efficiently recombined than the ROSA (ACTB-tdTomato,-EGFP+/+) reporter, 
as recombined cells, which included cells in which only one reporter allele recombined, were 
completely negative for the miR-17~92 locus (Figure 3.6B).  
To assess microRNA levels after genetic recombination of the miR-17~92 locus, qPCR 
was used to determine miR-17 expression as a proxy for the expression of other cluster members 
(Figure 3.6A). Preliminary data shows that recombined cells exhibited a significant reduction in 
miR-17 expression (Figure 3.6C, green and yellow striped bar) as compared to non-recombined 
cells that were either CreERT2- or CreERT2+ (Figure 3.6C, dark red and red bar respectively). As 
above, more efficient recombination was observed for miR-17~92 than for the reporter locus, as 
Cre+Tomato+ cells had lower levels of miR-17 than Cre-Tomato+ control cells. Therefore, for all 




miR-17~92 Deletion In Vitro 
miR-17~92 Deletion Impairs Adult NSC Activation, Proliferation, and Self-Renewal  
To assess the functional effect of deleting miR-17~92 in aNSCs, I first used in vitro 
assays where I could directly quantify the effect on activation, proliferation and self-renewal. I 
first tested the ability of FACS-purified aNSCs to give rise to neurospheres upon deletion of 
miR-17~92. FACS-purified aNSCs+ were plated in EGF, EGF and 4OHT, or EGF and vehicle 
Figure 3.6 Verification of miR-17~92 deletion by PCR and qPCR 
(A) Schema of miR-17~92 deletion verification assays. Red cells indicate that no recombination at the reporter 
locus has occurred (non-recombined), while yellow indicates that a single reporter locus has recombined and 
cells are expressing both tomato and eGFP protein. Both yellow cells and GFP+ cells were collected as 
recombined cells. (B) PCR results from genetic deletion assay. A band of 2.5kb indicates an intact miR-17~92 
locus, while a band of 1.2kb indicates that the miR-17~92 locus has been deleted (n=1). (C) qPCR results 
showing relative abundance of miR-17 in non-recombined Cre- (dark red) and Cre+ (red) or recombined cells  
(green and yellow striped bar) (n=1).  
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(ethanol, EtOH) for 24 hours to induce recombination. Five days after recombination, the 
number of neurospheres that formed was quantified (Figure 3.7A).  
Strikingly, miR-17~92 deletion had a dramatic effect on the ability of activated adult 
neural stem cells to form neurospheres; only 27% as many neurospheres were formed when miR-
17~92 was deleted (Figure 3.7E, p < 0.025), and those spheres were visibly smaller than their 
wild-type counter parts (Figure 3.7B-D). Therefore, miR-17~92 deletion reduces recruitment of 
aNSCs to form neurospheres, and reduces their ability to proliferate.  
To test the self-renewal capacity of these cells in vitro, I performed sphere passaging by 
enzymatic and physical dissociation of existing spheres into a single cell suspension, which was 
then re-plated to assess the cells’ continuing ability to form spheres. Notably, the cells from miR-
17~92 deleted spheres were never able to form secondary spheres, whereas their counterparts 





Figure 3.7 Assessing the effects of 17~92 deletion in vitro 
(A) Schematic of Neurosphere and adherent assays (B-D) Sphere formation for CreERT2- (Cre-) miR-17~92+ cells 
(left column) and Cre+ miR-17~92- cells (right column) (B) bright field (C) Tomato (D) GFP (E) Quantification of 
neurospheres formed, *p < 0.025. (F) Colonies formed in adherent conditions by Cre- miR-17~92+ cells (left) and by 
Cre+ miR-17~92 deleted cells (right). (G) Quantification of total cells in each condition at day 5, ***p < 0.005. 
 
 64 
To more accurately assess the effect of miR-17~92 deletion on aNSC+ proliferation, I 
used adherent assays. This assay uses adherent substrates to cause cells to grow as a monolayer, 
which greatly facilitates their quantification (Figure 3.7F). In the adherent condition, cells 
continued to show a deficit in proliferation when miR-17~92 was deleted; only 25% as many 
cells were present five days after plating (Figure 3.7G, p < 0.01).  
miR 17~92 and Survival 
The miR 17~92 cluster is known to promote cell survival via suppression of pro-
apoptotic factors such as Bim and Pten (Ventura et al., 2008; Xiao et al., 2008; Koralov et al., 
2008; Olive et al., 2009; Tung et al., 2015). To determine whether at least part of the activation 
and proliferation effects shown above might be due to a deficit in cell survival of aNSCs, cells 
were plated under adherent conditions. Unlike the above assays, after recombination cells were 
incubated in media without EGF in order to minimize the effects of activation and proliferation.  
To visualize changes in survival, cells were stained with Annexin V conjugated to 
Alexa647, which binds to phosphatidylserine, allowing visualization of apoptotic cells from the 
earliest to latest stages of apoptosis (vanEngeland et al., 1996). Cells were then fixed and stained 
with DAPI to visualize intact nuclei (Figure 3.8A). I then counted DAPI+ cells and recorded their 
co-expression of Tomato, eGFP, and Annexin V. Despite only being exposed to EGF for 24 
hours, there were differences in the sizes of colonies formed by CreER- and CreER+ cells. 
Regardless of size, colonies were always Annexin V-. Therefore, I counted each colony as a 
single clone rather than counting all of the individual cells within it, allowing me to assess 




Although the pro-survival properties of the miR-17~92 cluster have been demonstrated 
for other systems, in V-SVZ stem cells, miR-17~92 does not have a significant effect on cell 
survival for the first five days after the cluster is deleted (Figure 3.8B, p < 0.6, n=2). However, 
this finding does not preclude the possibility that miR-17~92 loss may affect survival of neural 
stem cells or their progeny at other stages.  
miR-17~92 is Necessary for Robust Neurogenesis 
The role of miR-17~92 in differentiation is beginning to be understood; several studies 
have reported that miR-17~92 is down-regulated during the differentiation process for many cell 
and cancer types (Beveridge et al., 2009; Westermark et al. 2011; Mogilyansky & Rigoutsos, 
2013). Recent work has shown that expression of the miR-17~92 cluster promotes neurogenesis 
Figure 3.8 miR-17~92 and survival 
(A) Schema of survival assay. (B) Normalized percentages of cells positive for 
annexin V- Alexa647. First bar (red) is the normalized percentage of Cre-miR-
17~92+AnnexinV+ cells, second bar (red) is normalized percent of Cre+miR-
17~92+Annexin V+ cells, third bar (green) is normalized percentage of Cre+miR-
17~92-Annexin V+ cells. (N=2).  
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in embryonic stem cells, and that overexpression delays the temporal switch to gliogenic 
competence (Naka-Kaneda et al., 2014). The ability to promote neurogenesis in adult neural 
progenitors has also been shown for the miR-17~92 paralog, miR 106b~25 (Brett et al., 2011).  
To establish the effect of miR-17~92 deletion on differentiation, FACS-purified aNSCs+ 
were first plated and expanded in EGF alone for five days to circumvent the effect of miR-17~92 
on activation and proliferation described above. At five days, 4OHT was added for 48 hours to 
induce recombination. Following recombination, cells were allowed to differentiate for 7 days in 
the absence of EGF, following which differentiation into neurons, astrocytes, and 
oligodendrocytes was quantified. All conditions were stained with DAPI to visualize nuclei. I 
stained the cells with O4 (a marker of oligodendrocytes), GFAP (a marker of astrocytes), or TuJ1 
(a marker of neurons). I then quantified DAPI+ cells for expression of tdTomato, eGFP, and 
either GFAP, O4, or TuJ1 (Figure 3.9A).  
Strikingly, miR-17~92-/- cells (CreERT2+eGFP+) only generated about 25% as many 
neurons as their miR-17~92+ counterparts (CreERT2-tdTomato+ cells) (Figure 3.9H-J, p < 0.039), 
while astrocyte and oligodendrocyte formation was not significantly affected (Figure 3.9B-G). 
Therefore, miR-17~92 cluster deletion selectively decreases the amount of neurogenesis in vitro, 
but does not affect astrocyte or oligodendrocyte formation, although these studies do not rule out 




Figure 3.9 miR-17~92 deletion alters neurogenesis in vitro 
(A) Schema of differentiation experiment timeline. Seven days after recombination, (B –C) GFAP+ astrocytes (blue) 
are made by both miR-17~92 + (B, red) and miR-17~92- (C, green) cells and the amount of astrocytes made by each 
is the same (D). (E-F) O4+ oligodendrocytes (blue) are made by both miR-17~92+ (E, red) and miR-17~92- (F, 
green) cells and the amount of oligodendrocytes made by each is the same (G). TuJ1+ neurons (blue) are made by 
both miR-17~92+ (H, red) and miR-17~92- (I, green) cells, although the amount of neurons made are reduced when 
miR-17~92 is deleted (J, n=3, p < 0.039). 
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miR-17~92 Deletion In Vivo 
In the first part of this chapter, I found that loss of the miR-17~92 cluster results in a lack 
of activation, proliferation, and neurogenesis in vitro. I then wanted to understand whether the 
same effects would occur when miR-17~92 was deleted in vivo. In order to selectively look at 
the effect of miR 17~92 cluster deletion on V-SVZ stem cells, which are GFAP+, I generated a 
new line of mice in which GFAP-CreERT2 is used to drive recombination. The mice possess 
miR-17~92 +/+ or fl/fl loci and the R26R lslTomato+/+ reporter. In these mice, tamoxifen treatment 
induces Cre activity only in cells expressing GFAP. These cells then either have no change to the 
miR-17~92 locus, or homozygously delete it. In all mice, CreERT2 expression drives expression 
of the Tomato protein by removal of a stop codon, which allows tracking of cells in which 
recombination has occurred (Figure 3.10).  
 
Young adult mice aged 2-4 months, were interperotineally injected with tamoxifen once a 
day for three days to induce recombination. Thirty days after induction of recombination, brains 
were sectioned and immunostained with GFAP (a marker of V-SVZ astrocytes), mini-
Figure 3.10 Schema of miR-17~92 recombination strategy in vivo 
Top- miR-17~92 fl/fl mice and +/+ mice before recombination by GFAP-driven CreERT2. After recombination, +/+ 
retain the miR-17~92 locus, while the fl/fl mice lose it (Bottom). Both types of mice recombine out the stop codon 
encoded before the Tomato protein and become Tomato positive (Bottom right). 
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chromosome maintenance protein 2 (MCM2, a marker of dividing cells), or Doublecortin (DCX, 
a marker of neuroblasts and newly generated neurons) (Figure 3.12A). To quantify changes in 
marker expression among recombined cells, the V-SVZ was imaged in z-stacks at 4 positions; 
the outermost lateral edge (OE), central wedge (W), most ventral edge (B), and halfway between 
the ventral edge and central wedge (C) (Figure 3.11).  
 
I counted Tomato+ cells and their co-expression with GFAP (Figure 3.12B-C, green), 
MCM2 (Figure 3.12B-C, blue), or DCX (Figure 3.12G-H, blue). Interestingly, there is a 32% 
increase in the proportion of Tomato+GFAP+ cells (Figure 3.12B-C, yellow) in mice that have 
lost the miR-17~92 locus (Figure 3.12D, p < 0.008), and a concomitant 60% decrease in the 
proportion of Tomato+MCM2+ (Figure 3.12B-C and E, purple, p < 0.0125). Importantly, the 
proportion of Tomato+DCX+ cells was reduced by almost 50% when miR-17~92 was deleted 
(Figure 3.12F-H, purple, p < 0.0001). Together, these data indicate that loss of miR-17~92 leads 
to a decrease in proliferation in GFAP-derived cells, and furthermore significantly reduces 
neurogenesis in vivo.  
Figure 3.11 Schema of in vivo 
imaging 
Anatomy: CC- corpus callosum, LV – 
lateral ventricle AC—anterior 
commissure. Imaging areas indicated 
by blue boxes: OE – outer lateral 
edge of the V-SVZ. W– the wedge of 
the V-SVZ where the dorsal and 
lateral walls meet. C – Center of the 
dorsal ventral axis of the V-SVZ. B – 
the bottom of the V-SVZ or	  most 








In this chapter, I have shown that miR-17~92 is enriched in aNSCs. By FACS purifying 
aNSCs from conditional miR-17~92 deletion mice, I have demonstrated that this cluster is 
responsible for most of the in vitro activation and proliferation activity exhibited by aNSCs. 
Importantly, my work shows, for the first time, that this miR cluster is involved in proliferation 
and activation at the stem cell level in the adult brain. Notably, this model showed that the miR-
17~92 cluster is not involved in aNSC survival at early time points after deletion. Finally, loss of 
the miR-17~92 cluster leads to a decrease in neurogenesis, but does not affect astrocyte or 
oligodendrocyte generation in vitro.  
After selective deletion of miR-17~92 in GFAP+ V-SVZ stem cells in vivo, there was a 
notable increase in the proportion of GFAP+ cells while there was a concomitant decrease in the 
number of MCM2+ cells, indicating that there is an increase in the number of non-dividing 
GFAP+ V-SVZ astrocytes. Furthermore, I showed that miR-17~92 also leads to decreased levels 
of neurogenesis. I will follow up these studies with immunostaining for mature neuron markers 
in the olfactory bulb to confirm that fewer neurons are made in vivo. Further studies are needed 
to determine if miR-17~92-/- cells are largely quiescent or differentiating prematurely into 
astrocytes via immunostaining with S100β, a marker of mature astrocytes. Given the continued 
radial morphology of cells in which miR-17~92 has been deleted, I predict that there will be no 
Figure 3.12 Effects of miR 17~92 deletion in vivo 
(A) Schema of miR 17~92 deletion in vivo. (B) Wild-type coronal section stained for GFAP (green) and MCM2 
(blue). (C) miR-17~92-/- brain section stained with GFAP (green) and MCM2 (blue). (D) Quantification of 
Tomato+GFAP+ cells. (E) Quantification of Tomato+MCM2+ cells. (F) Quantification of Tomato+DCX+ cells. 
(G) Wedge area of wild-type brain section stained for DCX (blue). (H) Wedge area of miR-17~92-/- brain section 
stained for DCX (blue). White asterisks indicate DCX- cells, while black asterisks indicate DCX+ cells. For all 
images, recombined cells are Tomato+. 
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change in the number of S100β positive cells, and that instead the proportion of quiescent stem 
cells will have increased.  
In the next chapter, I will explore potential targets of the miR-17~92 cluster that may 
mediate quiescence and have to be downregulated in order for miR-17~92 to have its pro-




RNA Collection for Profiling and Validation Experiments 
qNSCs, aNSCs and transit amplifying cells were purified from GFAP::GFP mice and processed 
into cDNA as outlined in Chapter 2 and Codega et al., 2014.  
miRNA Profiling 
RNA was extracted using the miRNeasy kit (Qiagen). cDNA was synthesized using the WT-
Ovation Pico System (NuGEN). cDNA was applied to Taqman low-density arrays as specified 
by the manufacturer at the Collaborative Science Genome Technology Center of New York 
University Langone Medical Center. 
Raw data from at least three replicates per cell type was then loaded into the Statminer program 
where several control RNAs were identified and used to normalize the dataset. Genespring GX 
11 was used to analyze the normalized dataset and identify differentially expressed miRs by 
analysis of variance (ANOVA).  
qPCR Validation 
RNA from FACS-purified populations was extracted for a miR-rich fragment using the 
miRNeasy kit as described in Codega et al., 2014. miR-rich cDNA was then created using the 
Exiqon miRCURY LNA Universal RT microRNA kit. qPCR for the six members of the miR-
17~92 cluster was then run using Exiqon miRCURY LNA probes for the mature forms of the 
miRs, in accordance with the LNA probes. 
Mice Breeding and Usage for miR-17~92 In Vitro Deletion Experiments 
CAGG-CreERT2+/-; miR-17~92fl/fl mice were a generous gift from Jun-An Chen of the Wichterle 
lab. These were then bred to ROSA (ACTB-tdTomato,-EGFP+/+) mice to generate CAGG-CreERT2+/- or -/-; 
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miR-17~92fl/fl; ROSA (ACTB-tdTomato,-EGFP+/+) mice. These mice express tdTomato before 
recombination, and eGFP afterwards, allowing tracking of recombination. 
Sort Strategy and in vitro assays 
CAGG-CreERT2+/- or -/-; miR-17~92fl/fl; ROSA (ACTB-tdTomato,-EGFP+/+) mice were processed for FACs 
as in Codega et al. and stained with CD24-FITC (1:1000; BD Pharmingen), EGF-Alexa647 
(1:300; Molecular Probes), and biotinylated rat anti-mCD133 (1:300, clone 13A4, 
eBioscience), which was followed by secondary staining with PE-Cy7-conjugated streptavidin 
(1:1000; eBioscience). 
For all in vitro assays, FACS-purified aNSC+ cells were purified from young adult mice aged 2-
4 months.  
Neurosphere Assay 
For the neurosphere assay, aNSC+ cells were plated at a density of 100 cells per well in 96-well 
low-attachment plates (Costar). Cells were grown in Neurosphere medium (NSM), composed of 
DMEM/F12 (Life Technologies) supplemented with 0.6% Glucose (Sigma), 1x Hepes (Life 
Technologies), 1x Insulin-Selenium-Transferrin (Life Technologies), N-2 (Life Technologies), 
and B-27 supplement (Life Technologies) in the presence of 20 ng/ml EGF (Upstate). For the 
first 24 hours immediately after plating, cells were also treated with 500nM hydroxytamoxifen 
(4OHT, Sigma) or vehicle (500nM ethanol, EtOH). At 24 hours, half of the media was replaced 
with NSM & EGF to reduce toxicity. The cells were then monitored every 2 days for sphere 
formation and recombination.  
Neurosphere Passaging 
At 7 days post-plating, the total content of each well was collected and dissociated with 3 mg 
(600 units) of papain for 10 min at 37°C. The reaction was stopped by adding ovomucoid 
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inhibitor (Worthington, 0.7 mg). DNAse (Worthington, 0.5 mg) was added and cells dissociated 
to single cells by pipetting. The resulting cells were then re-plated at a density of 100 live cells 
per well (as determined by trypan blue staining). This plating was then monitored for the 
formation of secondary spheres every two days.  
Adherent Assay 
This assay was used to monitor activation, proliferation, survival, deletion, and differentiation. 
96-well plates were coated with poly-D-lysine (Sigma, 10 μg/ml) and Fibronectin (Sigma, 2 
μg/ml). Cells were then plated at a density of 100 cells per well. For activation/proliferation 
during the first 24 hours after plating, cells were treated with NSM & EGF, NSM & EGF & 
250nM 4OHT, or NSM & EGF & 250nM vehicle (EtOH). At 24 hours, the entire media was 
replaced with NSM & EGF to prevent toxicity. Wells were imaged at 5 days post plating with 
DAPI to visualize cells present and recombination rates as shown by tdTomato or eGFP 
positivity.  
Survival Assay 
For survival assays, during the first 24 hours after plating, cells in NSM were treated with NSM 
& EGF, NSM & EGF & 250nM 4OHT, or NSM & EGF & 250nM vehicle (EtOH). At 24 hours 
the media was replaced with NSM alone for 5 days, at which point cells were stained with 
Annexin V-Alexa647 (1:500, Life Technologies), fixed for 30 minutes with 3.2% PFA, and 
stained for DAPI (1:1000, SIGMA). The wells were imaged on the ZEISS Observer 7.1 at 5x. 
DAPI+ cells were quantified for co-expression with Tomato, eGFP, and Annexin V using the cell 
counter plugin for FIJI.  
Deletion Assay 
To confirm deletion of the miR-17~92 cluster, after plating cells were grown in NSM & EGF for 
five days, then the entire media was replaced with NSM & EGF, NSM & EGF & 250nM 4OHT, 
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or NSM & EGF & 250nM vehicle (EtOH) for two days to induce recombination. At 7 days post-
plating, cells were given NSM & EGF for 5 days to allow recombined cells to further expand. At 
5 days post-recombination, cells were collected for sorting; they were first treated with Trypsin 
for 5 minutes at 37°C, then treated with NSM to stop the trypsin reaction. The cells were then 
dissociated into single cells by pipetting and passed through a 40-μm filter. DAPI was added 
prior to FACS to remove dead cells. Cells were then gated by their expression of tdTomato and 
eGFP. DNA was extracted using a specialized digestion buffer, provided by Chyuan-Sheng 
(Victor) Lin of the Columbia University Transgenic Core Facility. Deletion of the miR-17~92 




A band of ~2kb indicates an intact locus, whereas a band of ~1kb indicates deletion of miR-
17~92. To verify the loss of mature miR expression, RNA was extracted from sorted cells using 
the Exiqon miRCURY RNA extraction kit, and expression of mature miRs assayed by qPCR 
using the Exiqon probe for miR-17 as described above.  
Differentiation Assay 
For differentiation assays, after the initial five-day expansion with EGF and two days of 
recombination as performed for the deletion assay, cells were cultured with NSM only for 7 days 
to induce differentiation. Cells were then live stained with mouse IgM anti-O4 (1:500, 
Chemicon) for 30 minutes, fixed as above, and stained overnight with rat anti-GFAP (1:500, 
Table 3.1 miR-17~92 deletion primers 
17~92 deletion forward 
TCGAGTATCTGACAATGTGG  




Invitrogen) or mouse anti-βIII Tubulin (TuJ1, 1:500, Covance). All post-fix staining was 
performed in PBS with 10% normal goat or donkey serum and 0.5% Triton X-100. Secondary 
antibodies were used at 1:500 (Alexa fluor-conjugated, Molecular Probes). Prior to imaging cells 
were incubated for 5 minutes in DAPI. Images were then hand counted for the co-expression of 
DAPI with tdTomato, eGFP, and either O4, GFAP, or TuJ1.  
Mice Breeding and Usage for miR-17~92 Deletion In Vivo 
CAGG-CreERT2-/-; miR-17~92fl/fl; ROSA (ACTB-tdTomato,-EGFP -/-) mice were then crossed to GFAP-
CreERT2+/- mice and R26R lslTomato+/+ mice to generate GFAP-CreERT2+/-; miR-17~92+/+ or fl/fl; 
R26R lslTomato+/+ mice.  
Experimental Paradigm for In Vivo miR-17~92 Deletion 
To induce deletion of the miR-17~92 cluster, young adult GFAP-CreERT2+/-; miR-17~92+/+ or 
fl/fl; R26R lslTomato+/+ mice aged 2-4 months were intraperitoneally injected once every 24 hours 
over the course of three days with 0.1 mL of 30uM tamoxifen (Tam) in 90% sunflower seed oil, 
10% EtOH. After a 30-day chase, mice were transcardially perfused with saline and 3.2% PFA. 
Brains were then removed and placed in 3.2% PFA overnight at 4°C. 30-50μM thick sections 
were cut using a vibratome (Leica) and immunostained as previously described (Doetsch et al., 
2002; Doetsch & Alvarez-Buylla, 1996). Sections were then stained as described above with rat 
anti-GFAP (1:500, Invitrogen), goat anti-MCM2 (1:100, Santa Cruz Biotechnology), and guinea 
pig anti-DCX (1:1000, Millipore).  
The V-SVZ was imaged on a Zeiss 500 or 800 LSM confocal microscope in z-stacks at 4 
positions; the outermost lateral edge, central wedge, most ventral edge, and halfway between the 
ventral edge and central wedge. Images were quantified in FIJI using the Cell Counter plug-in to 
count each stack continuously.  
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Chapter 4 mRNA Targets of the miR-17~92 Cluster 
Introduction 
In Chapter 3, I show that the miR-17~92 cluster is important for adult neural stem cell 
activation, proliferation, and neurogenesis. The function and mode of action for microRNAs is 
largely dependent on the mRNAs available for targeting, i.e. the context of their expression. To 
identify potential targets of miR-17~92, I used databases of computationally predicted miRNA 
targets in combination with the high dimensional data sets for mRNAs and miRNAs (described 
in Chapter 2 and Chapter 3). I identified three interesting potential targets: Mycn, Lrig1 and 
S1pr1. In this chapter, I perform expression analyses to show that Mycn, Lrig1, and S1pr1 are 
expressed in V-SVZ stem cells, and focus on the functional interaction between miR-17~92 and 
S1PR1 in the adult V-SVZ. 
Results 
Computational Identification of miR-17~92 mRNA Targets, Including S1PR1 
 microRNAs repress gene expression at a post-transcriptional level through two 
mechanisms:  translational repression or mRNA decay, with mRNA decay being the dominant 
mode in mammals (reviewed in Li & Rana, 2014). In the mRNA decay mechanism, not only is 
there a reduction in the final gene product, i.e. protein, but there is also a measureable decrease 
in the mRNA present. Therefore, in my search for miR 17~92 cluster targets, I used our 
microarray data to look for genes which had enriched expression in qNSCs. 
First, I identified genes that were common targets for multiple members of the miR-
17~92 cluster. To do so, I obtained a list of predicted mRNA targets for each individual member 
of the 17~92 cluster (miR-17, 18a, 19a, 29a, 19b, and 92a) from the TargetScan 5.2 database 
(Lewis et al., 2005). I then cross-referenced these lists to find genes that were targeted by two or 
more miRs.   
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Interestingly, one of the common targets of all six members of the miR-17~92 cluster is 
Mycn/N-myc, which is a known activator of miR-17~92 transcription (Fontana et al., 2008; 
Schulte et al., 2008). By microarray and qPCR, Mycn expression is restricted to the aNSCs 
(Figure 4.1, green line), while the miR-17~92 cluster continues to be expressed in TACs (Figure 
4.1, royal blue lines). This expression pattern suggests that after being activated by N-myc in 
aNSCs, the miR-17~92 cluster forms a negative feedback loop by suppressing Mycn, the results 
of which may be the observed reduced expression of Mycn in TACs. Indeed Cloonan et al. 
showed that Mycn is a direct target of miR-17. Furthermore, N-myc is an immediate-early gene 
(Kenney et al., 2003), which suggests that N-myc expression induction may be a rapidly-induced 




I next focused my analysis on identifying genes that were targeted by multiple members 
of the miR-17~92 cluster and showed mRNA enrichment in the qNSCs over aNSCs, as 
downregulation of these targets might be relevant to achieving an activated or proliferative state. 
To find such genes, I used Genespring to generate a list of all genes that were targeted by at least 
two miR-17~92 cluster members and at least two-fold enriched in our qNSC population.  
From this analysis, I identified Lrig1, which I had already verified as expressed in our 
qNSCs by qPCR (Figure 2.6G, Figure 4.2, magenta line). TargetScan predicts it to be targeted by 
members of the miR-17/20 seed sequence family, as well as by the miR-19 family (Figure 4.2, 
Figure 4.1 Expression of N-myc and its targeting miRNAs 
Green- Mycn qPCR expression. Royal blue – expression of miR-17~92 cluster members that 
target Mycn by TLDA. All cluster members except for miR-92a are predicted to target Mycn. 














royal blue lines). As discussed in Chapter 2, Lrig1 functions to degrade EGFR protein, thereby 
preventing the cell from receiving EGF signaling (Gur et al., 2004). Therefore, downregulation 
of Lrig1 expression by the miR-17~92 cluster could be important for activation of qNSCs, as it 
would allow perdurance of EGFR proteins at the cell surface, and hence increased EGFR 
signaling. This hypothesis is supported by the fact that EGFR signaling is enriched in aNSCs and 
is important for maintaining proliferation in the V-SVZ (Figure 2.6, Doetsch et al., 2002). 
Notably, when I reversed this analysis and examined the expression of miRs predicted to target 
Lrig1 by our TLDA data, approximately 75% of these miRs are greater than 1.5-fold enriched in 
aNSCs over qNSCs (Figure 4.2, blue lines). This finding further highlights Lrig1’s potential 




The gene set enrichment analysis outlined in Chapter 2 showed that approximately 30% 
of the sets enriched for signaling in the qNSCs were involved in G-protein coupled receptor 
signaling, and that some of these had functional effects on the behavior of qNSCs (see Figure 
2.10). I was curious as to whether any of the genes identified in these sets were also targets of the 
miR 17~92 cluster. To determine whether there was overlap between GPCR genes and predicted 
17~92 targets, I downloaded individual target lists for each member of the 17~92 cluster (miR-
17, 18a, 19a, 29a, 19b, and 92a) from StarBase 2.0 (Yang et al., 2010; Li et al., 2013). I then 
cross-referenced these lists to the list of GPCR genes upregulated in qNSCs over aNSCs (Table 
Figure 4.2 Expression of Lrig1 and its targeting miRNAs 
Magenta line- Lrig1 expression by qPCR. Royal Blue lines- expression of members of the miR-17~92 
cluster predicted to target Lrig1 by TLDA. Medium Blue- miRs with at least 1.5x fold enrichment in 
aNSCs over qNSCs by TLDA. Light Blue Lines- expression of remaining miRs predicted to target 
Lrig1 by TLDA. N=3. 
 
 83 
2.2). Of these, S1pr1 was the top candidate as it had the most miR-17~92 cluster members 
computationally predicted to target it, and had an 11-fold increase in expression in qNSCs over 
aNSCs by microarray analysis (Table 4.1). S1PR1 is an especially interesting candidate as 
treatment of qNSCs with its ligand, S1P, decreased their activation and proliferation (Figure 
2.10).  
Shading in the column “Fold change from aNSC” relates to the magnitude of fold change with dark red 
corresponding to high enrichment in qNSCs and blues indicating enrichment in aNSCs 
 
Although there are five S1P receptors, S1pr1 and S1pr5 are the only members of the 
family expressed in the qNSC population. Of the two, S1pr1 has a much higher level of 
expression in qNSCs than S1pr5, suggesting that the effects observed from treatment of qNSCs 
Gene Name Gene Symbol Fold Change from aNSC Targeting 17~92 members 
Frizzled 6 Fzd6 18.597136 17, 20 
14.635587 
11.8910055 
Sphingosine 1 phosphate 
receptor 1 
S1pr1 11.028068 17, 19a, 19b, 20, 92a 
Opiate receptor-like 1 Oprl1 7.331031 19a, 19b 
G-protein coupled 
receptor 146 
Gpr146 6.4464536 17, 20 
-1.1891292 





Gpr174 1.2402235 17, 20 
-1.520696 
Table 4.1 Identification of potential targets of the 17~92 cluster from among genes involved in G-
protein coupled receptors  
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with S1P in Chapter 2 might be due almost entirely to S1PR1-mediated signaling (Figure 4.3, 
fuchsia line vs. dark blue line).  
 
As with Lrig1, I was interested in the expression pattern of other potential miR regulators 
of S1pr1. Interestingly, over 70% of the miRs computationally predicted to target S1pr1 were 
upregulated in aNSCs over the qNSCs (Figure 4.3, light blue lines), further highlighting the 
potential importance of S1pr1 in maintaining quiescence of qNSCs. This possible involvement of 
S1PR1 in maintaining quiescence suggests a regulatory role for miR-17~92 in mediating the 
Figure 4.3 microRNAs predicted to target S1pr1 are upregulated in aNSCs 
Dark Blue – microarray expression of S1pr1. Light blue- Expression of miRs predicted to 
target s1pr1 and also enriched in aNSCs by TLDA. Over 70% of the miRs predicted to 
target S1pr1 are enriched in aNSCs Pink- Expression of S1pr5 by microarray.  
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transition from quiescence to activation by repressing S1PR1 expression. I therefore focused on 
this miR-17~92 target for further functional studies.  
S1pr1 mRNA and Protein Expression in the V-SVZ 
I first verified S1pr1 mRNA expression in V-SVZ stem cells by performing qPCR in 
FACS-purified populations. S1pr1 expression was enriched in qNSCs over aNSCs (Figure 4.4).  
 
I then performed immunostaining for S1PR1 protein in coronal sections of the adult V-
SVZ of CD-1 (“wild-type”) mice for GFAP, MCM2, and S1PR1, using the same S1PR1 
antibody as characterized in Nishimura et al., 2010 and Akiyama et al., 2008. I found that V-
SVZ astrocytes, as well as those in the striatum, are S1PR1 positive, which is in accordance with 
the distribution observed by Akiyama et al., 2008 and Nishimura et al., 2010 (Figure 4.5A-D). 
Although GFAP co-immunostaining is difficult to quantify, most GFAP-positive cells were also 
S1PR1+. The vast majority of S1PR1+GFAP+ cells were negative for MCM2 (Figure 4.5E). 
Moreover, S1PR1 expression regardless of GFAP was largely restricted to non-dividing cells, as 
Figure 4.4 S1pr1 mRNA expression by qPCR 
S1pr1 mRNA expression was analyzed in indicated cells 
types by qPCR. Y axis is logarithmic fold change from 
total SVZ sample, calculated by the 2^ΔΔCt method. N=3. 
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only 1% of all S1PR1 positive cells were also MCM2 positive (Figure 4.5F). Conversely, less 







To investigate whether S1PR1 was a functional target of miR-17~92, I assessed changes 
in S1PR1 expression after deletion of miR-17~92 in GFAP-CreERT2+/-; miR-17~92+/+ or fl/fl; 
R26R lslTomato+/+ mice (described in Chapter 3). If S1PR1 is a target of miR-17~92, loss of this 
cluster should lead to an increase in MCM2+ cells expressing S1PR1 protein. To explore this 
possibility, mice received interperotineal injections of tamoxifen once a day for three days, 
followed by a 30-day chase. Brains were then immunostained for S1PR1 (Figure 4.6A and B 
green), and MCM2 (Figure 4.6A and B, blue). Tomato expression was used to track recombined 
cells (Figure 4.6A and B, red).  
When miR-17~92 was deleted, a greater proportion of Tomato+ cells expressed S1PR1 
than their wild-type counterparts (Figure 4.6C, p < 0.005). In agreement with earlier MCM2 
immunostaining data, in this instance I also observed fewer Tomato+MCM2+ cells when miR-
17~92 was deleted (Figure 4.6D). Strikingly, despite the overall decrease in Tomato+MCM2+ 
cells, there was an increase in Tomato+MCM2+S1PR1+ cells in the mutant mice, confirming that 
S1PR1 is normally targeted by miR-17~92 in these cells (Figure 4.6E) 
 
Figure 4.5 S1PR1 expression in the adult V-SVZ 
(A-D) The wedge of the V-SVZ showing expression of MCM2 (blue, B), S1PR1 (Red, C) and GFAP (green, D). 
merge (A) Yellow arrowheads indicate an example of a double positive cell, white asterisk shows an example of a 
cell expressing S1PR1 only. (E) Percentage of GFAP+ cells that are S1PR1 positive from all areas. (F) Percentage of 
S1PR1 positive cells that are MCM2+ (purple) or MCM2+ and GFAP+ (gray). (G) Percentage of MCM2+ cells that 






Figure 4.6 S1PR1+ cells increase in number when miR-17~92 is deleted 
(A) Merge of wedge region of wild-type mouse in which recombined cells are Tomato+ (red) sections stained for 
S1PR1 (green) and MCM2 (blue). Orange arrow indicates a Tomato+S1PR1+ cell. Red arrow indicates 
Tomato+MCM2+ (B) Merge of wedge region from miR-17~92-/- mouse recombined cells are Tomato+ (red) sections 
stained for S1PR1 (green) and MCM2. (blue). Orange arrow indicates a Tomato+S1PR1+ cell. Red arrow indicates 
Tomato+MCM2+. (C) Quantification of S1PR1+Tomato+ cells. (D) Quantification of MCM2+Tomato+ cells. (E) 





In this chapter, I have identified Mycn, Lrig1, and S1pr1 as potential targets of miR-
17~92 mediated repression and examined the functional consequences of miR-17~92 on S1PR1. 
S1pr1 is largely expressed, at both the RNA and protein levels, by non-dividing GFAP+ V-SVZ 
astrocytes.  
In the future, it will be important to establish whether S1PR1 expression is restricted to 
qNSCs or simply non-dividing astrocytes in both homeostatic and miR-17~92 deleted 
conditions. Co-immunostaining with S100β will determine whether S1PR1 is expressed by 
mature astrocytes. Nestin is a marker of aNSCs (Codega et al., 2014), therefore, co-staining with 
S1PR1 will further resolve whether S1PR1 is expressed in these cells. Interestingly, induction of 
S1PR1 signaling in angiogenic cells stops them from making new sprouts, but inhibition allows 
new vessels to grow ectopically (Gaengel et al., 2012). It could be that similar mechanisms are at 
work in regulating the behavior of angiogenic cells as well as neurogenic cells of the V-SVZ. 
The expression of S1pr1 in qNSCs in combination with the strong effect on blocking 
activation and proliferation that S1P treatment has on these cells (Figure 2.10), suggests that 
S1PR1 may be playing an important role in the active maintenance of the quiescent stem cell 
state. Furthermore, S1pr1 mRNA, but not protein, is expressed in aNSCs, and S1PR1 protein is 
upregulated upon miR-17~92 deletion in vivo, showing that S1pr1 is targeted by miR-17~92. 
Together, these findings suggest that in the adult V-SVZ, S1PR1 signaling works to maintain 
stem cell quiescence and needs to be downregulated in order for activation to take place 




Figure 4.7 Model of miR-17~92 mediated stem cell activation via repression of S1pr1 




Bioinformatic Analysis of miRNA and mRNA Interactions within V-SVZ Lineage Cells 
A list of genes involved in GPCR signaling was compiled from the GSEA enrichment results 
generated in Chapter 2. This list was then imported into Genespring where fold change for the 
probes for each gene were added to the table. In parallel, computationally predicted targets for 
the individual members of the miR-17~92 cluster, miR-17, 18a, 19a, 20a, 19b and 92a were 
downloaded from StarBase 2.0 (Li et al., 2013; Yang et al., 2010). The miR lists and GPCR lists 
were compared to find overlap. Those miRs that contained a given GPCR gene were then 
recorded into the GPCR table.  
To determine which miRs target S1pr1, a list of its computationally predicted targeting miRs was 
downloaded from StarBase 2.0 and imported into Genespring. Fold change analysis was then run 
on the expression of those miRs in aNSCs as compared to qNSCs. 
qPCR for S1PR1 
RNA was purified from FACS sorted populations by the miRNeasy kit (Qiagen) and cDNA 
was generated using WT- Ovation Pico System (NuGEN). The total SVZ sample consisted of 
all live cells (all cells in Figure 2.1A). For qRT-PCR, all reactions were carried out in triplicate 
on 3 biological replicates using Brilliant III Ultra Fast SYBR Green QPCR Master Mix (Agilent) 
in a Stratagene Mx3000P machine with an annealing temperature of 60ºC. Data was normalized 
to GAPDH expression and analyzed by the 2-ΔΔCT method (Livak & Schmittgen, 2001). 






Gene name Forward primer Reverse Primer 
S1pr1 ACAGCACCTTTGGCACTTTT TCTCCCCCAGTTGGTTGAAAT 
 
S1PR1 Expression in Wild-Type V-SVZ 
Young adult 2-3 month old CD-1 mice (Jackson Laboratories) were sacrificed and transcardially 
perfused to with saline and 3.2% PFA. Brains were then removed and placed in 3.2% PFA 
overnight at 4°C. Brains were then made into 50 μm sections using a vibratome (Leica) as 
previously described (Doetsch et al., 2002; Doetsch & Alvarez-Buylla, 1996). These sections 
were then stained for rabbit anti-S1PR1 (1:50, Santa Cruz Biotechnology), rat ant-GFAP 
(1:1000, Invitrogen), and goat anti-MCM2 (1:100, Santa Cruz Biotechnology). Sections were 
imaged on Zeiss 500 and 800 Confocals in four areas per section: the outermost lateral edge, 
central wedge, most ventral edge, and halfway between the ventral edge and central wedge. 
Staining was quantified in FIJI using the Cell Counter plug-in to count each stack continuously. 
For MCM2, only those cells showing a solid nucleus were counted as MCM2-positive, 
regardless of their size.  
S1PR1 Expression After miR-17~92 Deletion 
Young adult GFAP-CreERT2+/-; miR-17~92 +/+ or fl/fl; R26R lslTomato+/+ mice aged 2-4 months 
were intraperitoneally injected once every 24 hours over the course of three days with 0.1 mL of 
30uM tamoxifen (Tam) in 90% sunflower seed oil, 10% EtOH. After a 30-day chase, mice were 
sacrificed and their brains sectioned. Sections were then immunostained with rabbit anti-S1PR1 
(1:50, Santa Cruz Biotechnology) and goat anti-MCM2 (1:100, Santa Cruz Biotechnology) and 
quantified as described above.  
Table 4.2 Primers used for the detection of S1pr1 
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Chapter 5 Discussion and Future Directions 
Over the course of this dissertation, I have shown that the transcriptomes of quiescent and 
activated adult neural stem cells are significantly different, and share features with quiescent or 
activated stem cells of other tissue compartments. I identified the miR-17~92 cluster as 
significantly enriched in activated neural stem cells, and determined that it plays an important 
role in stem cell activation, proliferation, and neuronal differentiation. Finally, I identified 
S1PR1 as potential mediator of quiescence. S1PR1 expression increases when miR-17~92 is lost 
in vivo and therefore is a functional target of this cluster. 
Quiescent and Activated States are Transcriptionally Distinct and Actively 
Maintained 
Bioinformatic analysis shows that qNSC and aNSC populations possess strikingly and 
significantly different gene expression. aNSC transcriptomes are dominated by expression of 
genes related to cell cycling and the concomitant DNA/protein metabolism required to support 
this, a finding which has recently been confirmed (Llorens-Bobadilla et al., 2015). qNSCs show 
an enrichment for lipid metabolism, a feature found in the other quiescent cell types examined 
above, and is important for normal neurogenesis (Knobloch et al., 2013). Lipid metabolism as 
well as glucose metabolism were both confirmed to correlate with more quiescent adult neural 
stem cell populations both in the V-SVZ and SGZ (Llorens-Bobadilla et al., 2015; Shin et al., 
2015).Quiescent stem cells additionally expressed markers in common; for example, Lrig1 is 
common to the V-SVZ, intestine, and skin stem cells (Codega et al., 2014; Jensen & Watt, 2006; 
Jensen et al., 2009; Powell et al., 2012). 
 Both quiescent and activated neural stem cells show enrichment in diverse signaling 
pathways. aNSCs not only express EGFR but are also enriched for components of the EGFR 
signaling pathway. qNSCs are enriched for several types of cell signaling, the largest of which is 
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GPCR mediated signaling. It will be important to functionally explore the signaling pathways 
active in qNSCs to determine which are important for maintaining quiescence, and how qNSCs 
integrate information from the niche to determine whether to become activated. 
A promising candidate for further investigation into quiescence and activation mediation 
is the Lrig1-EGFR signaling axis. Lrig1 has high expression among the qNSCs, while EGFR is 
highly expressed by the aNSCs. Previous work has shown that Lrig1 targets EGFR for 
degradation from the membrane, thereby downregulating EGFR signaling (Gur et al., 2004). 
Interestingly, loss of Lrig1 function causes hyperplasias in skin (Gur et al., 2004). Lrig1 is a 
predicted target of the miR-17~92 cluster, as well as many other miRs expressed in aNSCs. 
Therefore, Lrig1 expression in the qNSCs may maintain their quiescent state by degrading 
EGFR, thereby preventing premature activation by downregulating the cell’s ability to respond 
to EGFR signaling. Lrig1’s repression of this pathway must be downregulated in order for cells 
to have sustained EGFR expression and become activated. Greater understanding of the normal 
function of Lrig1 may be pivotal to developing cancer treatments, as Lrig1 was recently 
identified as one of four genes with prognostic impact in glioma (reviewed in Simion et al., 
2014).  
Of the signaling pathways enriched in qNSCs, the best-represented family is GPCRs. 
While GPCRs modulate many different facets of adult neurogenesis (reviewed in Doze & Perez, 
2013), for instance the CXCR4 mediated homing of aNSCs in the V-SVZ to blood vessels 
(Kokovay et al., 2010), our findings highlight that GPCRs are also key regulators of qNSCs. In 
particular, we show that S1P inhibits the activation of qNSCs, lending weight to the idea that 
stem cell quiescence is an actively maintained state (Codega et al., 2014).  
 
 96 
This idea was confirmed by Llorens-Bobadilla et al. who show that inhibition of the 
Notch receptors is sufficient to activate quiescent stem cells. Interestingly, upon ischemic injury, 
Llorens-Bobadilla et al.  show that qNSCs are more capable of responding than aNSCs, and that 
qNSCs recruitment is dependent on interferon-γ signaling. Llorens-Bobadilla et al. further 
confirm our finding that qNSCs are enriched for many receptors. Together with their functional 
data on Notch and interferon- γ, it is now established that qNSCs are especially attuned to 
environmental cues, and that these signals can be used to both reinforce a quiescent state and 
recruit quiescent stem cells to activate. 
S1P is present in the CSF (Sato et al., 2007), which is emerging as a reservoir of factors 
important for stem cell regulation in both the embryo and the adult (Silva-Vargas et al., 2013). 
Furthermore, microarray analysis of the lateral ventricle choroid plexus (CP), a mini-organ 
located within the ventricles that produces the CSF, revealed that this organ expresses several 
genes involved in S1P metabolism and export (Table 5.1, CP expression is unpublished data 
from Violeta Silva-Vargas). Strikingly, many of the same genes are enriched in qNSCs over 
aNSCs (Table 5.1). In fact, S1P can act in an autocrine and paracrine manner in many tissues, 
including during angiogenesis (reviewed in Maceyka et al., 2012). Therefore, in the V-SVZ, both 
the CP and qNSCs may produce S1P in order to mediate quiescence. As such, the CSF, CP, and 













family A (ABC1), member 1 Abca1 
+ 1605.413833 562.3829267 
1421840_at +++++ 7125.9598 2478.051867 
1450392_at No information 4313.761967 1255.742033 
1421378_s_at ATP-binding cassette, sub-
family C (CFTR/MRP), 
member 1 
Abcc1 
No information 724.84283 291.1922367 
1452233_at No information 488.38209 430.0338433 
1451601_a_at spinster homolog 2 (Drosophila) Spns2 + 203.0812567 104.382625 
1451596_a_at sphingosine kinase 1 Sphk1 --  6.499328967 14.954722 
1417431_a_at 
sphingosine kinase 2 Sphk2 
+ 552.66867 505.7168133 
1426230_at ++ 4125.5728 371.5279733 
1416735_at N-acylsphingosine amidohydrolase 1 Asah1 ++++ 4755.463333 2000.9459 
1425994_a_at 
N-acylsphingosine 
amidohydrolase 2 Asah2 
+ 98.998609 19.8882152 
1450726_at No information 205.5453933 13.1566699 
1458849_at -- 75.68537167 5.707459667 
1450825_at 
alkaline ceramidase 1 Acer1 
-- 8.482901533 5.2214446 
1439183_at -- 12.26565573 9.265371367 
1421496_at 
alkaline ceramidase 2 Acer2 
+ 666.9655433 284.8136767 
1451355_at + 190.1910633 42.403121 
1429520_a_at 
alkaline ceramidase 3 Acer3 
+ 359.5338 96.31067333 
1438435_at + 209.51215 73.9261998 
1453179_at + 103.3996717 31.70996767 
1459771_x_at + 51.15177567 25.89181567 
 
 
Another key component of the niche in mediating quiescence is adhesion, especially to 
the extra-cellular matrix. Bioinformatic analysis shows that genes involved in cell adhesion such 
as Vcam1, Ncam1, and Inta6 are upregulated in the qNSC population of the V-SVZ, as well as 
Table 5.1 Genes involved in S1P metabolism and transport 
Probeset IDs for less than optimal probes have been italicized. Expression in choroid plexus, qNSCs and aNSCs 
has been color coded: no information is white, not present (expression under 50) is gray, expression greater than 




being up regulated in other quiescent stem cells (Table S4). Given the current data, adhesion for 
these cells enhances the reception of quiescence maintenance signals, which may only be present 
in certain restricted domains within the V-SVZ niche, as for example, S1P in CSF.  
As additional anatomical and cellular features of the V-SVZ stem cell niche are 
uncovered, the transcriptome data I present in this thesis will be a tremendous resource to define 
specific molecular candidates. In addition, it will illuminate the gene regulatory networks that 
functionally mediate stem cell quiescence and activation in the adult V-SVZ. 
V-SVZ Stem Cell Heterogeneity 
Recent work has shown that stem cells within the V-SVZ exhibit regional heterogeneity 
in terms of transcription factor expression, and type of olfactory bulb interneuron they generate 
(Merkle et al., 2014; Jhaveri et al., 2015; Ravi et al., 2015; reviewed in Lim & Alvarez-Buylla, 
2014 and Bayraktar et al., 2014). Regional differences in response to injury or diffusible signals 
have also been observed (Lopez-Juarez et al., 2013; Jhaveri et al., 2015). A very recent paper 
performing single cell analysis of adult NSC FACS-purified using GLAST and CD133 have 
begun to dissect the heterogeneity of these cells (Llorens-Bobadilla et al., 2015). Notably, this 
study revealed that qNSCs and aNSCs can be subdivided into four classes; dormant qNSCs, 
primed qNSCs, aNSCs, and dividing aNSCs. Broadly speaking, these cells correspond well with 
molecular features we defined for our qNSCs and aNSCs purified using GFAP::GFP, EGF, and 
CD133. They confirm the expression of Id2 and 3, Hes5, Notch2, Blbp, Bmpr1a, Aldh1l1, and 
Glast in quiescent stem cells, while showing that Sox11 and 4, Ascl1, Dlx1 and 2, as well as Dll1 
are enriched in aNSCs (Table S4).  
In terms of pathway analysis, Llorens-Bobadilla et al. find that lipid metabolism genes 
are expressed in both qNSCs and aNSCs, but are more highly expressed in qNSCs. Furthermore, 
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they find that glycolysis is enriched in qNSCs, which we also found via GSEA (Figure 2.9A, 
Table S3). In accordance with our findings, Llorens-Bobadilla et al. also find that protein 
metabolism correlates activation (Figure 2.9B, Table S3), and can use the amount of protein 
synthesis to differentiate between dormant and primed qNSCs.  
miR-17~92 Mediates Activation and Proliferation of aNSCs 
During my thesis work, I focused on miRs enriched in aNSCs. My bioinformatic analysis 
identified members of the miR-17~92 cluster as highly enriched in aNSCs, as compared to 
qNSCs, In the course of this work, I also identified miRNAs that are enriched in qNSCs, which 
will be very interesting to examine in the future. 
In vitro studies in which miR-17~92 was conditionally deleted suggest that this cluster is 
important to activation of V-SVZ stem cells. Furthermore, those cells that did manage to activate 
proliferated less, suggesting that this cluster is also important to support proliferation. I 
confirmed this finding in vivo, where deletion of the miR-17~92 locus results in reduced 
expression of MCM2 (Figure 5.1, blue group), as well as in decreased neurogenesis.  
Although miR-17~92 has been found to act in a pro-survival manner in the hematopoietic 
system as well as in cancers (summarized in Figure 5.1, Gray group, reviewed in Concepcion et 
al., 2012), there was no effect on apoptosis for aNSCs within the first five days of culturing. A 
lack of survival defects has also been observed in other systems (Bian et al., 2013; Chen et al., 
2013). However, it is possible that miR-17~92 is important for survival at later stages in the V-
SVZ lineage, such as in newly generated neurons. Indeed, the reduction in neurogenesis I 
observed could be due to fewer stem cells becoming activated and progressing down the lineage, 
as well as to selective survival defects in neurons. Distinguishing between these two possibilities 
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is important in determining which mRNAs are being targeted by miR-17~92 in order to drive 
neurogenesis (Figure 5.1 red and gray groups). 
 
In neural stem cells in the embryo, miR-17~92 regulates a temporal switch from 
neurogenesis to gliogenesis, and specifically keeps cells in a neuro-competent state (Naka-
Kaneda et al., 2014). Loss of miR-17~92 in this context causes an increase in the generation of 
GFAP+ cells (Naka-Kaneda et al., 2014). Although a switch to gliogenic competence is an 
intriguing possibility for adult NSCs that have lost miR-17~92 expression, there was no increase 
in GFAP+ cells concomitant with the loss of neurons in my differentiation experiments. This 
disparity may be due to differences between stem cells in the embryo and in the adult. 
Figure 5.1 Model of miR-17~92 functions relevant to the V-SVZ niche based on downstream 
gene repression 
(Gray) miR-17~92 is known to suppress Pten and Bim, thereby evading apoptosis and mediating cell survival 
(Blue) In our study, we find that miR-17~92 expression is important for normal levels of activation. This could 
be achieved through the repression of genes important to maintain a quiescent state. Previous studies and the 
work herein have shown that miR-17~92 promotes a proliferative state. This is achieved in part through the 
suppression of p21, a cell cycle regulatory gene. (Red) miR-17~92 expression is needed for neurogenesis, 
however it is unclear from our studies whether this is achieved through miR-17~92 mediated survival, or failure 
to repress programs for maturation of a different cell type. 
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Conditional miR-17~92 Overexpression Studies 
In addition to conditional deletion of miR-17~92, the effect of ectopic miR-17~92 
overexpression has been well studied. Previous research has found that overexpression of miR-
17~92 leads to marked increase in proliferation of cells in many systems (Olive et al., 2013a; 
Yang et al., 2013; Carraro et al., 2009; Lu et al., 2007; Chen et al., 2013; Li et al., 2012; Liu et 
al., 2013; Trompeter et al., 2011; Venturini et al., 2007; Meenhuis et al., 2011). Confoundingly, 
some studies have found that the forced overexpression of miR-17~92 leads to a concomitant 
increase in apoptosis (Olive et al., 2013a), while others have seen no difference (Liu et al., 2013, 
work done on ischemic V-SVZ and progenitors), or found a protective effect (Tung et al., 2015). 
Additionally, it has been shown that ectopic miR-17~92 overexpression leads to a delay in 
neuronal differentiation (Naka-Kaneda et al., 2014; Lu et al., 2007).  
It would be interesting to overexpress miR-17~92 in the V-SVZ using conditionally 
inducible mice, and to assess the functional consequences on proliferation and neuronal 
production. It would also be exciting to determine if miR-17~92 overexpression induces 
astrocytes in non-neurogenic brain regions to become actively dividing and neurogenic, 
especially as qNSCs have a very similar transcriptome to cortical astrocytes. 
Dissection of the Role of Individual Members of miR-17~92 Cluster 
In the future, it will also be important to dissect which miRNA(s) in the miR-17~92 
cluster contribute to the functional effects described in this thesis. For example, miRs 19a and 
92a are thought to sometimes act antagonistically (Olive et al., 2013b). Understanding which 
components of the miR-17~92 cluster are responsible for which aspects of the phenotypes 
described above could prove essential for fine-tuning V-SVZ stem cell behavior. To dissect the 
effects of each miR or seed sequence family, individual members or small cohorts sharing seed 
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sequences (e.g. 17 and 20a) could be overexpressed in cells to determine their effects on 
behavior. Conversely, it might be more advantageous to knock down all but one miR-17~92 
cluster member or seed sequence family. This could be achieved via nucleofection or viral 
delivery of a microRNA sponge vector, i.e. a sequence(s) of DNA designed to be anti-sense to 
the miRNA(s) of interest. A sponge could be designed to be anti-sense to all but one member of 
the miR-17~92 cluster, thereby inhibiting the activity of all but one of the miR-17~92 members 
by out-competing potential mRNA targets for miRNA binding (Ebert & Sharp, 2010; Ebert et 
al., 2007), and revealing the function of the non-blocked microRNA. 
Regulation of miR 17~92 Expression 
miR-17~92 is highly expressed in aNSCs, but not in qNSCs— yet a direct driver for this 
change in expression is unknown. N-myc is a transcription factor, and an “immediate early” gene 
which “respond[s] rapidly to growth factors in the absence of protein synthesis” (Lau & Nathans, 
1987) and drives cell cycling. Both N-myc and its closely related family member C-myc are 
known to drive miR-17~92 expression (Fontana et al., 2008). N-myc overexpression has been 
observed in 20% of neuroblastomas, where it correlates with higher glade tumors and poor 
prognosis due to the rapid progression of such tumors, and is furthermore known to drive 
expression of miR-17~92 in this context (reviewed in Buechner & Einvik, 2012). For N-myc, 
two induction factors have been identified so far; sonic hedgehog (Shh, Kenney et al., 2003) and 
estrogen (Murphy et al., 1987). Indeed, by qPCR I find that Mycn expression spikes in the 
aNSCs (Figure 4.1). Interestingly, the miR-17~92 cluster also targets Mycn mRNA, and 
reflecting this, Mycn expression rapidly declines as cells become TACs (Figure 4.1) suggesting 
an auto-regulatory loop, which may function to prevent overexpression of either the transcription 
factor or the cluster (Figure 5.2, Buechner & Einvik, 2012).  
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Taking all of these ideas into account, I propose that N-myc, via a yet to be determined 
exogenous signal, is rapidly expressed by aNSCs and translated into protein. N-myc then 
activates transcription of the miR-17~92 cluster, which down regulates mediators of quiescence, 
such as S1PR1. At the same time, N-myc activates transcription of cell cycle and DNA/RNA 
metabolism genes important for activation and proliferation. These genes, unlike the miR-17~92 
cluster, are protein encoding and thus, must be translated in order to have an effect. The time 
delay caused by translation may be helpful to the transition from quiescence to activation as 
some activation-important genes, like EGFR, seem to be actively targeted by genes expressed in 
the qNSCs, like Lrig1 (Perini et al., 2005; Gur et al., 2004). In turn, miR-17~92 downregulates 
Mycn expression, thereby tightly regulating the expression of the “activation/proliferation” 
factors, as well as its own transcription, which likely acts to prevent overproliferation and 




Further studies should be done on the expression of N-myc protein in the adult V-SVZ 
stem cells, and what signals coming from the niche might be inducing Mycn expression in these 
aNSCs, as this could reveal a “prime mover” for activation in this system. Interestingly, while 
the majority of Feingold syndrome cases are caused by mutations in the MYCN gene (van 
Bokhoven et al., 2005), a subset of the cases have been found to be caused by mutations in 
MIR17HG-- the host gene of the miR-17~92 cluster (Concepcion et al., 2012; de Pontual et al., 
Figure 5.2 Model of how activation occurs over the S1pr1-miR-17~92 axis including 
regulation by Mycn 
Activation process proceeds from left to right. Transcriptional activation indicated by ‘à’, while 
miRNA inhibition is indicated by ‘!’ 
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2011; Tassano et al., 2013). In patients with the miR-17~92 mutation cases, fewer of the clinical 
features of Feingold syndrome are apparent than patients harboring Mycn mutations. These 
findings suggest that the activation of miR-17~92 by N-myc is important for normal brain 
development. 
S1pr1 Expressed in qNSCs and is a Target of miR-17~92 
S1pr1 is highly enriched in qNSCs, and S1PR1 highly expressed by GFAP+ cells, while 
having little co-expression with MCM2. Treatment of qNSCs with S1PR1 ligand S1P reduces 
their activation and proliferation, and S1PR1 is the most expressed S1PR family member among 
the qNSCs. Together, this data suggests that S1P acts through S1PR1 to induce or reinforce a 
quiescent state. To more directly probe the function of S1PR1 in mediating quiescence, it will be 
important to manipulate S1PR1 signaling via different routes, either pharmacologically, or with 
viral approaches. It will also be interesting to overexpress S1PR1 in aNSCs to determine if this is 
sufficient to induce quiescence.  
Potential miR-17~92 Targeting of S1pr1 
Bioinformatic analysis shows that S1PR1 is a computationally predicted target of 
members of the miR-17~92 cluster, which is highly enriched in the aNSCs, suggesting that 
suppression of S1PR1 signaling may be important to achieving an active state. When miR-17~92 
is deleted in vivo, S1PR1 expression increases, even on MCM2-positive cells, further supporting 
the idea that miR-17~92 targets this mRNA.  
Recent work has shown that the 3’ UTR of S1pr1 is directly targeted by miR-363, a 
microRNA which shares its seed sequence with miR-17, -20a and -20b (Zhou et al., 2014). Other 
recent studies have shown that overexpression of miR-92a, a member of the miR-17~92 cluster, 
is sufficient to reduce levels of S1pr1 mRNA and protein in an angiogenesis model (Bonauer et 
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al., 2009; Ando et al., 2013). However, direct interaction of miR-92a and S1pr1 by luciferase 
assay was not shown. These findings support the idea that miR-17~92 regulation of S1pr1 may 
proceed via the mRNA degradation route, the mechanism most common in mammals. To date, 
no one has shown direct regulation of S1pr1 by any members of the miR-17~92 cluster. Ongoing 
studies in the lab are aimed at determining whether direct interaction between miR-17~92 and 
the 3’ UTR of S1pr1 occurs. 
S1PR1 Function in Humans and in Disease 
S1pr1 has been found to promote tumor growth or cell proliferation in some contexts. 
Elevated expression of S1pr1 has been found in tumor-derived myeloid cells (Lee et al., 2010), 
and correlates with poor prognosis in glioblastoma multiforme (Marfia et al., 2014), as well as 
directly driving proliferation in hepatocellular carcinoma (Zhou et al., 2014) and in diffuse large 
B-cell lymphoma (Liu et al., 2012). However, these effects may be explained, in part, by the 
known pro-survival effect of S1pr1 (reviewed in Blaho & Hla, 2014) working in the context of 
malignancy.  
Fingolimod, an immunomodulatory drug approved by the Food and Drug Administration 
for the treatment of multiple sclerosis (Kappos et al., 2006), acts on S1P receptors, primarily 
through S1PR1 (Chun & Hartung, 2010). Recent studies have shown that fingolimod also acts on 
multiple CNS cell types (Groves et al., 2013), including astrocytes. Our identification of S1P as a 
regulator of stem cell quiescence and S1PR1 expression in the V-SVZ suggests that this drug 
may have additional effects on stem cells in the adult brain. 
Final Conclusions 
I have shown that quiescent and activated adult neural stem cells have very different 
transcriptomes, especially in areas of signaling and metabolism. In depth analysis of these 
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transcriptomes revealed potential bi-directional regulation between these cells. Comparison of 
these transcriptomes with quiescent or activated counterparts from other tissues revealed that 
features of these states are conserved. I found that miR-17~92 is upregulated in aNSCs, and that 
it is needed for normal activation, proliferation and neurogenesis both in vitro and in vivo. 
Finally, I explored a few potential miR-17~92 targets, and found that S1pr1 is an excellent 
candidate for direct targeting by miR-17~92, and potentially mediates quiescence. Indeed, the 
response of qNSCs to S1PR1’s ligand, S1P, and its increased expression after miR-17~92 
deletion, even in dividing cells, highlight its functional importance in quiescent neural stem cells 
residing in the V-SVZ.  
In conclusion, this data provides the first evidence that miRs are involved in the transition 
from neural stem cell quiescence to activation and could provide a powerful approach to harness 
adult neural stem cells for brain repair after injury, stroke, or onset of neurodegenerative 
disorder. Moreover, miRNAs have altered expression patterns in many cancers, and play a role 
in the development of many cancer types (reviewed in Ha, 2011). Therefore, this work will also 
have important implications for cancer, providing mechanistic insight into pathways that may 
become misregulated and revealing which cells in the V-SVZ may be capable of giving rise to 
tumors. Finally, S1pr1 is emerging as a target of miR-17~92 that may have an integral role in 
mediation of quiescence. Having the ability to suppress or induce quiescence will be pivotal for 
upregulating stem cell activity in the context of brain repair, or downregulating it in the context 
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cells; however, their in vivo identity has been elusive.
Here, we prospectively isolate GFAP+CD133+ (quies-
cent neural stem cells [qNSCs]) and GFAP+CD133+
EGFR+ (activated neural stem cells [aNSCs]) from
the adult ventricular-subventricular zone. aNSCs are
rapidly cycling, highly neurogenic in vivo, and en-
riched in colony-forming cells in vitro. In contrast,
qNSCs are largely dormant in vivo, generate olfac-
tory bulb interneurons with slower kinetics, and only
rarely form colonies in vitro. Moreover, qNSCs are
Nestin negative, a marker widely used for neural
stemcells. Upon activation, qNSCs upregulateNestin
and EGFR and become highly proliferative. Notably,
qNSCs and aNSCs can interconvert in vitro. Tran-
scriptome analysis reveals that qNSCs share features
with quiescent stem cells from other organs. Finally,
small-molecule screening identified the GPCR li-
gands, S1P and PGD2, as factors that actively main-
tain the quiescent state of qNSCs.
INTRODUCTION
Quiescent and actively dividing (activated) stem cells coexist in
adult stem cell niches (Li and Clevers, 2010). Stem cell quies-
cence and activation play an essential role in many organs, un-
derlying tissue maintenance, regeneration, function, plasticity,
aging, and disease. Quiescent stem cells dynamically integrate
extrinsic and intrinsic signals to either actively maintain their
dormant state or become activated to divide and give rise to
differentiated progeny (Cheung and Rando, 2013). To illuminate
their biology and their molecular regulation, it is essential to be
able to prospectively identify and purify quiescent stem cells.
However, this has been exceedingly difficult in any organ,
including the adult brain.
Adult neural stem cells (NSCs) continuously generate neurons
throughout life in two brain regions: the subgranular zone (SGZ)
of the hippocampus and the ventricular-subventricular zone
(V-SVZ), adjacent to the lateral ventricles. The V-SVZ is the
largest germinal region in the adult mammalian brain and gener-
ates olfactory bulb interneurons and oligodendrocytes. Within
the V-SVZ, glial fibrillary acidic protein (GFAP)-positive type
B cells with hallmark features of astrocytes are stem cells and
have multipotent self-renewing capacity in vitro (Doetsch et al.,
1999a; Laywell et al., 2000; Imura et al., 2003; Garcia
et al., 2004; Sanai et al., 2004; Ahn and Joyner, 2005; Mirzadeh
et al., 2008; Beckervordersandforth et al., 2010; Lee et al.,
2012). In vivo, actively dividing V-SVZ stem cells are eliminated
by antimitotic treatment (Pastrana et al., 2009). In contrast, slowly
dividing astrocytes are label-retaining cells (LRCs), survive treat-
ment with antimitotic drugs and regenerate the V-SVZ, and give
rise to neurons under homeostasis (Doetsch et al., 1999a; Ahn
and Joyner, 2005; Giachino and Taylor, 2009; Nam and Benezra,
2009; Kazanis et al., 2010; Basak et al., 2012).
Recently, novel features of the anatomical organization of the
V-SVZ stem cell niche have been uncovered. GFAP+ type B1
cells have a radial morphology and span different compartments
of the stem cell niche (Silva-Vargas et al., 2013). Their apical pro-
cesses contact the lateral ventricle at the center of pinwheel
structures formed by ependymal cells, exhibit a primary cilium,
and are exposed to signals in the cerebrospinal fluid (CSF)
(Doetsch et al., 1999a, Mirzadeh et al., 2008, Beckervordersand-
forth et al., 2010, Kokovay et al., 2012). Their basal processes
contact blood vessels, which are an important proliferative niche
in the adult V-SVZ (Shen et al., 2008; Mirzadeh et al., 2008; Ta-
vazoie et al., 2008; Kazanis et al., 2010; Kokovay et al., 2010, La-
car et al., 2011, 2012).
Neuron 82, 545–559, May 7, 2014 ª2014 Elsevier Inc. 545
Variousmolecular markers have been used for the in vivo iden-
tification of V-SVZ stem cells and their purification (reviewed in
Pastrana et al., 2011). Nestin and Sox2 are widely used as
NSC markers in both the embryonic and adult brain (Lendahl
et al., 1990; Graham et al., 2003; Kazanis et al., 2010; Imayoshi
et al., 2011; Marqués-Torrejón et al., 2013). CD133 (Prominin),
a transmembrane glycoprotein expressed on primary cilia of
neural progenitors (Uchida et al., 2000; Marzesco et al., 2005;
Pinto et al., 2008; Cesetti et al., 2011) has been used to distin-
guish GFAP+CD133+ stem cells from niche astrocytes (Mirzadeh
et al., 2008, Beckervordersandforth et al., 2010). Combinations
of markers are beginning to be identified that allow the purifica-
tion of different subpopulations of V-SVZ cells, in particular of
activated stem cells, including epidermal growth factor receptor
(EGFR) (Doetsch et al., 2002; Pastrana et al., 2009), and brain
lipid binding protein (BLBP) (Giachino et al., 2014). To date, how-
ever, combinations of markers have not been identified that
allow the prospective isolation of quiescent V-SVZ stem cells.
This is crucial to illuminate the functional properties and gene
regulatory networks of quiescent adult NSCs.
Herein, we prospectively identify and isolate quiescent adult
NSCs from their niche. Our findings reveal that CD133+ astro-
cytes comprise two functionally distinct populations, quiescent
NSCs (qNSCs) and activated NSCs (aNSCs), which differ
dramatically in their in vivo cell cycle status and lineage kinetics,
their in vitro colony-forming efficiencies, and their molecular
signatures. Notably, qNSCs only rarely form colonies in vitro
Figure 1. Two Populations of CD133+ V-SVZ
Astrocytes Contact the Ventricle
(A and B) A subset of GFAP+ cells at the center of
pinwheels express EGFR. (A) Confocal image of a
whole mount immunostained for b-catenin ([bCat]
red) to visualize pinwheels, GFAP (blue), and
EGFR (green). (B) Schematic representation of
whole mount shown in (A). Individual pinwheels
are highlighted in different colors, and EGFR-
expressing cells are green.
(C–F) Optical slice of a confocal z stack at the
ventricular surface of a whole mount showing
endogenous GFP expression (C) under the control
of the human GFAP promoter and immunostained
for (D) CD133 and (E) EGFR. (F) Merged image.
Note that astrocytes contacting the ventricle with
diffuse CD133 staining are EGFR+ (arrowheads),
whereas those with CD133 restricted to the pri-
mary cilium are EGFR! (arrow).
(G) Schema showing type B1 astrocytes contact-
ing the ventricle at the center of a pinwheel
structure formed by ependymal cells (gray).
CD133 (Prominin, magenta) is detected on the cilia
of ependymal cells, some primary cilia of some
type B1 astrocytes (blue), and is diffusely ex-
pressed on the apical surface of EGFR+ type B1
astrocytes (cyan). Scale bars, 30 mm.
See also Figures S1 and S2.
and are natively Nestin negative but
upregulate both Nestin and EGFR on
activation. qNSCs also share common
molecular features with their counter-
parts in other organs. Finally, we identify GPCR ligands that
actively maintain the quiescent state of qNSCs.
RESULTS
Two Populations of CD133+ V-SVZ Astrocytes Contact
the Lateral Ventricle
The intermediate filament GFAP is one of the few markers of type
B1 astrocytes (Doetsch et al., 1997; Mirzadeh et al., 2008). How-
ever, due to its filamentous nature, it is difficult to perform colocal-
ization studieswithGFAP,and itcannotbeused for livecell sorting.
GFAP::GFP mice, in which GFP is expressed under the control
of the human GFAP promoter (Zhuo et al., 1997), are a useful
tool for visualizingV-SVZastrocytes invivoand for theirpurification
by fluorescence-activated cell sorting (FACS) (Tavazoie et al.,
2008; Platel et al., 2009, Shen et al., 2008, Pastrana et al., 2009;
Beckervordersandforth et al., 2010). Whole-mount preparations
allow the pinwheel architecture of the walls of the lateral ventricle
to be clearly visualized. We confirmed that, in GFAP::GFP mice,
type B1 astrocytes contacting the ventricle at the center of pin-
wheels were GFP+ and GFAP+, and frequently had a primary
cilium, but lacked S100b expression, a marker of mature astro-
cytes that are found deeper in the tissue at the interface with the
striatum (Figures S1A, S1C, and S1D available online).
Notably, a subset of cells localized within individual pinwheels
was EGFR+ (11.4% ± 1.3%; n = 129 pinwheels) (Figures 1A
and 1B). These ventricle-contacting EGFR+ cells coexpressed
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both GFAP protein and GFP in GFAP::GFP mice (Figure S1B;
Pastrana et al., 2009) and were observed throughout the rostro-
caudal axis of the V-SVZ, with 45.7% ± 4.4% of pinwheels con-
taining EGFR+ cells.
To define markers for EGFR-negative type B1 cells contacting
the ventricle, we examined the expression of CD133 (Prominin),
which is expressed by ependymal cells and on the primary cilium
of some type B1 cells (Coskun et al., 2008; Mirzadeh et al., 2008;
Beckervordersandforth et al., 2010). We immunostained whole
mounts of GFAP::GFP mice for EGFR and CD133 in conjunction
with b-catenin (to label pinwheels) or acetylated tubulin (to detect
primary cilia). We thereby identified two CD133+ astrocyte pop-
ulations: GFAP::GFP+CD133+ and GFAP::GFP+CD133+EGFR+
(Figure 1G). GFAP::GFP+CD133+ cells had a primary cilium
with CD133 staining localized to its tip (Figures 1C–1F; Figures
S2A and S2C). In contrast, GFAP::GFP+CD133+EGFR+ cells ex-
hibited diffuse CD133 staining over their apical surface and
lacked a primary cilium (Figures 1C–1F; Figures S2B and S2D).
Finally, we also observed GFAP::GFP+ cells contacting the
ventricle, which had a primary cilium that was CD133 negative
(Figures S2A and S2C).
Visualizing the in vivo morphology of CD133+ type B1 cells is
not feasible by immunostaining. To this end, we cloned and elec-
troporated a construct that expresses membrane-targeted
mCherry under the control of the mouse minimal P2 (Prominin-1)
Figure 2. Both Quiescent and Activated
CD133+ V-SVZ Astrocytes Have Radial
Morphology and Contact the Ventricle and
Blood Vessels
(A) Confocal images of whole mounts immuno-
stained with b-catenin ([b-cat] green, superficial
optical slice) showing cells labeled by in vivo
electroporation of the mP2-mCherry construct
(red, z stack projection). Labeled cells are either
radial cells that contact the ventricle at the center
of pinwheels (open arrowheads in insets) or
ependymal cells (asterisks).
(BI–CIII) Confocal images of whole mounts immu-
nostained with Laminin (cyan), b-catenin (green),
and MCM2 (blue) showing projections of mP2-
mCherry+ cells (BI and CI). Insets show superficial
(BII and CII) and deep (BIII and CIII) optical slices.
Both MCM2! and MCM2+ cells contact the
ventricle at the center of pinwheels as well as
blood vessels.
(DI–EIII) Confocal images of whole mounts immu-
nostained with MCM2 (cyan) and b-catenin (blue)
and labeled with EGF-A647 (green) showing pro-
jections of mP2-mCherry+ cells (DI and EI). Insets
show superficial (DII and EII) and deep (DIII and EIII)
optical slices. Note that EGF-negative cells are
MCM2!. Scale bars, 30 mm.
See also Figure S3.
promoter (mP2-mCherry; Figure S3A)
into the lateral ventricle and analyzed
whole mounts 2 days later. Both multicili-
ated flat ependymal cells possessing
typical cuboidal morphology and radial
cells with B1 morphology were labeled by this construct (Fig-
ure 2A), and all coexpressed CD133 protein (23/23 cells; Figures
S3B–S3D). Radial mP2-mCherry+ cells expressed CD133 either
at the tip of their primary cilium (Figure S3C) or diffusely on their
apical surface (Figure S3D) and were GFAP+ (data not shown).
To define the cell cycle status and relationship of radial mP2-
mCherry+ cells with ependymal cells and blood vessels, electro-
porated whole mounts were immunostained for combinations of
EGF-A647, MCM2, b-catenin, and Laminin to label activated
stem cells, dividing cells, pinwheels, and blood vessels, respec-
tively. All radial mP2-mCherry+ cells, regardless of MCM2
expression or epidermal growth factor (EGF)-ligand binding,
had a typical B1 morphology with an apical process contacting
the ventricle at the center of pinwheels and a long basal process
extending away from the surface, which frequently terminated on
blood vessels (Figures 2BI–2BIII; Figures 2CI–2CIII; Figures S3E–
S3N). Importantly, all MCM2+ radial mP2-mCherry+ astrocytes
were colabeled with EGF-ligand (70/70 cells MCM2! and
EGF!; 5/5 cells MCM2+ and EGF+; Figures 2DI–2DIII; Figures
2EI–2EIII).
Prospective Purification of V-SVZ Astrocytes
The aforementioned in vivo characterization suggests that
CD133 and EGFR could be used as markers to prospectively
purify quiescent and activated NSCs directly from their in vivo
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niche using FACS. We previously developed a simple strategy
to simultaneously isolate activated stem cells (GFAP::GFP+
EGFR+), transit-amplifying cells (EGFR+), and neuroblasts
(CD24+) by combining EGF-A647 and CD24 in GFAP::GFP
mice (Pastrana et al., 2009). By including CD133 in this sorting
strategy, we separated two CD133+ astrocyte populations,
GFAP::GFP+CD133+ and GFAP::GFP+CD133+EGFR+, from the
remaining GFAP::GFP+-only cells (Figures 3A and 3B; Figures
S4A–S4I). GFAP::GFP+CD133+ (ranging from 25% to 30% of
total GFP+ cells) and GFAP::GFP+CD133+EGFR+ (20%–25% of
total GFP+ cells) were both abundant but differed in their GFP
brightness (Figure 3C).
We assessed the purity of the sorted populations using qRT-
PCR and acute immunostaining. qRT-PCR confirmed that sorted
populations were appropriately enriched in Gfap, GFP, Prom1,
and Egfr expression (Figures S4Q–S4T). Acute immunostaining
showed that both GFAP::GFP+CD133+ and GFAP::GFP+
CD133+EGFR+ populations were highly enriched in GLAST and
GLT1 (Figures S4J and S4K)—glutamate aspartate transporters
expressed in astrocytes—as well as BLBP (Figure S4M), that
they largely or completely lacked S100b (Figure S4L) and that
they were almost completely negative for the neuroblast markers
DCX and bIII tubulin (Figures S4O and S4P). Notably, more than
90% of GFAP::GFP+CD133+ and GFAP::GFP+CD133+EGFR+
populations expressed the NSC transcription factor Sox2
(Figures S4N and S4U). High Sox2 levels are related to a more
proliferative state (Marqués-Torrejón et al., 2013); of note,
92.8% ± 1.5% of GFAP::GFP+CD133+EGFR+ cells expressed
high levels of Sox2 protein, whereas only 38.4% ± 3.5% of
GFAP::GFP+CD133+ cells were Sox2 bright, with the remainder
being Sox2 dim. In contrast, the GFAP::GFP+-only population
was more heterogeneous with significant neuroblast contamina-
tion, likely due to perdurance of GFP in neuroblasts (Figures S4O
and S4P). We therefore focused our functional analyses below
on GFAP::GFP+CD133+ and GFAP::GFP+CD133+EGFR+ popu-
lations (all data regarding the GFAP::GFP+-only population are
included in Figure S6).
Purified GFAP+CD133+ V-SVZ Cells Have Different Cell
Cycle Properties
Quiescent stem cells are largely dormant and lack markers of
proliferation such as Ki67 and MCM2 that are expressed in
actively dividing cells, but not during the quiescent G0 state
(Maslov et al., 2004). Both markers are expressed during G1,
with MCM2 being expressed earlier than Ki67. Cycling GFAP+
V-SVZ cells in vivo have a fast cell cycle (Ponti et al., 2013). To
determine the cell cycle properties of CD133+ astrocyte sub-
populations in vivo, we used multiple approaches. First, we
determined the instantaneous cell cycle status of FACS-purified
cells by acute immunostaining for proliferation-associated
markers. GFAP::GFP+CD133+EGFR+ cells were highly enriched
in both Ki67 and MCM2 (64% ± 5.2% and 87.3% ± 1.2%,
Figure 3. Prospectively Purified CD133+
Astrocyte Subpopulations Exhibit Different
Cell Cycle Properties
(A and B) Representative FACS plots showing
gating strategy. In (A), the gate used to select
GFAP::GFP+CD24- cells, which are then gated on
EGF-A647 and CD133-PE-Cy7. In (B), three pop-
ulations are clearly defined: GFAP::GFP+ (gray),
GFAP::GFP+CD133+ (blue), and GFAP::GFP+
CD133+EGFR+ (cyan).
(C) Histogram showing the intensity of GFP
signal in GFAP::GFP+, GFAP::GFP+CD133+, and
GFAP::GFP+CD133+EGFR+ populations (gray,
blue, and cyan, respectively) compared to other
V-SVZ cells (GFP!, black). Note that GFAP::
GFP+CD133+EGFR+ cells are dimmer than
GFAP::GFP+ and GFAP::GFP+CD133+ cells.
(D) Proportion of each CD133+-purified astrocyte
subpopulation that expresses Ki67 and MCM2
(n = 3; **p < 0.01, unpaired Student’s t test;
mean ± SEM).
(E) Proportion of each CD133+-purified astrocyte
subpopulation labeled after a single pulse of BrdU
(light green) or after 14 days of BrdU in the drinking
water (dark green) (n = 3 and n = 4, respectively,
**p < 0.01, unpaired Student’s t test, mean ± SEM).
(F) LRC fraction in the CD133+-purified astrocyte
populations 14 or 30 days after 14 days of BrdU
administration (n = 4, mean ± SEM).
(G) Representative FACS plots of CD133+ astro-
cyte subpopulations from saline- and Ara-C-
treated mice.
(H) Summary of markers expressed by CD133+-
purified astrocytes.
See also Figures S4 and S6.
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respectively) whereas these two markers were almost absent in
GFAP::GFP+CD133+ cells (1.4% ± 0.9% and 0.0% ± 0.0%,
respectively) (Figure 3D). Similar patterns of proliferation were
observed after a single in vivo pulse of bromodeoxyuridine
(BrdU) 1 hr prior to FACS isolation: 35.5% ± 1.8% of
GFAP::GFP+CD133+EGFR+ cells were BrdU+, in contrast to
0.8% ± 0.8% of GFAP::GFP+CD133+ cells (Figure 3E). Thus, at
any given moment, the vast majority of GFAP::GFP+CD133+
cells are not proliferating.
LRCs are slowly cycling cells whose DNA remains labeled
after prolonged administration of thymidine analogs and a long
chase period (Wilson et al., 2008). To label dividing cells and to
identify LRCs, we administered BrdU via drinking water for
2 weeks and analyzed the proportion of each population that
was BrdU+. Immediately after BrdU treatment, almost all
GFAP::GFP+CD133+EGFR+ cells were labeled, whereas only
3.9% ± 0.4% of GFAP::GFP+CD133+ cells had incorporated
BrdU, reflecting their much slower rate of division (Figure 3E).
Fourteen days after ceasing BrdU treatment, GFAP::GFP+
CD133+EGFR+ cells had already almost completely lost BrdU
labeling (Figure 3F). In contrast, 52.4% ± 17.3% of GFAP::GFP+
CD133+ cells were still BrdU+ 30 days after BrdU withdrawal
(Figure 3F).
Finally, we confirmed the different proliferation characteristics
of both populations in vivo by infusing cytosine-b-D-arabinofur-
anoside (Ara-C) directly on the brain surface to eliminate dividing
cells (Doetsch et al., 1999b). GFAP::GFP+CD133+ cells survived
6 days of Ara-C treatment, whereas the more rapidly dividing
GFAP::GFP+CD133+EGFR+ cells were eliminated (Figure 3G).
Thus, although CD133 is regulated in a cell-cycle-dependent
manner in dividing neural cell lines (Sun et al., 2009), in the
V-SVZ niche, CD133 is expressed in both dividing and nondi-
viding cells in vivo.
Together, these findings reveal that GFAP::GFP+CD133+ cells
are largely quiescent in vivo, whereas GFAP::GFP+CD133+
EGFR+ cells are actively dividing. Based on their cell cycle prop-
erties and the functional studies described below, hereafter we
refer to these populations as qNSCs and aNSCs, respectively
(Figure 3H).
qNSCs and aNSCsAreBothNeurogenic In Vivo butDiffer
in Their Kinetics
To assess the in vivo potential of quiescent and activated stem
cells, we transplanted purified qNSCs (1 week, n = 8; 1 month,
n = 5) and aNSCs (1 week, n = 5; 1 month, n = 11) isolated
fromGFAP::GFP;b-Actin-PLAPmice (Zhuo et al., 1997; DePrimo
et al., 1996) into the SVZ of wild-type recipient mice (Figure 4A).
The donor cells were histochemically visualized based on their
expression of the reporter human placental alkaline phospha-
tase (PLAP). In mice transplanted with aNSCs, many migrating
neuroblasts were present in the V-SVZ, the rostral migratory
stream (RMS), and the olfactory bulb after only 1 week (Figures
4E–4G), confirming their activated state. However, in mice trans-
planted with qNSCs, no neuroblasts were observed at this time
point, and PLAP+ cells were only present in the V-SVZ (Figures
4B–4D). In contrast, after 1 month, both populations generated
mature olfactory bulb interneurons (Figures 4J and 4M), and
PLAP+ cells were still present in the V-SVZ in all transplants (Fig-
ures 4H and 4K). Interestingly, migrating neuroblasts were also
present in the RMS in 3 out of 5 qNSC and 3 out of 11 aNSC
transplanted brains, demonstrating that both populations
continue to generate neurons after 1 month in vivo (Figures 4I
and 4L). Oligodendrocytes were also formed by both trans-
planted populations (data not shown). These data show that
both qNSCs and aNSCs can give rise to neurons and retain
long-term neurogenic potential in vivo but exhibit very different
kinetics of cell generation.
qNSCs and aNSCs Differ in Their In Vitro Behavior and
Can Interconvert States
Two in vitro assays are widely used to assess stem cell proper-
ties and to enumerate in vivo stem cells: adherent colony forma-
tion and neurospheres (Pastrana et al., 2011). With the ability to
now prospectively purify qNSCs, we directly tested their in vitro
behavior in both assays, as compared to aNSCs.
qNSCs and aNSCs were plated as single cells under adherent
conditions in the presence of EGF or EGF/basic fibroblast
growth factor (bFGF). Whereas aNSCs were enriched in colony
formation (47.9% ± 11.9% in EGF and 41.4% ± 1.8% in EGF/
bFGF), in striking contrast, qNSCs only rarely gave rise to
colonies (1.2% ± 0.1% in EGF and 0.7% ± 0.2% in EGF/bFGF)
(Figure 5A) and did so with much slower growth kinetics than
aNSCs. Importantly, although rare, the colonies formed by single
qNSCs were large and multipotent, giving rise to neurons, oligo-
dendrocytes, and mature astrocytes (Figures 5B and 5C).
We next compared the ability of qNSCs and aNSCs to form
neurospheres and assessed self-renewal by serial passaging.
Again, qNSCs only rarely gave rise to neurospheres (0.85% in
EGF, 0.82% in EGF/bFGF) in contrast to aNSCs, which robustly
generated neurospheres (Figure S5B). Moreover, the prolifera-
tion of the qNSC population was delayed by 6 days compared
to aNSCs (Figures 5D and S5A). However, once activated,
qNSCs exhibited similar rates of division to aNSCs. Neuro-
spheres from both populations could be serially passaged
more than three times and were multipotent, giving rise to
neurons, astrocytes, and oligodendrocytes (Figures S5B and
S5E). Finally, we examined whether more qNSCs were recruited
to form neurospheres during in vivo regeneration, at 12 hr post-
Ara-C removal when stem cell astrocytes start to divide (Doetsch
et al., 1999a, 1999b; Pastrana et al., 2009). Notably, the effi-
ciency of neurosphere formation of qNSCs purified after Ara-C
treatment did not increase (Figure 5K). However, as previously
shown, total neurosphere formationwas almost completely elim-
inated after Ara-C treatment (Doetsch et al., 2002; Imura et al.,
2003;Morshead et al., 2003; Garcia et al., 2004; data not shown),
confirming that the vast majority of neurospheres arise from
actively dividing cells.
Together, these results reveal that aNSCs are highly enriched
in colony formation. In contrast, the qNSC population rarely
forms colonies and does so more slowly than aNSCs. However,
once activated, qNSCs are highly proliferative and multipotent,
almost indistinguishable from aNSCs (Figure S5B). We therefore
assessedwhether qNSCs and aNSCs can interconvert in vitro by
dissociating and analyzing primary spheres by flow cytometry.
Intriguingly, the vast majority of cells in neurospheres derived
from qNSCs expressed both EGFR and CD133 (Figures 5E
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and 5G), revealing that qNSCs give rise to GFAP::GFP+CD133+
EGFR+ cells in vitro. Conversely, aNSCs gave rise to both
GFAP::GFP+CD133+ and GFAP::GFP+ populations (Figures 5F
and 5H). Moreover, when primary spheres were dissociated
and GFAP::GFP+CD133+, GFAP::GFP+CD133+EGFR+, and
GFAP::GFP+ cells were reisolated, each population exhibited
similar sphere formation efficiencies to primary isolated cells,
with the GFAP::GFP+CD133+EGFR+ population being greatly
enriched in neurosphere formation compared to GFAP::GFP+
CD133+ andGFAP::GFP+ populations (Figures 5I and 5J; Figures
S5C and S5D). Therefore, qNSCs and aNSCs can interconvert
between more quiescent and activated states, with each popu-
lation giving rise to all other populations in vitro.
Figure 4. qNSCs and aNSCs Are Neuro-
genic In Vivo
(A) Schema of experimental design.
(B–G) Horizontal brain sections showing PLAP+
cells (purple, arrowheads) 1 week after trans-
plantation of qNSCs (B–D) and aNSCs (E–G). At
this time point, aNSCs generated numerous
migrating neuroblasts, whereas no cells were de-
tected in the RMS or in the olfactory bulb of brains
transplanted with qNSCs.
(H–M) Horizontal brain sections showing PLAP+
cells (purple, arrowheads) 1 month after trans-
plantation of (H–J) qNSCs and (K–M) aNSCs. In
transplants from both populations, cells were
present in the V-SVZ and RMS and had generated
mature olfactory bulb interneurons. Scale bars,
200 mm. STR, striatum; CP, choroid plexus; LV,
lateral ventricle; GCL, granular cell layer; PGL,
periglomerular layer.
qNSCs Do Not Express Nestin but
Upregulate EGFR and Nestin on
Activation
Nestin is an intermediate filament protein;
its expression is widely considered a
hallmark of NSCs, both during develop-
ment and in the adult (Lendahl et al.,
1990; Imayoshi et al., 2011). Unexpect-
edly, our microarray analysis (see below)
suggested that qNSCs express very low
to no levels of Nestin mRNA, in contrast
to aNSCs, in which Nestin mRNA is highly
expressed. We confirmed this observa-
tion by qRT-PCR (Figure S8E) as well as
by immunostaining of acutely purified
cells (Figure 6A). Out of 1,582 plated
qNSCs, none were Nestin protein posi-
tive. Finally, to assess the Nestin status
of NSCs in vivo, we electroporated mice
with the mP2-mCherry construct and
coimmunostained whole mounts with
Nestin and EGF-ligand. In vivo, Nestin is
highly expressed by ependymal cells
(Doetsch et al., 1997; Figures 6DI and
6EI) as well as SVZ cells (Figures 6DII
and 6EII). All radial EGF-ligand-negative mP2-mCherry+ cells
were Nestin protein negative (Figures 6DI and 6DII; 0/79 cells
in seven whole mounts). In contrast, only EGF-ligand-positive
cells coexpressed Nestin protein (Figures 6EI and 6EII; 32/34
cells in seven whole mounts).
To investigate whether qNSCs upregulate Nestin protein on
activation, we performed a time-course analysis of qNSCs
cultured in adherent conditions and immunostained for Nestin,
EGFR, and MCM2 (Figures 6B and 6C). When first isolated and
plated, qNSCswere small and round and did not express Nestin,
EGFR, or MCM2 (type 1). As qNSCs became activated in vitro,
they underwent morphological and molecular changes,
enlarging their nuclei and upregulating all three markers
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(type 2). They then extended processes (type 3) (Figures 6B and
6C) and began to proliferate extensively, closely resembling
cultured aNSCs.
To independently confirm the lack of Nestin expression in
qNSCs and its upregulation on activation, we usedNestin::Kusa-
bira Orange reporter mice (Kanki et al., 2010; Ishizuka et al.,
2011) to FACS-purify CD133+Nes::OR!EGFR!CD24! (Nestin-
and EGFR-negative) cells (Figure S7A). Acutely plated cells all
lacked Nestin protein (Figure S7B) and, when cultured, only
rarely gave rise to neurospheres (Figures S7C and S7E). Impor-
tantly, CD133+Nes::OR-EGFR!CD24! cells, which originally
lacked Nestin::Kusabira Orange reporter expression, upregu-
lated the reporter in all neurospheres that formed (Figure S7C).
In contrast, purified CD133+Nes::OR+EGFR+CD24! cells were
very efficient in neurosphere formation (Figures S7D and S7E).
Finally, we examined whether Nestin-negative qNSCs
contribute to the lineage during regeneration. At present, it is
not feasible to directly trace the lineage of qNSCs in vivo
due to the lack of specific markers. We therefore adminis-
tered tamoxifen to adult GFAP::CreERT2;Rosa26tdTomato mice
to induce recombination in GFAP-expressing cells and chased
for 10 days after the first injection to allow actively dividing
cells to progress down the lineage (Figure S7F). We then
infused Ara-C for 6 days to eliminate dividing cells (Fig-
ure S7F) and confirmed that all remaining lineage-labeled
cells were Nestin negative (0 of 951; Figure S7G) immediately
after termination of treatment. Six days after Ara-C removal,
tdTomato+Nestin+ cells were present (Figures S7H and S7I), as
well as tdTomato+DCX+ neuroblasts (Figure S7I). These data
reveal that qNSCs upregulate Nestin, as well as EGFR, during
Figure 5. Purified qNSCs and aNSCs Give Rise to Neurospheres with Different Proliferative Properties and Kinetics
(A) Single cell colony formation efficiency of FACS-purified qNSCs and aNSCs in adherent cultures (n = 3, mean ± SEM).
(B) Representative phase contrast image of an adherent colony from a single qNSC after 12 days in the presence of EGF. Scale bar, 100 mm.
(C) Confocal image of neurons (bIII Tubulin [b III Tub], red), astrocytes (GFAP, green) and oligodendrocytes (O4, blue) derived from qNSCs plated under adherent
conditions. Scale bar, 10 mm.
(D) Quantification of cell proliferation when plated at 1.4 cells per microliter with EGF under nonadherent conditions after 6 or 12 days (n = 5; **p < 0.01 compared
to qNSCs at the same time point, unpaired Student’s t test, mean ± SEM).
(E–H) Representative FACS plots of, in (E) and (F), purified CD133+ astrocytes immediately resorted after isolation from the brain and, in (G) and (H), of primary
neurospheres (NS) derived from each population after 12 days for qNSCs and 6 days for aNSCs cultured in EGF.
(I and J) Clonal activation efficiency of purified GFAP::GFP+, GFAP::GFP+CD133+, and GFAP::GFP+CD133+EGFR+ cells, isolated from primary neurospheres of
each population (in EGF, n = 3; *p < 0.05, **p < 0.01, unpaired Student’s t test; mean ± SEM).
(K) Neurosphere formation 12 hr (12h) after Ara-C treatment as compared to saline-treated controls (n = 6, mean ± SEM).
See also Figures S5 and S6.
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activation and contribute to the lineage during regeneration
in vivo.
Gene Expression Analysis of Purified qNSCs and aNSCs
Reveals Distinct Molecular Signatures
To gain insight into the biological properties of qNSCs and to
define their molecular signatures, we performedmicroarray anal-
ysis on RNA from FACS-purified populations isolated directly
from their in vivo niche (Figure 7A; Table S1). Gene ontology
(GO) and gene set enrichment analysis (GSEA) (Subramanian
et al., 2005) revealed that qNSCs and aNSCs have distinct
molecular features (Figures 7B–7D). Confirming the actively
dividing state of aNSCs in vivo, their transcriptome was enriched
in genes involved in the cell cycle, transcription and translation,
and DNA repair (Figures 7C and 7D; Tables S2 and S3). In
contrast, qNSCs were enriched in the GO categories of cell
communication, response to stimulus, and cell adhesion (Fig-
ure 7B; Table S2), underscoring the dynamic regulation of the
quiescent state via interaction with the microenvironment.
Indeed, the most represented GSEA groups for qNSCs were
related to transport, signaling, receptors, cell surface, and extra-
cellular matrix (Figure 7D; Table S3). Notably, qNSCs and aNSCs
exhibited different metabolic profiles; themajority of the differen-
tially enriched GSEAmetabolism subsets in qNSCs were related
Figure 6. qNSCs Are Nestin Negative
(A) Proportion of acutely plated purified qNSCs and aNSCs immunopositive for MCM2 and Nestin (n = 3, mean ± SEM).
(B) Images of FACS-purified qNSCs cultured in EGF, fixed at different time points, and immunostained with EGFR, MCM2, and Nestin. Three types of cells are
present: rounded cells with a condensed nucleus that do not express EGFR, MCM2, or Nestin (type 1); rounded cells with a larger nucleus that express EGFR,
MCM2, and Nestin (type 2); and EGFR+MCM2+Nestin+ cells with elongated processes (type 3). Type 3 cells resemble aNSCs after 3 days in culture. Scale bars,
10 mm.
(C) Quantification of activated qNSCs in culture after 2 hr or after 1, 3, 5, or 7 days after plating (n = 4, mean ± SEM).
(DI–EII) Confocal images showing mP2-mCherry+ cells (red) in whole mount labeled with EGF-A647 (green) and immunostained for Nestin (blue). In (D), two cells
contact the ventricle between ependymal cells, do not bind EGF-A647 (DI, arrows), and are Nestin negative in the subventricular projection (DII). In (E), an EGF-
A647-labeled cell (EI, arrow) is coimmunostained with Nestin in the subventricular projection (EII, arrowheads in inset). Notably, not all processes contained
Nestin. Scale bars, 30 mm.
See also Figure S7.
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to metabolism of lipids (Figure S8A), which are emerging as
important signals in NSC regulation (Knobloch et al., 2013),
whereas those in aNSCs were DNA/RNA-related metabolism
and proteasome activity (Figure S8B).
Functional studies have implicated numerous genes in the
regulation of adult neurogenesis. Many of these were differen-
tially expressed in qNSCs and aNSCs (Table S5). Moreover,
direct comparison of qNSC and aNSC transcription profiles
with those of purified GFAP::GFP+CD133+ V-SVZ stem cells
(Beckervordersandforth et al., 2010) revealed that we have
resolved two distinct subsets of NSCs with different molecular
and functional properties within their data (Figures S8C and
Figure 7. Gene Expression Analysis of qNSCs and aNSCs Reveals Distinct Molecular Signatures
(A) Volcano plot of differentially expressed probesets in qNSCs and aNSCs. Probes have at least 2-fold change in expression and a corrected p value < 0.05.
(B and C) Pie charts showing representative GO categories for differentially expressed probesets in (B) qNSCs and (C) aNSCs, as determined in (A).
(D) GSEA for qNSCs versus aNSCs. Sets have a false discovery rate (q value) <0.05 and are hand curated into thematic categories.
(E and F) Percentage of overlap with signatures of quiescent and dividing stem cells from other organs: (E) long-term (LT)/quiescent signatures and (F) short-term
(ST)/proliferative signatures as determined by fold-change analysis of published lists compared to qNSC and aNSC populations. Qui, quiescent; HSC,
hematopoietic stem cells; qMuSC, quiescent muscle stem cells; qBulgeSC, quiescent bulge stem cells; qISC, quiescent intestinal stem cells.
(G–J) Targeted GPCR ligand screen. (G) Quantification of qNSC activation (fold change in % Nestin+ clones) as compared to controls (empty dots). (H) Quan-
tification of percentage of MCM2+ cells within activated Nestin+ clones. (I) Quantification of aNSC clones (fold change of percentage of clones that underwent
division) as compared to controls (empty dots). (J) Quantification of percentage of MCM2+ aNSCs. Data are represented as means ± SEM.
n = 3. *p < 0.05; ***p < 0.001. ns, not significant.
See also Figure S8 and Tables S1, S2, S3, S4, S5, S6, S7, and S8.
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S8D; Table S8). Indeed, we found that neurogenic transcription
factors such as Dlx1, Dlx2, Sox4, Sox11, and Ascl1, which
were proposed to be hallmarks of NSCs (Beckervordersandforth
et al., 2010), were in fact primarily expressed by or restricted to
aNSCs (Table S4). We confirmed enrichment ofDlx2 andAscl1 in
aNSCs by qRT-PCR (Figures S8F and S8G), as well as enrich-
ment of Dll1 (Figure S8H), which is expressed in aNSCs (Kawa-
guchi et al., 2013). In contrast, qNSCs expressed high levels of
factors reported to be markers of quiescent stem cells in the
adult V-SVZ, such as Vcam1 (Figure S8I and Table S5; Kokovay
et al., 2012), and in other organs, such as Lrig1 (Figure S8J and
Table S1; Jensen and Watt, 2006; Jensen et al., 2009; Powell
et al., 2012).
We then performed comparative analysis of our gene expres-
sion data with transcriptional signatures from quiescent or prolif-
erative hematopoietic, muscle, skin, and intestinal stem cells
(Ivanova et al., 2002; Venezia et al., 2004; Forsberg et al.,
2010; Pallafacchina et al., 2010; Powell et al., 2012; Blanpain
et al., 2004: Fukada et al., 2007; Cheung and Rando, 2013).
The majority of genes in long-term/quiescent populations were
upregulated in our quiescent V-SVZ stem cells, whereas those
in the short-term/proliferative stem cell lists from other tissues
were upregulated in our activated population (Figures 7E and
7F; Table S6). Together, this suggests that common transcrip-
tional programs for quiescence or activation are shared between
stem cell lineages in different tissues.
GPCR Signaling Maintains the Quiescent State
To gain insight into signaling pathways that modulate quies-
cence in qNSCs, we mined our transcriptome data. G protein-
coupled receptor (GPCR) signaling was highly enriched in
qNSCs (30% of all GSEA signaling sets; Table S3). We selected
25 GPCRs that were more than 10-fold enriched in qNSCs over
aNSCs (Table S7) as a basis for a functional screen to assess
Figure 8. In Vivo and In Vitro Properties of
V-SVZ Stem Cells and Their Progeny
Quiescent stem cells (GFAP+CD133+) are Nestin
negative, label-retaining (blue line), and neuro-
genic in vivo (magenta line) but only very rarely give
rise to neurospheres and adherent colonies in vitro
(light blue line). Activated stem cells (GFAP+
CD133+EGFR+) are highly proliferative (green line)
and rapidly generate neurons in vivo and are en-
riched in neurosphere/colony formation. Previous
work has shown that EGFR+ transit amplifying cells
are also highly proliferative in vivo and give rise to
neurospheres. Of note, quiescent stem cells were
also present among CD133- astrocytes. Niche
astrocytes have a branched morphology.
their role in the regulation of qNSCs.
FACS-purified qNSCs were plated under
adherent conditions for 4 days in the
presence of different ligands, and their
activation (number of Nestin+ clones)
was quantified (Figure S8K). Two com-
pounds, sphingosine-1-phosphate (S1P)
and prostaglandin D2 (PGD2), had a significant effect, with both
decreasing the activation of qNSCs by approximately one half
(Figures 7G and S8L). Both ligands also decreased the number
of MCM2+ qNSCs (Figure 7H). PGD2 exerted a more potent
effect, completely abolishing MCM2 expression. To determine
whether these compounds act specifically on qNSCs or also
affect aNSCs, we plated FACS-purified aNSCs in the presence
of S1P or PGD2 and fixed the cells after 24 hr. This shorter
time course is necessary as aNSCs divide very rapidly, making
it difficult to distinguish individual clones (Figure S8K). S1P did
not alter the number of aNSC clones (Figure 7I) or percentage
of MCM2+ cells (Figure 7J). As such, S1P selectively targets
qNSCs and appears to act at the level of qNSC recruitment
(Figure 7H). In contrast, PGD2 had a potent inhibitory effect
on the number of clones formed by aNSCs (Figure 7I). PGD2
also reduced the percentage of MCM2+ aNSCs (Figure 7J).
As such, PGD2 acts on both qNSCs and aNSCs. Thus,
these GPCR ligands actively maintain the adult NSC quiescent
state.
DISCUSSION
Here, we prospectively identified and isolated quiescent
adult NSCs by defining a combination of markers (CD133,
GFAP, and EGFR) that allows the simultaneous purification of
quiescent and activated populations of stem cell astrocytes.
Together, our analyses of their cell cycle properties, their
morphological and anatomical localization, their in vitro and
in vivo functional behavior, and their gene expression profiles
highlight the distinct functional and molecular properties of
qNSCs and aNSCs (Figure 8). Our functional analyses reveal
important features of quiescent NSCs, which affect the interpre-
tation of commonly used in vitro NSC assays and lineage-tracing
strategies.
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In the adult mouse brain, CD133 was originally proposed to be
exclusively expressed by ependymal cells, with FACS-purified
CD133+ cells giving rise to neurospheres in vitro and generating
neurons in vivo (Coskun et al., 2008). However, CD133 is also
expressed by a subset of astrocytes, which behave as NSCs
(Mirzadeh et al., 2008; Beckervordersandforth et al., 2010), sug-
gesting that the earlier findings can be attributed to CD133+
astrocytes instead of ependymal cells. Here, we show that
CD133 is expressed by both quiescent and activated V-SVZ
stem cells.
The neurosphere assay is widely used as a readout of in vivo
stem cells (reviewed in Pastrana et al., 2011). Neurospheres
were originally proposed to arise from relatively quiescent stem
cells in vivo (Morshead et al., 1994). With the ability to prospec-
tively purify cells at different stages of the stem cell lineage, it is
now feasible to directly assess the potential of distinct popula-
tions to give rise to neurospheres. Here, we show that qNSCs
only very rarely give rise to either neurospheres or adherent
colonies and do not increase their neurosphere-forming effi-
ciency during regeneration. In contrast, aNSCs are enriched in
neurosphere and adherent colony formation. Together, our
current findings and previous reports highlight that the major
source of neurosphere-initiating cells are actively dividing in vivo,
and include both GFAP+ aNSCs and EGFR+GFAP- transit-ampli-
fying cells (Doetsch et al., 2002, Imura et al., 2003; Morshead
et al., 2003; Garcia et al., 2004, Pastrana et al., 2009; data not
shown). Thus, the neurosphere assay is a useful tool for assess-
ing the in vitro stem cell potential of proliferative populations but
does not allow the identification and enumeration of in vivo
quiescent stem cells. This emphasizes the need to develop novel
assays, or identify additional niche factors, that allow qNSCs to
be expanded in vitro.
Nestin is frequently usedboth as amarker of NSCs and for their
geneticmanipulation and lineage tracing in the embryonic (Lend-
ahl et al., 1990; Zimmerman et al., 1994) and adult brain (reviewed
in Imayoshi et al., 2011). Nestin+ cells have also been implicated
as putative glioblastoma-forming cells (Holland et al., 2000, Chen
et al., 2012). Notably, we found that adult V-SVZ qNSCs do not
express Nestin but upregulate it on activation in vitro, as well
as during regeneration in vivo. These data are consistent with
previous observations that Nestin!/CD133+ cells are neurogenic
in vivo and give rise to Nestin+ neurospheres in vitro (Coskun
et al., 2008). Recently, both Nestin-negative and Nestin-positive
radial glia-like stem cells have also been described in the hippo-
campus (DeCarolis et al., 2013). Aswe show here in the V-SVZ, in
the SGZ, almost all of the dividing radial glia-like stem cells
express Nestin (DeCarolis et al., 2013). It is interesting that, in
embryonic development, Nestin expression is also regulated in
a cell-cycle-dependent manner (Sunabori et al., 2008). Thus,
Nestin expression is dynamically regulated in NSCs. Importantly,
our study highlights that Nestin immunostaining cannot be used
to identify adult qNSCs in vivo. Thus, whether recombination and
reporter expression occur in qNSCs needs to be carefully
assessed when using Nestin transgenes for in vivo targeting of
adult NSCs, V-SVZ lineage tracing, genetic manipulation, or
purification. Moreover, interpretation of such assays is further
complicated by the high expression of Nestin in ependymal cells,
which can lead to nonautonomous effects.
qNSCs are multipotent and self-renewing in vitro. In vivo,
qNSCs are long-term neurogenic and exhibit delayed kinetics
of neuron formation compared to aNSCs. Interestingly, some
aNSC transplants also continue to make neurons 30 days after
transplantation. These may arise from a more quiescent sub-
population of aNSCs or from aNSCs that have reverted back
to the quiescent state, as occurs in vitro. We also observed
oligodendrocyte formation by both transplanted qNSCs and
aNSCs (data not shown). In vivo, adult V-SVZ NSCs have
regional identity and generate distinct neuronal subtypes, or
oligodendrocytes (Merkle et al., 2007; Ventura and Goldman,
2007; Young et al., 2007; Ortega et al., 2013). At present, we
cannot distinguish whether neurons and oligodendrocytes arise
from regionally distinct subpopulations of NSCs in the trans-
planted populations or whether some, or all, NSCs are multipo-
tent in vivo. The extent of in vivo V-SVZ stem cell heterogeneity
and population dynamics of qNSCs and aNSCs, as well as their
lineage relationships and potential under homeostasis and dur-
ing regeneration, will require the identification of novel markers
allowing the specific targeting of qNSCs and aNSCs. Impor-
tantly, our present strategy allows qNSCs to be isolated
irrespective of their regional origin. Of note, the GFAP::GFP+
CD133- population also contains quiescent stem cells. By
combining different reporter mice, it is emerging that V-SVZ
stem cells are molecularly heterogeneous (Giachino et al.,
2014). The iterative identification of additional markers that
allow subpopulations of NSCs to be isolated and targeted in vivo
is a key future step.
Recent findings suggest that quiescent and activated states
are differentially regulated at multiple levels, including cell-cell
and extracellular matrix interactions, diffusible signals and
distinct transcriptional programs coupling cell cycle regulators,
quiescence, self-renewal, and differentiation (Kazanis et al.,
2010; Young et al., 2011; Le Belle et al., 2011; Alfonso et al.,
2012; Basak et al., 2012; Marqués-Torrejón et al., 2013;
Kokovay et al., 2012; Porlan et al., 2013; Giachino et al.,
2014; Kawaguchi et al., 2013, López-Juárez et al., 2013;
Martynoga et al., 2013). Our transcriptome data of qNSCs
and aNSCs isolated directly from their in vivo niche provide
a platform to functionally assess the gene regulatory networks
active in each state. Interestingly, our GSEA analysis reveals
that GPCR signaling is specifically enriched in qNSCs. While
GPCRs modulate many different facets of adult neurogenesis
(Doze and Perez, 2012), our findings highlight that they
are also key regulators of qNSCs. Strikingly, both functional
ligands we identify in our GPCR screen, S1P and PGD2, inhibit
the activation of qNSCs, suggesting that stem cell quiescence
is an actively maintained state. Both S1P and PGD2 are present
in the CSF (Sato et al., 2007; Kondabolu et al., 2011), which
is emerging as a reservoir of factors in the embryo and the
adult important for stem cell regulation (Silva-Vargas et al.,
2013). As such, the CSF may be a key niche compartment
mediating quiescence in the adult V-SVZ. Interestingly, PGD2
has been implicated in promoting the quiescent phase of the
hair follicle cycle (Garza et al., 2012), which is consistent with
our transcriptome data suggesting that quiescent and activated
stem cells in different tissues share common molecular
pathways.
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As additional mediators of stem cell quiescence and activation
are uncovered, it will be important to investigate how clinical
drugs targeting these pathways impact NSCs in vivo. For
instance, fingolimod, an immunomodulatory drug approved by
the Food and Drug Administration for the treatment of multiple
sclerosis (Kappos et al., 2006), acts on S1P receptors. Recent
studies have shown that fingolimod also acts on multiple CNS
cell types (Groves et al., 2013), including astrocytes. Our identi-
fication of S1P as a regulator of stem cell quiescence suggests
that this drug may have an effect on NSCs in the adult brain.
The ability to purify quiescent NSCs from the adult brain opens
new vistas into elucidating the biology of stem cell quiescence,
enabling studies in their intrinsic and extrinsic molecular regula-
tion and defining their dynamics during development and aging.
V-SVZ GFAP+ stem cells are also present in humans, where they
are largely quiescent (Sanai et al., 2004, 2011; van den Berge
et al., 2010). Understanding the biology of stem cell quiescence
and activation will ultimately lead to insight into how NSCs




Experiments were performed in accordance with Columbia University institu-
tional and national guidelines for animal use. All mice usedwere between 2 and
3 months old.
FACS
The FACS strategy was adapted from Pastrana et al. (2009). Briefly, the V-SVZ
was microdissected from GFAP::GFP mice and dissociated with papain, the
single cell suspension was immunostained, and cell populations were purified
by FACS as described in the detailed protocol in Supplemental Experimental
Procedures.
Immunostaining
Whole mounts were dissected and processed as described elsewhere
(Doetsch et al., 1999b; Tavazoie et al., 2008; Mirzadeh et al., 2010). Briefly,
whole mounts were blocked in 10% serum, incubated with primary antibodies
for 48 hr at 4"C, revealed with secondary antibodies, and imaged with a Zeiss
LSM510 or Leica TCS SP5 II confocal microscope. All immunostainings were
performed in triplicate. Immunostaining details for whole mounts and cell
cultures are in the Supplemental Experimental Procedures.
In Vitro Assays
For neurosphere assays, FACS-purified cells were collected in neurosphere
medium without growth factors and plated at clonal density with EGF
(20 ng/ml) or EGF/bFGF (20 ng/ml each). For adherent cultures, purified cells
were collected in neurosphere medium and plated on poly-D-lysine and fibro-
nectin-coated 96-well plates as single cells or at clonal density and cultured
with EGF or EGF/bFGF. Further details are given in the Supplemental Experi-
mental Procedures.
Ara-C Infusion
A micro-osmotic pump (ALZET, 1007D) filled with 2% Ara-C (Sigma) in 0.9%
saline was implanted on to the surface of the brain as described elsewhere
(Doetsch et al., 1999b). After 6 days of Ara-C infusion, mice were sacrificed
either immediately or 12 hr after pump removal.
Electroporation
One microliter of a solution containing 5 mg/ml of the mP2-mCherry plasmid in
0.9% saline was electroporated according to Barnabé-Heider et al. (2008),
using the following coordinates: anterior-posterior (AP), 0.0; lateral (L), 0.85;
ventral (V), !2.5 mm relative to bregma. The mP2-mCherry plasmid was
made by cloning the mouse P2 element of the Prominin1 promoter into the
CherryPicker control vector (Clontech), using the XhoI and AgeI digestion
sites. See the Supplemental Information for details.
Transplants
Three injections of 0.2 ml delivering 1,000–3,000 cells purified from
GFAP::GFP/b-actin-PLAP mice were performed in the SVZ of wild-type recip-
ient mice, using the following coordinates: (1) AP, 0.0; L, 1.4; V, !2.1; (2) AP,
0.5; L, 1.1; V,!2.2; (3) AP, 1.0; L, 1.0; V,!2.5mm relative to bregma. Recipient
mice were sacrificed 1 week or 1 month after transplantation. Transplanted
cells were revealed by NBT/BCIP staining.
RNA Isolation and Microarray Hybridization
RNA was purified from FACS-sorted populations with the miRNeasy kit
(QIAGEN) from three biological replicates. cDNA was synthesized with the
Nugen Pico amplification kit and hybridized to Affymetrix MOE430.2 chips.
See Supplemental Information for details of the bioinformatic analysis.
qRT-PCR
RNA was purified from FACS-sorted populations with the miRNeasy kit
(QIAGEN) and cDNA generated using WT-Ovation Pico System (NuGEN).
See Supplemental Information for details on primer sequences.
GPCR Compound Screen
Cells were isolated by FACS and plated on poly-D-lysine- and fibronectin-
coated 96-well plates in the presence of EGF. To assay the effect on qNSCs,
compounds were added 1 day after plating, and cells were fixed and immuno-
stained at day 4. To assay the effect on aNSCs, cells were plated with com-
pounds and fixed and immunostained 1 day later. Further details are in the
Supplemental Experimental Procedures.
ACCESSION NUMBERS
All data are deposited in the National Center for Biotechnology Information
Gene Expression Omnibus under accession number GSE54653.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
eight figures, and eight tables and can be found with this article online at
http://dx.doi.org/10.1016/j.neuron.2014.02.039.
ACKNOWLEDGMENTS
Thanks to the F.D. and Wichterle labs for insightful discussion and to Hynek
Wichterle and Jun-An Chen for comments.We thank Hideyuki Okano for kindly
providing the Nestin::Kusabira Orange and James Stringer for providing the
alkaline phosphatase reporter mice; Kristie Gordon and Sandra Tetteh of the
Herbert Irving Comprehensive Cancer Center of Columbia University for assis-
tance with FACS and flow cytometry; and Jiri Zavadil and Yutong Zhang of the
Office of Collaborative Science Genome Technology Center of New York Uni-
versity LangoneMedical Center for microarray processing. This work was sup-
ported by the National Institute of Neurological Disorders and Stroke (NINDS)
grant NS053884, funding from the NINDS-American Recovery and Reinvest-
ment Act (NS053884-03S109), NINDS grant NS074039, New York State
Stem Cell Science contracts C024287 and C026401, funding from The Leona
M. andHarry B. Helmsley Charitable Trust, The Irma T. Hirschl Foundation, and
The David and Lucile Packard Foundation (to F.D.); a Human Frontiers Scien-
tific Program Long-Term Fellowship (to V.S-V.); NIH grant T32 MH 15174-29
and a fellowship from the Spanish Ministerio de Educación y Ciencia
(to E.P.); NINDS grant 1F31NS079057 (to A.R.M.-S.), and NIH grants T32
GM008224, TL1 TR000082 and NINDS grant 1F31NS081990 (to A.M.D.).
Work was also supported by the Jerry and Emily Spiegel Laboratory for Cell
Replacement Therapies.
Neuron
Purification of Adult Quiescent Neural Stem Cells
556 Neuron 82, 545–559, May 7, 2014 ª2014 Elsevier Inc.
Accepted: February 10, 2014
Published: May 7, 2014
REFERENCES
Ahn, S., and Joyner, A.L. (2005). In vivo analysis of quiescent adult neural stem
cells responding to Sonic hedgehog. Nature 437, 894–897.
Alfonso, J., Le Magueresse, C., Zuccotti, A., Khodosevich, K., and Monyer, H.
(2012). Diazepam binding inhibitor promotes progenitor proliferation in the
postnatal SVZ by reducing GABA signaling. Cell Stem Cell 10, 76–87.
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Figure S1. Characterization of V-SVZ astrocytes, related to Figure 1 
(A) Confocal images at the ventricular surface of a whole mount preparation showing endogenous expression of 
GFAP::GFP (AII) and immunostained for Acetylated Tubulin (AI) and GFAP (AIII). AIV is a merged image. Some GFAP+ and 
GFAP::GFP+ cells contact the ventricle and have a single cilium (arrowheads). 
(B) Confocal images at the ventricular surface of a whole mount preparation showing endogenous expression of 
GFAP::GFP (BII) and immunostained for β-Catenin (BI), GFAP (BIII) and EGFR (BIV). BV is a merged image. Note that 
some GFAP+ and GFAP::GFP+ cells are EGFR+ (arrowhead). 
(C) Confocal images at the ventricular surface of a whole mount preparation (CI-CIV) immunostained with β-Catenin (CI), 
S100β (CII) and GFAP (CIII). CIV is a merged image. In CV, GFAP and S100β subventricular projection (excluding the 
ventricular surface) is shown. Note that astrocytes contacting the ventricle are S100β negative.  
(D) Confocal subventricular projection for S100β (DI) and GFAP (DII). Large stellate GFAP+ cells, adjacent to the striatum, 
are S100β positive. 
Scale bars: 30 µm. 
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Figure S2. V-SVZ astrocytes contacting the ventricle are heterogeneous, related to Figure 1 
(A-B) Confocal images of the ventricular surface of whole mount preparations immunostained for β-Catenin (AI and BI), 
Acetylated Tubulin (AII and BII) and CD133 (AIII and BIII). AIV and BIV are merged images. AV and BV are schematic 
representations of the pinwheels shown in AI-IV and BI-IV. Schema on the right summarizes the profiles of astrocytes 
contacting the ventricle: red arrows indicate cells contacting the ventricle with a CD133+ primary cilium; blue arrowheads 
indicate cells with diffuse CD133 and lacking a primary cilium; white arrowheads indicate cells contacting the ventricle with 
a single cilium that is negative for CD133. 
(C-D) Confocal images of the ventricular surface of whole mount preparations immunostained for β-Catenin (CI and DI) 
and CD133 (CIII and DIII) and showing endogenous expression of GFAP::GFP (CII and DII) and EGF ligand-A647 binding 
(CIV and DIV). CV and DV are merged images. Examples of GFAP::GFP+CD133+ cells that do not bind EGF ligand (red 
arrows in C and D); GFAP::GFP-dim cells with diffuse CD133 bind EGF ligand (blue arrowhead in D); GFAP::GFP+ cells 
that lack CD133 and EGF ligand (white arrowhead in C). 
Scale bars: 30 µm. 
! !
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Figure S3. In vivo validation of mP2-mCherry transgene and examples of astrocyte morphology, related to   
Figure 2 
(A) Schema of the transgene used for morphological studies. A plasmid containing an mCherry-transferrin receptor 
membrane-anchor domain (TRMD) fusion gene under the control of the mouse P2 element of the Prominin1 promoter 
was electroporated into V-SVZ cells lining the ventricle. 
(B-D) Confocal images of the ventricular (superficial) surface of whole mounts immunostained with Acetylated Tubulin (BI, 
CI, DI) and CD133 (BII, CII, DII), showing mP2-mCherry+ cells (BIII, CIII, DIII). BIV, CIV and DIV are merged images. BV, CV and 
DV are z-stack projections of the same cells through the entire depth of the V-SVZ. BVI, CVI and DVI are side views of the 
projections. The transgene is expressed in multiciliated CD133+ ependymal cells (B, asterisk), CD133+ monociliated cells 
(C, arrowhead and inset) and non-ciliated diffuse CD133+ cells (D, arrowhead). 
(E-F) Confocal images of whole mounts showing projections of EGF-ligand negative (E) and positive (F) cells labeled by 
mP2-mCherry transgene (red) and immunostained with laminin (cyan). In the insets, superficial optical slices of the same 
cells showing EGF-A647 (green) and β-Catenin (blue). 
(G-N) Confocal images of whole mounts showing examples of EGF- (G-J) and EGF+ (K-N) mP2-mCherry+ cells. Upper 
panels (GI-NI) show EGF-ligand and mP2-mCherry labeling in an optical slice at the ventricular surface. Lower panels (GII-
NII) show depth-coded projections of the same mP2-mCherry labeled cells, where orange/yellow is superficial and 
blue/violet is deep. Scale bars: 30 µm. 






























































Figure S4. Gating strategy for V-SVZ astrocyte purification by FACS and marker validation of purified 
populations, related to Figure 3 
(A-I) FACS plot flow chart of the 5 color strategy used for sorting and analyzing V-SVZ astrocyte subpopulations using 
DAPI, CD24-PE, EGF-A647 and CD133-PE-Cy7 in GFAP::GFP mice. After excluding cell debris (A), and gating for single 
cells (B) and live DAPI negative cells (C), GFP+CD24-
 
cells were selected (E) and subsequently three populations were 
defined (F): GFAP::GFP+, GFAP::GFP+CD133+ and GFAP::GFP+CD133+EGFR+. A wild type (WT) mouse control stained 
with all the markers was used to set the gate for GFAP::GFP+CD24- population (D). The gates for CD133+ astrocytes were 
set according to the isotype control (G) and the “NO CD133” control (H) in which all markers but CD133 primary antibody 
were added. Similarly for the “NO EGF” control (I). 
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(J-P) Proportions of acutely-plated purified cells immunopositive for GLAST (J), GLT1 (K), S100β (L), BLBP (M), Sox2 
(HIGH: bright expression darker colors, LOW: dim expression, lighter colors) (N), β-III Tub (O), and DCX (P) (average of 3 
independent sorts; mean±SEM). 
(Q-U) Gene expression levels of Gfap (Q), GFP (R), Prom1 (S), Egfr (T), and Sox2 (U) detected with qRT-PCR in purified 
populations as compared to sorted total SVZ cells (as gated in S4C) (n=3; mean±SEM). Note that 
GFAP::GFP+CD133+EGFR+ Prom1 gene level is 34 fold enriched over the GFAP::GFP+ population, which is CD133-, but 
does not show enrichment when compared to total SVZ control that also includes ependymal cells, which express very 
high levels of CD133. 
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Figure S5. Purified qNSCs and aNSCs exhibit different proliferation kinetics in vitro, related to Figure 5 
(A) Quantification of cell proliferation when purified cells are plated at clonal density (1.4 cell/µl) in the presence of 
EGF/bFGF (n=3, mean±SEM, **p<0.01, unpaired Student’s t-test). 
(B) Percentage of activating clones for primary, secondary and tertiary neurospheres from purified populations cultured in 
the presence of EGF/bFGF or EGF only (n=5, mean±SEM, **p<0.01, unpaired Student’s t-test). 





primary neurospheres of qNSCs and aNSCs cultured in EGF/bFGF (n=3, mean±SEM, *p<0.05, unpaired Student’s t-test). 
(E) Confocal images of differentiated primary and secondary neurospheres. All populations give rise to astrocytes 
(GFAP+), oligodendrocytes (O4+) and neurons (βIII Tubulin+). Scale bar: 10µm.!  
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Figure S6. Cell cycle and functional data of GFAP::GFP+only population, related to Figure 3 and Figure 5 
(A) Proportion of FACS-purified GFAP::GFP+only population that expresses Ki67 and MCM2 (n=3), and the fraction 
labeled after a single pulse of BrdU (light green) or after 14 days of BrdU in drinking water (dark green) (n=3 and n=4, 
respectively) (mean±SEM). 
(B) Percentage of βIII Tubulin positive cells in the Ki67+ fraction in GFAP::GFP+only population detected by double acute 
immunostaining (n=2, mean±SEM). 
(C) Label-retaining cell (LRC) fraction in the GFAP::GFP+only population 14 and 30 days of chase after 14 days of BrdU 
administration (n=4, mean±SEM).  
(D) Single cell colony formation efficiency of FACS-purified GFAP::GFP+only population in EGF/bFGF or EGF only in 
adherent conditions (n=3, mean±SEM). 
(E) Quantification of cell proliferation when purified cells are plated at clonal density (1.4 cell/µl) with EGF/bFGF or EGF 
only in floating conditions (n=5, mean±SEM). 
(F) Percentage of activating clones for primary, secondary and tertiary neurospheres from purified GFAP::GFP+only 
population cultured in the presence of EGF/bFGF or EGF only (n=5, mean±SEM, **p<0.01, unpaired Student’s t-test). 
(G-H) Representative FACS plots of purified GFAP::GFP+only population resorted immediately after isolation from the 
brain (G) and of primary neurospheres cultured in EGF for 12 days (H). 
(I) Neurosphere formation efficiency of purified GFAP::GFP+, GFAP::GFP+CD133+ and GFAP::GFP+CD133+EGFR+ cells 
from GFAP::GFP+only population derived primary neurospheres (in EGF/bFGF or EGF only, n=3, mean±SEM, *p<0.05, 
**p<0.01, unpaired Student’s t-test).!  
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Figure S7. Nestin-negative cells give rise to Nestin-positive cells in vitro and during regeneration in vivo, related 
to Figure 6 
(A-E) In vitro upregulation of Nestin in live cells.  
(A) Schema of the experimental design. CD133+Nes::OR-EGFR-CD24- and CD133+Nes::OR+EGFR+CD24- cells were 
isolated from the V-SVZ of adult Nestin::Kusabira Orange (Nes::OR) mice and plated for neurosphere formation.  
(B) Quantification of acute immunostaining for Nestin in CD133+Nes::OR-EGFR- and CD133+Nes::OR+EGFR+ populations 
(n=3, mean±SEM). 
(C-D) Fluorescent images of neurospheres after 6 days in culture from CD133+Nes::OR-EGFR- (C) and 
CD133+Nes::OR+EGFR+ (D) populations. All neurospheres were Nestin::Kusabira Orange positive. Note that the sphere 
from CD133+Nes::OR-EGFR- cells is much smaller. Scale bar: 200 µm. 
(E) Quantification of the efficiency of neurosphere formation from purified populations (n=3, mean±SEM).  
(F-I) Nestin-negative cells give rise to the SVZ lineage during regeneration in  GFAP::CreERT2;Rosa26tdTomato 
mice. 
(F) Schema of the experimental design. Recombination was induced in adult GFAP::CreERT2;Rosa26tdTomato mice by 
three tamoxifen injections 10 days before Ara-C treatment. Brains were harvested at day 0 or 6 days after terminating 
Ara-C  treatment (asterisks). Whole mounts were immunostained for Nestin (green) and doublecortin (blue).  
(G-H) Confocal images of z-stacks of whole mount preparations at 0 days and 6 days after Ara-C treatment. Radial 
tdTomato+ cells were all Nestin negative at 0d. Radial tdTomato+Nestin+ cells (white arrows) were detected at 6 days.  
(I) Confocal image of a whole mount preparation showing tdTomato expression (II, red) and immunostained for Nestin (III, 
green) and Doublecortin (IIII, blue) showing tdTomato+Nestin+cells (white arrow) and tdTomato+Doublecortin+ (open 
arrows) at 6 days after Ara-C removal. IIV is a merged image. Scale bar: 30 µm.  
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Figure S8. Gene expression profiling and targeted GPCR screen, related to Figure 7 
(A-B) Pie charts showing GSEA metabolism subgroups for qNSCs and aNSCs (first bars in Figure 7D) 
(C-D) Comparison of our microarray data with those of Beckervordersandforth et al. 2010. The expression of genes 
present in “genes enriched in adult NSCs in comparison to diencephalic astrocytes” (C) (corresponding to Table S5 from 
Beckervordersandforth et al., 2010) and “adult NSC-enriched genes” (D) (corresponding to Table S6 from 
Beckervordersandforth et al., 2010) lists was analyzed and genes subcategorized by enrichment in qNSCs and aNSCs, 
expression in both or not present (as defined by expression in raw data < 50 for no expression). Gene lists are in 
Supplementary Table S8. 
(E-J) qRT-PCR validation of microarray genes showing fold-change of Nestin (E), Dlx2 (F), Ascl1 (G), Dll1 (H), Vcam1 (I), 
and Lrig1 (J) in qNSCs and aNSCs populations relative to sorted total SVZ cells (as gated in S4C) (n=3, mean±SEM). 
(K) Schema of experimental design for the qNSC and aNSC GPCR ligand screen.  
(L) Plot of the fold change of qNSC activated Nestin+ clones. Compounds that were statistically significant are in red (n=3, 
mean±SEM, *p<0.05, unpaired Student’s t-test). Different shades of grey demarcate compounds in the same diluent, and 
open circles are controls.  
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SUPPLEMENTAL TABLE LEGENDS 
 
Table S1, related to Figure 7A  
Genes differentially regulated in qNSCs and aNSCs 
This table reports the lists of differentially expressed genes in qNSCs and aNSCs. 
 
Table S2, related to Figure 7B-C 
Gene Ontology categories for genes differentially regulated in qNSCs and aNSCs 
This table reports the lists of genes differentially expressed in qNSCs and aNSCs, grouped by GO categories. 
 
Table S3, related to Figure 7D 
GSEA sets for qNSCs and aNSCs 
This table reports all the GSEA sets for qNSCs and aNSCs and their link to the Broad Institute Database. 
 
Table S4, related to Figure 7 
Expression value and fold change of transcription factors previously reported to be important in neurogenesis 
This table reports the mean gene expression values for qNSCs and aNSCs (average of three replicates, ± standard 
deviation) and the fold change (positive and highlighted in red if upregulated in aNSCs, negative and highlighted in green 
if upregulated in qNSCs, color intensity indicates magnitude of fold change) for transcription factor genes previously 
reported to be involved in adult neurogenesis. 
 
Table S5, related to Figure 7 
Expression value and fold change of markers and factors previously reported to be important in neurogenesis 
This table reports the mean gene expression values for qNSCs and aNSCs (average of three replicates, ± standard 
deviation) and the fold change (positive and highlighted in red if upregulated in aNSCs, negative and highlighted in green 
if upregulated in qNSCs, color intensity indicates magnitude of fold change) for markers and factors previously reported to 
be involved in adult neurogenesis. 
 
Table S6, related to Figure 7E-F 
Comparison of qNSC- and aNSC-enriched genes and molecular signatures of long term/quiescent and short 
term/proliferative stem cells in other organs 
Tab1) Genes from the molecular signatures of long term/quiescent stem cells in other organs were included if they were 
enriched in qNSCs (more than 2-fold expression compared to aNSCs). Annotation is color-coded by the number of lists 
they were present in (purple=5; blue=4; light blue=3; green=2; black=1).  
Tab2) Genes from the molecular signatures of short term/proliferative stem cells in other organs were included if they 
were enriched in aNSCs (more than 2-fold expression compared to qNSCs). Annotation is color-coded by the number of 
lists they were present in (blue=4; light blue=3; green=2; black=1). 
Data are from the following articles: Ivanova et al., 2002; Venezia et al., 2004; Forsberg et al., 2010; Pallafacchina et al., 
2010; Powell et al., 2012; Blanpain et al., 2004: Fukada et al., 2007; Cheung and Rando, 2013. 
 
Table S7, related to Figure 7 
Expression levels of GPCRs in qNSCs and aNSCs. 
This table reports the expression levels in qNSCs and aNSCs for all the genes encoding G Protein Coupled Receptors. 
Genes that were enriched more than 10-fold in qNSCs (in bold) were selected for the small molecule screen. 
 
Table S8, related to Figure 7 
Comparison of our microarray data with those of Beckervordersandforth et al. (2010) 
The expression of genes present in “genes enriched in adult NSCs in comparison to diencephalic astrocytes” 
(corresponding to Table S5 from Beckervordersandforth et al., 2010) and “adult NSC-enriched genes” (corresponding to 
Table S6 from Beckervordersandforth et al., 2010) lists was analyzed and genes subcategorized by enrichment in qNSCs 
and aNSCs, expression in both or not present (as defined by expression in raw data < 50 for no expression). 
  
Supplemental Information – Codega et al., 2014 S11 
SUPPLEMENTAL EXPERIMENTAL PROCEDURES 
 
Immunostaining 
Whole mounts were fixed overnight in 3.2% paraformaldehyde, washed in PBS, incubated for 2 hrs in blocking solution 
(10% serum with or without Triton-X), incubated in primary antibodies in blocking solution for 24-48 hrs at 4ºC, washed 6 
times and incubated in secondary antibodies overnight. Whole mounts were then further dissected and the SVZ removed, 
prior to mounting in Aqua Polymount (Polysciences, Inc.), and imaged using a Zeiss LSM 510 or Leica TCS SP5 II 
confocal microscope. For acute immunostaining, FACS-purified populations were plated without mitogens on poly-D-
lysine coated 16-well Lab-Tek chamber slides (Thermo Scientific) for 2 hours, then fixed for 20 min with 3.2% 
paraformaldehyde. For EGF-ligand labeling, 0.5 µl of a 40 µg/ml of EGF-A647 (Invitrogen) was stereotaxically injected 
into the ventricle of deeply anesthetized mice 10 minutes before sacrifice as previously described (Pastrana et al., 2009). 
For BrdU labeling, mice were either injected intraperitoneally with 100 µl of 10mg/ml BrdU 1 hour before sacrificing or 
given BrdU in the drinking water (0.75% BrdU 1% glucose) for 14 days and sacrificed immediately, 14 or 30 days after 
stopping BrdU administration. Cells were FACS purified, acutely plated for 2 hours without mitogens and fixed. For BrdU 
detection, cells were treated with 2N HCl for 20 min at 37ºC, followed by 1 min 0.1M Boric Acid (pH=8.5), then washed in 
PBS and processed for immunostaining as above. 
 
Antibodies 
The following antibodies were used: rabbit anti-GFP (1:500, Invitrogen); sheep anti-GFP (1:200, AbD Serotec); mouse 
anti-GFAP (1:200, Millipore); rabbit anti-GFAP (1:500, DAKO); rat anti-GFAP (1:500, Invitrogen); rat anti-CD133 (1:100, 
Chemicon); mouse anti-β-Catenin (1:200, BD Bioscience); sheep anti-EGFR (1:50, Upstate); rabbit anti-EGFR (1:200, 
Millipore); rabbit anti-Ki67-A555 (1:100, BD Pharmingen); mouse anti-βIII Tubulin (Tuj1,1:500, Covance); rabbit anti-
S100β (1:1000, DAKO); guinea pig anti-GLAST (1:1000, Chemicon); guinea pig anti-GLT1 (1:200, Millipore); rabbit anti-
BLBP (1:100, Abcam); rat anti-BrdU (1:200, Accurate Chemical); goat anti-MCM2 (1:50, Santa Cruz Biotechnology); 
rabbit anti-Laminin (1:200, SIGMA); mouse IgM anti-O4 (1:500, Chemicon); mouse anti-Nestin (1:5, rat-401 DSHB); 
mouse anti-Acetylated Tubulin (1:2000, SIGMA); rabbit anti-Sox2 (1:200, Millipore); guinea pig anti-DCX (1:1000, 
Millipore). All staining was performed in PBS with 10% normal goat or donkey serum and 0.5% Triton X-100, except for 
EGFR staining (no Triton X-100). Secondary antibodies were used at 1:500 (Alexa fluor-conjugated, Molecular Probes) or 
1:200 (Cy- or DyLight-conjugated, Jackson ImmunoResearch Laboratories). 
 
FACS 
The SVZs from 2-3 month old heterozygous GFAP::GFP mice (The Jackson Laboratory), which express GFP under the 
control of the human GFAP promoter (Zhuo et al., 1997), or wild-type CD-1 mice (Charles River Laboratories) were 
dissected, digested with papain (Worthington, 1,200 units per 5 mice, 10 min at 37ºC) in PIPES solution (120 mM NaCl, 5 
mM KCl, 50 mM PIPES (SIGMA), 0.6% glucose, 1x Pen/Strep (Gibco) in water, pH adjusted to 7.6) and mechanically 
dissociated to single cells after adding ovomucoid (Worthington, 0.7 mg per 5 mice) and DNAse (Worthington, 1,000 units 
per 5 mice). Cells were centrifuged for 10 min at 4ºC without brakes in 22% Percoll (SIGMA) to remove myelin and 
incubated for 15 min with PE-conjugated rat anti-mCD24 (1:1000; BD Pharmingen), A647-complexed EGF (1:300; 
Molecular Probes) and biotinylated rat anti-mCD133 (1:300, clone 13A4, eBioscience), washed by centrifugation and 
incubated for 15 min with PE-Cy7-conjugated streptavidin (1:1000; eBioscience). All stainings and washes were carried 
out on ice in 1% BSA, 0.1% Glucose HBSS solution. To assess cell viability, 4’,6-diamidino-2-phenylindole (DAPI; 1:1000; 
SIGMA) was added to the cells before sorting. All cell populations were isolated in a single sort using a Becton Dickinson 
FACS Aria II using 13 psi pressure and 100-µm nozzle aperture. Cells were collected in neurosphere medium (details 
below) without growth factors. Gates were set manually by using control samples (Fig. S2). Data were analyzed with 
FlowJo 9.3 data analysis software and displayed using biexponential scaling. For the Nestin-Kusabira Orange FACS, 
isolated cells were processed as described above and purified using the following markers: CD24-FITC (1:500), Nestin-
Kusabira Orange, EGF-A647 (1:300), biotinylated CD133 and PE-Cy7 conjugated streptavidin (1:300 and 1:1000, 
respectively). CD133+Nes::OR-EGFR- and CD133+Nes::OR+EGFR+ were gated from the CD24 negative population. 
 
In vitro assays 
For single cell assays, one cell per well of each sorted population was manually plated into 96 well plates previously 
coated with Poly-D-Lysine (Sigma, 10 µg/ml) and Fibronectin (Sigma, 2 µg/ml). Cells were grown in Neurosphere (NS) 
medium, composed of DMEM/F12 (Life Technologies) supplemented with 0.6% Glucose (Sigma), 1x Hepes (Life 
Technologies), 1x Insulin-Selenium-Transferrin (Life Technologies), N-2 (Life Technologies) and B-27 (Life Technologies) 
supplement in the presence of 20 ng/ml EGF (Upstate) or 20 ng/ml EGF and 20 ng/ml bFGF (Life Technologies). For 
proliferation assays, each sorted population was centrifuged after FACS for 10 min at 1300 rpm at 4ºC and seeded in NS 
medium at a density of 700 cells/well in 500 µl of medium (density of 1.4 cell/µl) in 24 well plates. To assess FACS sorting 
efficiency, cells were counted in a control well and this value was used to normalize cell number across the plate. For 
quantification of activated clones, cells were counted 2 days after plating and clusters of two or more cells with large, 
bright, refractant cytoplasm were counted as activated clones. For neurosphere passaging at all cell densities, the total 
content of each well was collected and dissociated with 3 mg (600 units) of papain for 10 min at 37ºC. The reaction was 
stopped by adding ovomucoid inhibitor (Worthington, 0.7 mg). DNAse (Worthington, 0.5 mg) was added and cells 
dissociated to single cells by pipetting. Live dissociated cells were counted incubating with Vybrant dye (Invitrogen, 
1:1000) at 37ºC and plated at a density of 700 cells/well in 500 µl (density of 1.4 cell/µl) in 24 well plates for 6 days. For 
total cell number counts (live and dead), the cell suspension was plated and incubated 30 min at 37ºC with Vibrant Dye 
and DAPI (both at 1:1000) and total cells were counted. For differentiation assays, neurospheres were plated in adherent 
conditions in a 16-well chamber coated with poly-D-Lysine (Sigma, 0.01 mg/ml) and Laminin (Invitrogen, 10 µg/ml) with 
NS medium alone without B-27 supplement and growth factors for 7 days. For flow cytometry of neurospheres, 
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neurospheres were collected and dissociated with papain, immunostained with antibodies and sorted at the flow 
cytometer as described in the FACS methods section. 
 
Lineage Tracing 
For lineage tracing experiments, GFAP::CreERT2 mice (Ganat et al., 2006, The Jackson Laboratory) were crossed with 
Rosa26tdTomato mice (Madisen et al., 2010, The Jackson Laboratory) to generate GFAP::CreERT2;Rosa26tdTomato mice. 
Tamoxifen (10 mg/ml, Sigma) diluted in 90% oil and 10% ethanol was I.P. injected into adult 
GFAP::CreERT2;Rosa26tdTomato mice (33mg/kg). 
 
Bioinformatic analysis 
Normalization, quality control, differential expression, and gene ontology analysis were carried out using Genespring GX 
11. Differentially expressed probesets were filtered by average expression level greater than 50 in at least 1 population, at 
least 2-fold differential expression and corrected p-value less than 0.05 by Benjamini-Hochberg multiple testing correction. 
GO categories were obtained with p-value less than 0.05. GSEA sets with FDR (q value) < 0.05 were hand-curated into 
thematic categories to highlight transcriptional differences between populations. Analysis was carried out with GSEA 
software from the Broad Institute, using MSigDB v3.0. 
 
Cloning 
The mP2-mCherry plasmid was generated by cloning the mouse P2 element, homologous to the human P2 element 
(Shmelkov et al., 2004), of the Prominin1 promoter into the CherryPicker control vector (Clontech), using the XhoI and 
AgeI digestion sites. The following primers were used to amplify the mP2 element by PCR from mouse genomic DNA:  
FOR: ACTCTCGAGGGTCCAATCAGTGCGCTCAGAC  REV: ATGACCGGTCCTCTCCGGTCCAGCTCTCCT 
 
GPCR compounds screen 
The following compounds were tested (final concentration is noted): 
Sphingosine-1-phosphate    1µM as in Im et al. 2001, reconstituted in PBS, Tocris 
1-Oleoyl lysophosphatidic acid sodium salt  100nM as in Hecht et al. 1996, reconstituted in PBS, Tocris 
Adenosine     10µM as in Hill et al. 2013, reconstituted in DMSO, Tocris 
Neuropeptide Y     1µM as in Weng et al. 1995, reconstituted in water, Tocris 
Histamine dihydrochloride    100µM as in Liu et al. 2001, reconstituted in water, Tocris 
Endothelin 1     1µM as in Maguire and Davenport 1995, reconstituted in water, Tocris 
Leukotriene D4     1µM as in Lynch et al. 1999, reconstituted in MeOH, Sigma 
(-)-Epinephrine  10µM as in Shibata et al. 1995, and Jasper et al. 1998, reconstituted in 
HCl, Sigma 
(-)-Norepinephrine  10µM as in Shibata et al. 1995, and Jasper et al. 1998, reconstituted in 
HCl, Sigma 
Amylin      1µM as in Armour et al. 1999, reconstituted in water, Tocris 
L-CCG-I      10µM as in Johnson et al. 1999, reconstituted in NaOH, Tocris 
Neurotensin     1µM as in Cusack et al. 2000, reconstituted in water, Tocris  
R-spondin1     100nM as in Carmon et al. 2011, reconstituted in water, Sigma 
α-Latrotoxin     1nM as in Krasnoperov et al. 1997, reconstituted in water, Enzo LifeSci 
Proinsulin C-Peptide    1nM as in Yosten et al. 2013, reconstituted in PBS, Sigma  
Orexin A      10µM as in Sakurai et al. 1998, reconstituted in water, Sigma 
Neurokinin A     1µM as in Gether et al. 1992, reconstituted in water, Tocris 
Prosaptide     1µM as in Meyer et al. 2013, reconstituted in 1%NH4OH, Anaspec Inc 
Serotonin Hydrochloride    1µM as in Boess et al. 1997, reconstituted in water, Tocris 
GRF      100nM as in Katsushima et al. 2013, reconstituted in water, Sigma 
Secretin      100nM as in Ganguli et al. 1998, reconstituted in water, Tocris 
Prostaglandin D2     1µM as in Sugimoto et al. 2005, reconstituted in PBS, Sigma 
 
qRT-PCR 
RNA was purified from FACS sorted populations by the miRNeasy kit (Qiagen) and cDNA was generated using WT-
Ovation Pico System (NuGEN). The total SVZ sample consisted of all live cells (as gated in Figure S3C). For qRT-PCR, 
all reactions were carried out in duplicate on 4 biological replicates using Brilliant III Ultra Fast SYBR Green QPCR Master 
Mix (Agilent) in a Stratagene Mx3000P machine with an annealing temperature of 60ºC. Data was normalized to GAPDH 
expression and analyzed by the 2-ΔΔCt method. 
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